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South Africa has the largest HIV/AIDS epidemic in the world and due to the rapid scale up of 
access to antiretroviral drugs now has the largest antiretroviral program in the world. 
However access to antiretroviral treatment remains a challenge and the scale up of the drug 
programs has caused an additional burden on an already stretched and stressed public 
healthcare sector.  
 
At present there are only two lines of drug regimens available to the general public that rely 
on the public healthcare sector for the supply of their antiretroviral drugs. Resistance to the 
current regimens is a major concern that is not effectively being addressed. One of the major 
aspects that can contribute to a rise in resistance is barriers to continually accessing 
antiretroviral treatment. 
 
This ethnographic investigation into the barriers to accessing antiretroviral treatment was 
conducted in a public health sector clinic based at a large hospital in Durban. The specific 
objectives of the study were to elucidate the major barriers to accessing the treatment as 
perceived by the patients of the clinic, to understand the structural drivers behind the barriers 
and to capture the patients’ reactions to these obstacles that they face on a continuous basis.   
 
Unlike most studies that focuses only on adherence this study’s focus was rather on the 
concept of access to healthcare and how barriers perceived by the patients influence their 
ability to effectively access their treatment. Thus the concept of access to healthcare is 
explored in detail and an argument is made for the importance of understanding and applying 




An ethnographic approach was adopted to conduct this study, and the study utilized a 
triangulation of data collection techniques including participant observation, in-depth 
interviews, focus groups and a questionnaire. The research was done over a period of seven 
months and focused on adults who were already part of a regimen for a period of at least one 
year. 
 
Antiretroviral treatment regimens are for life and once people start with these regimens they 
cannot stop. However this study found that a range of barriers exist that present obstacles for 
patients to continually access ART drugs. Structural violence theory provided the framework 
for contextualizing the specific barriers that were reported and is important in terms of 
situating the barriers within the larger structures that create them. What is evident is that poor 
healthcare related policies, stigma, discrimination, economic inequality, gender and poverty 
are the structural drivers behind barriers to accessing ART. By incorporating a broader 
understanding of access to healthcare a deeper understanding of the barriers is gained and 
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CHAPTER ONE: Introduction 
 
“It does not matter how many people can access treatment if we cannot keep them alive 
and receiving treatment” (Michel Sibide in UNAIDS, 2012: 11).  
 
1.1) An Overview of the HIV/AIDS Pandemic 
 
In 1981 the first four reported cases of Acquired Immune Deficiency Syndrome (AIDS) were 
documented in the United States of America. Initially thought to be a disease that only 
affected homosexual males, AIDS has become the plague of our modern times (Oldstone, 
2010, Shilts, 1987). In 1983 the virus that caused AIDS, known as the Human 
Immunodeficiency Virus (HIV) was isolated and identified. Despite the discovery of a new 
virus the response to the new disease by governments, institutions and civil society was slow 
and mirrored the pathological latency of the virus itself (Shilts, 1987, Barnett and Whiteside, 
2006). By the time governments and institutions took notice of what was happening it was 
too late; the virus that was thought to only occur in an isolated group was now also reportedly 
infecting the general population and was on its way to developing into the pandemic it is 








1.2) Epidemiology: From Global to Local 
 
Thirty years after the first reported cases in Los Angeles, USA, there is no country in the 
world that is not affected by this devastating disease (Barnett and Whiteside, 2006, Abdool 
Karim and Abdool Karim, 2010). More than 60 million people across the world from all 
races, economic sectors and cultures have been infected with the virus and nearly half of 
those have died due to AIDS related illnesses (Abdool Karim et al., 2010, UNAIDS, 2012)
1
. 
Globally women comprise half of all people living with HIV (49%) and it is the leading cause 
of death for women between the ages of 15 and 49 years worldwide. It is estimated that one 
young women is infected with HIV every minute (UNAIDS, 2012). 
 
Sub-Saharan Africa has a generalized epidemic. The main mode of transmission remains a 
predominantly heterosexual epidemic with unprotected sex, multiple concurrent partners, 
gender inequalities, poverty, mother to child transmission, and high levels of stigma and 
discrimination identified as key drivers behind the region’s epidemic (UNAIDS, 2012). 23.5 
million people of the global total of 34 million people infected with HIV live in sub-Saharan 
Africa but the region only holds 10 % of the world’s total population (UNAIDS, 2012). This 
area remains disproportionately affected by the disease and continues to have the highest 
prevalence, incidence and mortality rates due to HIV infection on the global stage. More than 
17 million people have already died in this region due to AIDS related diseases and most of 
all the new infections worldwide occurred in this region in 2011, with 1.5 million new 
infections occurring that year alone (UNAIDS, 2012). Women continue to be unevenly 
affected in this region where 6 out of 10 infected individuals are female, comprising an 
estimated 59%, which is significantly higher than the global trend of 49%. 92% of all 
pregnant women infected with HIV live in this region (UNAIDS, 2012). 
                                                 
1
 UNAIDS: Joint United Nations Programme on HIV/AIDS 
3 
 
South Africa, considered to be the epicentre of the pandemic within the sub-Saharan region, 
similarly has a generalized epidemic with heterosexual transmission being the dominant form 
of infection followed by mother to child transmission. The country has the largest HIV 
epidemic in the world with an estimated 5.6 million people living with HIV/AIDS (PLWHA) 
(UNAIDS, 2012). The estimated prevalence rate for the general adult population is 17% and 
the antenatal prevalence rate has levelled off at an estimated 30%. An estimated 380 000 new 
infections occurred during the 2011-2012 year and the annual number of deaths due to AIDS 
related illnesses was 270 000 people during the same period (NDOH, 2012)
2
. Women, in 
South Africa like in sub-Saharan Africa, remain disproportionately affected by the disease 
and comprise more than half of all people living with HIV/AIDS. The age group 30-34 years 
shows the highest antenatal prevalence rate of 42.6% (NDOH, 2012).  
Key drivers behind HIV transmission in South Africa are intergenerational sex, multiple 
concurrent partner, low condom use, alcohol use, and low rates of male circumcision 
(NDOH, 2012, Van Dyk, 2012) . A significant statistic is the difference in age prevalence 
categories for women and men where women tend to become infected at a younger age than 
men (Abdool Karim and Abdool Karim, 2010).    
The province of KwaZulu Natal (KZN), the province in which this study was conducted, is 
particularly affected by the epidemic. An estimated 38% of women attending antenatal 
classes in KZN are infected and the province is home to an estimated 1 600 000 people living 
with HIV, the largest epidemic in the country (NDOH, 2012, Abdool Karim and Abdool 
Karim, 2010). Prevalence is highest in KZN amongst the adult population aged 15-49 years 
where prevalence is estimated to be at 39.5% (NDOH, 2012).  
 
                                                 
2
 NDOH: National Department of Health  
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1.3) HIV/AIDS Prevention and Treatment: The Global Perspective 
 
 
According to Barnett and Whiteside (2006) there is no sector in the global and local society 
that has not been affected by the HIV/AIDS epidemic. The widespread devastation of the 
disease has resulted in a global response to curb the pandemic. The epidemic is being 
challenged on two fronts; by prevention, and by treatment.  
Like all sexually transmitted diseases, HIV infection is in theory totally preventable. Correct 
and consistent condom use, it has exhaustively been argued, is highly effective in preventing 
the transmission of HIV infection (Myer in Abdool Karim et al., 2010, Van Dyk, 2012), yet 
new infection rates remain high, especially in sub-Saharan Africa where there is a relatively 
low condom use rate (Van Dyk, 2012). Despite the limited success of male condoms, 
behaviour change strategies have constantly been heralded as key in fighting HIV/AIDS on a 
global level (UNAIDS, 2012) The most popular prevention strategy is known as the ABC of 
HIV prevention. The acronym stands for A to be abstinent, B to be faithful to one partner, 
and C to condomise if being faithful to one partner (B) is not a viable option (Epstein, 2007).  
Although the ABC campaign had potential by sending an informative message to people on 
how to protect themselves from HIV infection, the campaign has largely failed, especially in 
sub-Saharan Africa (Epstein, 2007). The Global HIV Prevention Working Group (2007) 
noted that: “We should be winning in HIV prevention. There are effective means to prevent 
every mode of transmission; political commitment on HIV has never been stronger; and 
financing for HIV programs in low-and middle-income countries increased six-fold between 
2001 and 2006. However, while attention to the epidemic, particularly for treatment access, 
has increased in recent years, the effort to reduce HIV incidence in faltering” (Global HIV 
Prevention Working Group in Boler and Archer, 2008: 46).  
5 
 
Some of the contributing factors to the failure of prevention campaigns in sub-Saharan Africa 
include poverty, gender-based violence, stigma, and the generalized nature of the epidemic in 
the region (Leclerc-Madlala, 2009). The generalized nature of the epidemic makes it difficult 
to identify ‘risk groups’ who engage in ‘risky sexual behaviour’, as defined by UNAIDS and 
WHO
3
, since most individuals who are engaged in long-term concurrent relationships do not 
perceive their behaviour to place them at risk for infection since they do not identify with the 
definitions of risk groups (Boler and Archer, 2008, Epstein, 2007). In addition the term ‘risk 
group’ coined by epidemiologists has become a taboo category in HIV/AIDS discourse 
because of the stigmatising nature of the externally imposed category and the repercussions 
of imposing the category upon certain groupings, such as, sex workers and individuals 
engaged in sexual networks. Stigma thus has negated the possibility of individuals identifying 
themselves as being a ‘risk group’ and has severely impacted upon prevention efforts. 
However, despite the problems inherent in prevention campaigns, long-term concurrent 
relationships remain the greatest contributor to the spread of HIV in this region (Epstein, 
2007, Leclerc-Madlala, 2009).        
While prevention efforts have experienced only limited success, the emphasis on 
antiretroviral treatment (ART)
4
 has changed the course of the epidemic by changing a death 
sentence into a chronically manageable disease. In 1987 Zidovudine (AZT) was the first 
antiretroviral drug to show clinical benefits against the virus (Abdool Karim and Abdool 
Karim, 2010). Mono-drug therapy 
5
 showed short term benefits but it became clear after 
further drug trials that mono-therapy was not sufficient, as the levels of mortality and 
                                                 
3
 WHO: World Health Organisation 
4
 ART: Antiretroviral Therapy refers to the class of drugs used to treat HIV-infection. 
5
 Mono-drug Therapy: Using only one ART drug. This was the treatment at the beginning of ART and the drug 
most commonly used was Zidovudine (AZT). Mono-drug therapy has now been shown to be ineffective and as 
contributing to drug-resistance. It should not be used under any circumstances.  
6 
 
morbidity did not improve significantly (Wood, 2010). Dual-drug therapy 
6
 in a similar vein 
did not show much improved clinical efficacy either. Initially the stance was to ‘hit early- hit 
hard’ with the mono-therapy regimens but the HI virus quickly mutated and soon resistant 
strains to mono and dual therapy drugs were encountered. Over time longitudinal studies 
showed that high levels of toxicity were reported without much clinic benefit such as 
increased mortality and morbidity rates and decreased CD4+T-cells
7
 (CD4) cell counts 
(Abdool Karim et al., 2010). Several years later in 1995 Highly Active Antiretroviral Therapy 
(HAART) 
8
showed to have effective clinical results and the triple use of drug classes were 
recommended as treatment for those infected with the HI-virus (Wood, 2010, WHO, 2013).  
In 1995 the WHO recommended that patients should be commenced on ART at a CD4 count 
level of 500 cells/mm
3
 and less and that the use of triple combination therapy (HAART) 
should be the standard care of treatment for HIV infection (Wood in Abdool Karim, 2010). 
These guidelines are produced by the WHO to standardize treatment regimens but are better 
suited to an individualistic treatment plan, such as those in so-called developed countries. In 
countries, like South Africa, where generalized care is the standard treatment plan for all the 
citizens of the country who utilize the public healthcare sector, the individualistic treatment 
regimens of the ‘developed nations’ are ill suited. The major reason behind this situation is 
the cost factor. Before ART was made available in South Africa to the general public, the 
South African government cited that the lack of funding prevented the acquisition of ART 
drugs, and therefore ART drugs were not available to the general public (Govender, 2009).    
                                                 
6
 Dual-drug Therapy: This refers to two classes of ART drugs being used. Like Mono-drug Therapy it was 
ineffective and contributed to resistance. It is now used only for prevention of mother to child transmission. 
7
 CD4+T-cells count is the measure of the immunological response to HIV infection. The CD4+T-cells are the 
main cells responsible for initiating an immune response to infections and pathogens in the immune system. 
They are the cells most affected by the HI-virus that causes a depletion of CD4+T-cells (Abdool-Karim 2012).    
 
8
 Highly Active Antiretroviral Therapy (HAART): This is the current ART therapy that has been shown to be 
most effective in treating HIV infection. It is the combination of three or more classes of antiretroviral drugs that 
work together.   
7 
 
In South Africa the CD4 count level was initially set at 200 cells/mm
3
 but was changed in 
2011 to 350 cells/mm
3
 and less for adult patients (NDOH, 2013). This change in the CD4 
count level greatly improved the accessibility of ART drugs by the general population. ART 
is a lifelong commitment by both the person needing the drugs and by the healthcare system 
providing the service. For this reason when commencing treatment careful attention is paid to 
the person’s willingness and readiness to commit to lifelong treatment (WHO, 2011, Van 
Dyk, 2012). To start a patient on ART is a lengthy and complicated process and is never 
considered as an emergency, except in cases of post-exposure prophylaxis (NDOH, 2013, 
Van Dyk, 2012). To be considered for ART the patient must meet the clinical indicators of 
WHO staging, laboratory markers, psychosocial factors, have access to laboratory facilities 
and have access to health care services for the treatment of opportunistic infections and side 
effects of the drugs (NDOH, 2013).  
The “3 by 5” Initiative was the first plan implemented in 2003 by the World Health 
Organization and UNAIDS as a collective global response to combat the devastating effect 
that the HIV/AIDS epidemic had caused across the world. The “3 by 5” Initiative laid the 
foundations for the global reaction and effort that would be required to get all those eligible 
for ART onto treatment (UNAIDS et al., 2011). The main objective set by the “3 by 5” 
Initiative was to get 3 million people onto ART by 2005. At this stage, in 2003, only 400 000 
people in low and middle income countries had access to ART. By the end of 2005 1.4 
million people were receiving ART globally. While the nations
9
 who had committed to the 
challenge of Universal Access fell short of achieving this goal lessons were learnt especially 
about service delivery of the drugs to low and middle income countries as well as the 
economic and political effort that would be required to provide treatment for those who need 
it (UNAIDS et al., 2011).  
                                                 
9
 Nations: these include the Member States of the United Nations. 
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Universal Access to ART is one of the main goals set by The World Health Organization and 
the United Nations Joint Programme on HIV/AIDS (UNAIDS) and is a central concern for 
the Millennium Developmental Goal Number 6 to combat HIV/AIDS, malaria and other 
diseases (UN, 2013, UNAIDS et al., 2011). The Millennium Development Goals (MDG) 
were established and accepted by all member states of the United Nations in the year 2000. 
The goal to combat HIV/AIDS has two broad targets: to increase access to ART and have 15 
million people who require ART on treatment by 2015; and to halt new infections and reverse 
the spread of the disease by the same year (UN, 2013).      
In 2010 The Treatment 2.0 Initiative was launched by the WHO and UNAIDS to continue 
with the effort to reach the targets set by the MDG Goal 6. Five key pillars were established 
namely: to create a better ART pill and diagnostics; to use treatment as prevention especially 
in the prevention of mother to child sector; to stop health care and treatment costs from being 
an obstacle; to improve HIV testing and linkage to care; and to strengthen community 
mobilization to better reach key risk populations and assist them to access ART and care 
(UNAIDS and WHO, 2011, UNAIDS et al., 2011). In 2010 more than 6.65 million people 
were receiving ART and by 2012 the number had increased to more than 8 million people 
(UNAIDS, 2012). But with 2.5 million new infections in 2011 and an increase in the 
eligibility criteria to commence on ART for specific populations, such as pregnant women 
who are positive, this target seems to be shifting (UN, 2013).   
The Global Health Sector Strategy on HIV/AIDS 2011-2015 implemented by the WHO and 
UNAIDS was endorsed by all member states in 2011. It stipulates the next steps that should 
be taken to begin the reversal of the epidemic in the next five years and to get all those 
eligible for ART onto treatment. The main vision guiding this plan is to achieve zero new 
infections; zero AIDS-related deaths; and zero discrimination towards PLWHA (WHO, 
2011). The four main strategies proposed by the Global Health Sector Strategy on HIV/AIDS 
9 
 
2011-2015 include: optimizing HIV prevention, diagnosis, treatment and care; leveraging 
broader health outcomes through HIV responses; building strong and sustainable health and 
community systems; and reducing vulnerability and removing structural barriers to accessing 
services (WHO, 2011, UNAIDS et al., 2011).  
Treatment 2015 is the latest framework created by the WHO and UNAIDS to reach the MDG 
Goal 6 of having halted all new infections and to have all those eligible for ART on treatment 
within the next thousand days. It also lays the foundation for achieving zero new infections, 
zero AIDS related deaths and zero discrimination (UNAIDS, 2013). The priority now shifts 
towards greatly increasing access to treatment. However, the goal post keeps moving for the 
member states, especially the developing countries who face economic restraints, as the latest 
WHO guidelines on The Use of Antiretroviral Drugs for Treating and Preventing HIV 
Infection recommends an increase of the CD4 count to 500 cells/mm
3
 resulting in greatly 
increasing the number of people living with HIV who are eligible to start treatment, but with 
the result of fewer AIDS related deaths (WHO, 2013, WHO, 2011, UNAIDS, 2013) .   
Antiretroviral Treatment halts the progression of HIV infection into AIDS, and therefore has 
the potential to turn a life-threatening infectious disease into a chronic, manageable one. ART 
is life-long therapy and the initiation of drugs is only one of the first steps in access to 
treatment and care. Expanded access to ART has resulted in an increased number of people 
living with HIV for longer. In 2012 the global total of people living with HIV/AIDS was 
estimated to be more than 34 million. This is the largest number of people living with the 
disease since the start of the epidemic (UNAIDS 2012). The increased access to ART has 
decreased the mortality rate
10
 due to AIDS. The total estimated number of deaths due to 
AIDS related causes was 1.7 million people in 2011 worldwide as compared to a peak in 
                                                 
10
 Mortality rate:  This is the number of deaths due to AIDS divided by the number of people at risk, multiplied 
by 1000, as mortality rates are taken per 1000 people of the population.  
10 
 
2005 at 2.3 million deaths, but it still remains one of the leading causes of death due to an 
infectious disease worldwide (UNAIDS 2012).  
 
1.4) South Africa and Antiretrovirals  
 
According to the Constitution of the Republic of South Africa (see The Constitution of the 
Republic of South Africa Act 108 of 1996) all citizens have a right to access health care 
services. To gain access to antiretroviral drugs, activists, and specifically the Treatment 
Action Campaign (TAC), protested until the government finally relented and started 
supplying antiretroviral therapy in 2004. Roll-out of ART to the general population began in 
2004 when the National Department of Health began providing ART to adults, adolescents 
and pregnant women with a CD4 count of less than 200cells/mm
3
 or a World Health 
Organization (WHO) stage IV AIDS defining illness
11
, irrespective of CD4 count (DOH, 
2004). 
Access to treatment has been drastically scaled-up over the past couple of years. On 1 
December 2009 President Jacob Zuma announced the change in policy that would allow all 
pregnant women and people co-infected with tuberculosis (TB) who have a CD4 count below 
350cells/mm
3
 to be commenced on ART. In April 2012 it was announced that in accordance 
with the World Health Organizations’ recommendation, all patients with a CD4 count below 
350cells/mm
3





should be fast tracked
12
.  
                                                 
11
 WHO staging of AIDS defining illness: The WHO established clinical stages in which to classify HIV 
disease. Each progressive stage is an indication of severity of infection and decreased chances of survival. See 
Appendix 1 for the staging classification tables.  
 
12
 Fast tracked: This refers to the procedure that patients have to undergo to start ART. The usual waiting period 
for a person who is eligible for ART is two weeks or more. Those individuals who have a CD4 cell count of 
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On 1 April 2013 new South African Antiretroviral Treatment Guidelines were implemented 
in an effort to further expand access to ART. The new guidelines established the procedure to 
implement the new Fixed Dose Combination (FDC) tablets and entailed a revision of 
eligibility criteria (NDOH, 2013). CD4 cell count remained at 350cells/mm
3
, but WHO 
clinical staging now includes stage III and IV infection regardless of CD4 cell count along 
with drug sensitive and drug resistant TB infection. The most significant change came for 
pregnant women. Pregnant women with a CD4 cell count of 350cells/mm
3
 and below are 
eligible for lifelong ART which should be commenced on the day of HIV diagnosis while 
those with a CD4 cell count greater than 350cells/mm
3
 will also be started on ART but their 
regimens will only last for as long as they are breastfeeding (NDOH, 2013).  
Currently there are only two ART regimens available to people who utilize the public health 
care system (Van Dyk, 2012, NDOH, 2013). If patients develop resistance due to treatment 
failure, for whatever reason, referral to a specialist is indicated as the route to follow (NDOH, 
2013). However, there are only a few HIV specialists available and these doctors are located 
in the private health care sector or in tertiary hospitals that are far from the rural public health 
clinics (NDOH and HST, 2012). 
As a result of these expanded eligibility criteria together with drastic turnabout in terms of 
ART policy, South Africa now has the largest anti-retroviral programme in the world with 
approximately 1 500 000 people receiving treatment at the end of 2012 (UNAIDS, 2013, 
UNAIDS, 2012).   
The increased workload of the HIV/AIDS epidemic on the public health care sector is well 
documented (Barnett and Whiteside, 2006, Abdool Karim and Abdool Karim, 2010, Zelnick 
and O'Donnell, 2005). According to the National Health Care Facilities Audit in 2012, 82.5% 
                                                                                                                                                        
200cells/mm
3
 or less, Stage IV WHO defining illness regardless of CD4 count, any Tuberculosis infection, and 
pregnant women eligible for lifelong ART should start treatment within two weeks.  
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of South Africa’s total population utilizes the public health care sector as their primary health 
care facility with only 17.6% of the population using private medical care (NDOH and HST, 
2012). This imbalance of healthcare service utilization has resulted in the public healthcare 
sector bearing the majority of the HIV/AIDS workload (Barnett and Whiteside, 2006). The 
rapid expansion of the ART program has resulted in an increase in the work and patient load, 
and has placed additional financial strain on the health care budget (Barnett and Whiteside, 
2006). Clinics have been particularly affected by this and are struggling to meet the targets 
set by National Government, UNAIDS and WHO in the plan to address the HIV epidemic by 
having 3 million people who are eligible for ART on treatment by 2016 (NDOH, 2012). This 
figure stipulated by the National Department of Health (NDOH) translates to nearly double 
the current number of people on treatment to be commenced on ART within the next two 
years.  
 
1.5) Access to Health care and its related Barriers 
 
In her address to the 64
th
 World Health Assembly in April 2011 Margaret Chan, the Director-
General of the World Health Organization, said that “at a time of multiple calamities in the 
world, we cannot allow the loss of essential medicines, essential cures for many millions of 
people, to become the next global crisis” (Chan in Rossouw et al., 2013: 5). This warning 
gives rise to the need to expand the limited use of the definition of access to HIV/AIDS 
health care beyond the availability of drugs, and by doing so to incorporate a more holistic 





Merten el al., (2010) note that : “Although it has been shown that adherence (to ART) in SSA 
(sub-Saharan Africa) can be comparable or even superior to that in Western countries, 
retention in programs still poses problems” (Merten et al., 2010). Much of the success 
achieved in scaling up the availability of ART over the next couple of years will depend on 
whether continuous access to ART can be maintained at levels high enough at the local 
setting to significantly decrease deaths due to AIDS-related diseases.  
Access to health care is a complex concept that involves five main dimensions, namely: 
availability, accessibility, affordability, acceptability, and accommodation (Penchansky and 
Thomas, 1981). The barriers to accessing ART related health care can be classified into four 
main categories, namely: physical, organisational, social, and economic barriers. The five 
dimensions and the related barriers are often interlinked and overlap in their definitions and 
operationalization. This has, in much of the literature, erroneously led to the synonymous use 
of the five dimensions with each other and with the term access to health care; as well as to 
the overlap in the usage of the terms of the identification of barriers to accessing ART 
healthcare with barriers to adherence to antiretroviral drugs.   
Much focus has been placed on adherence to ART in the literature to reflect whether people 
are taking their drugs or not, and adherence is often used as a measure to indicate that 
treatment is now more accessible. However the term adherence is limited in its definition, 
since it is focused on individual behaviour and ability to comply with the prescribed drug 
regimen (Hardon et al., 2006). Adherence to ART is considered a personal patient 
perspective, since it involves the individual patient’s reaction to the drug regimen that the 
patients receive. The WHO defines adherence as: “the extent to which a person’s behaviour – 
taking medication, following a diet, and/or executing lifestyle changes, corresponds with 
agreed recommendations from a health care provider”.(WHO, 2003: 3). Considering this 
definition it then becomes clear that adherence forms part of the larger concept of access to 
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healthcare, and falls under the user characteristics of access and the perceived need, adopting 
the ‘sick role’ and agreeing to care and instruction of the health care provider. While 
adherence remains an important concept it merely is the end point of access to ART 
healthcare services (Posse et al., 2008).   
In the HIV/AIDS setting the scale up of accessing ART drugs has expanded rapidly over the 
past couple of years and is often used in the context of availability of antiretroviral drugs (van 
Dyk, 2010). While it is true that antiretroviral drugs are more available it does not necessarily 
mean that access to HIV/AIDS related treatment and care has scaled up. There is an overlap 
of identified barriers to adherence and access to health care in the literature. The argument 
made in this study is that the confusion and overlap between access and adherence is 
occurring because proper attention is not being given to the actual definitions of these two 
very important concepts. However, barriers to accessing ART does impact on adherence as 
Mukherjee et al., (2006) found it their study about barriers to accessing ART in resource poor 
settings. According to these actors the larger structural barriers and factors present in society 
play a larger role in discontinuation or interruption of treatment than individual patient 
factors (Mukherjee et al., 2006). 
Van Dyk (2010) identified four main barriers to adherence, namely: the treatment regimen, 
environmental and service related constraints; patient centred barriers; and the relationship 
with health care workers. Although van Dyk (2010) mentioned all four of these as barriers to 
adherence, it should perhaps be recognised that environmental and services related 
constraints along with the relationships with health care workers speak more to the 
dimensions of access to health care and are perhaps better defined as barriers to accessing 
care, rather than barriers to adherence.  
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The distinction is important since the factors that influence access are usually embedded 
within the larger social structure within which the patients live and the health care service is 
situated, and therefore the patients have very limited control over these aspects. Personal 
barriers such as alcohol consumption or injection drug use that lead to non-adherence are 
personal factors that the patient can address (van Dyk, 2010). However service related factors 
such as stock short outs or discrimination from health care workers are beyond the control of 
the patient, and therefore to categorize a patient as non-adherent due to these causes is not 
just.  
Adherence is a measurable entity and the result of non-adherence is the development of 
resistance to ART. However, measuring adherence is complicated and not exact as it is 
embedded within the biomedical paradigm which is not adept to consider the larger context in 
which the concepts of health and access to health care are situated, or the barriers that affect 
these concepts. Techniques for measuring adherence include: pill counts, interviews, self-
reporting, pharmacy records, monitored computerized medication caps, and using biological 
markers such as viral load
13
 testing (Reda and Biadgilign, 2011, WHO, 2003). In resource 
poor countries like South Africa, computerized caps are not available because it is such an 
expensive tool (Stott et al., 2013). Viral load monitoring is also expensive but is 
recommended as the technique to measure adherence. However, due to the expense and 
specialised lab facilities required viral load monitoring is not yet available in all clinical 
settings (Stott et al., 2013). 
 
 
                                                 
13
Viral Load: This refers to the amount of virus particles in a millimetre of blood plasma. 
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For anti-retroviral treatment to be effective a 95% adherence rate is required (van Dyk, 2010, 
Wood, 2010). Some studies have shown that adherence to ART in sub-Saharan Africa is 
comparable with that in middle and higher income countries, but according to van Dyk 
(2010), “we have no accurate record of what percentage of patients may fall in the ‘danger 
zone’ rate of ARV adherence (between 70% and 90%)” (van Dyk, 2010: 236). In her 2010 
study van Dyk found that in South Africa only approximately 40.1% of patients were able to 
adhere to the optimal level of 90%. 49% managed to adhere between 70% and 90% of the 
time and 10.9% could not manage to adhere above 70% (van Dyk 2010).  
For this reason a more holistic definition of access to health care (and the barriers that affect 
access) that looks beyond the confines of mere adherence and individual health related 
behaviour is required. This is necessary to understand the complex barriers to accessing 
HIV/AIDS related health care and to contextualize these barriers in a more comprehensive 
























1.6) The Research Problem 
 
Studies have shown that loss to follow-up
14
 in the clinical ART setting is a growing concern, 
however, not much attention is being paid to this issue nor to the reasons why patients stop 
coming to collect their treatment after a period of time (Brinkhof et al., 2009, Ware et al., 
2013). This loss to follow-up has significant implications for the ART programme, both 
globally and locally, as ART resistance is already emerging against the first and second line 
triple drug regimens (Rossouw et al., 2013, Brinkhof et al., 2009).  
In South Africa this presents a potential problem since there is limited third line treatment 
available for the general public at this time and patients who stop taking their ART will 
contribute to the AIDS mortality rate since they are no longer taking their life-saving 
medication (NDOH, 2013, Brinkhof et al., 2009). Despite this harrowing fact not much 
research had been done within the South African setting on the large group of virologically 
stable patients who experience barriers to continuous access to care and who may result in 
lost to follow-up cases.  
From working in the ART clinic, the site of this research, for the past four years it has come 
to my attention that the patients attending the clinic on a monthly basis experience difficulty 
when they come to collect their ART. This is of great significance as by identifying the 
specific barriers to accessing ART early, interventions can be shaped around these local 
barriers which can potentially assist in retaining the virologically stable patients in the ART 
program. This study is an investigation into the barriers to accessing antiretroviral treatment 
as experienced by the patients who attend a public health clinic located at one of Durban’s 
largest public health sector hospitals, on a monthly basis.   
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 Lost to follow-up - This refers to the patients who have not returned to the ART clinic for some time, usually 
six months, after initiating treatment and consequently have stopped taking their ART drugs.  
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1.7) The Aim and Objectives of the Study 
 
The aim of this research is thus to elucidate the specific barriers to accessing HIV/AIDS 
related health care services encountered by individuals enrolled in an ART programme in a 
public health clinic located at a large public hospital in Durban, South Africa. Understanding 
and identifying these obstacles is important in the ART setting to ensure continued access to 
health care services is maintained by those receiving life-long ART.  
This study has four central objectives; namely: 
1) To identify the most important barriers as perceived by the patients once they have 
been on ART for longer than a year.  
2) To identify the drivers behind the barriers to continuous access to care. 
3) To understand the impacts that these barriers have on the patients’ ability to 
continually access their treatment.  
4) To understand the patients’ reactions to the perceived barriers in the clinic.   
 
1.8) The Research Setting 
 
As previously noted, the high level of HIV/AIDS prevalence has resulted in an increased 
burden on the public health care sector which has in turn led to an increased demand for 
services. The public health clinic, where the research for this thesis was conducted, was 
therefore established at the hospital to provide services for people diagnosed with HIV/AIDS 
who are in need of care.  
Initially this particular clinic was restricted to providing only supporting medical care and 





 was established at the clinic and patients in need of HIV related care was referred 
to the clinic from the hospital and from nearby clinics. The clinic presently offers services to 
paediatric, maternity, and adult patients.  
The clinic is located at the top end of the hospital grounds and occupies its own building. The 
health care professional staff of the clinic comprises of one operational manager, two 
registered professional nurses, seven enrolled nurses and five enrolled nursing assistants; with 
one phlebotomist to collect the blood samples. There are three medical doctors allocated for 
the adult population of the clinic. Furthermore there are six lay counsellors who provide the 
counselling services and who are responsible for the adherence counselling and monitoring.  
The clinic also has a contingent of administrative personnel consisting of three data capturers, 
four social support officers and one admin clerk. There are also two general orderlies who are 
in charge of keeping the clinic neat and clean. Associated with the ART clinic is a pharmacy 
that deals only with antiretroviral drugs and treatment related to HIV care such as Bactrim 
and vitamin B-Complex supplements. The pharmacy is run by two senior pharmacists, two 
pharmacy assistants and two pharmacy interns. All other medications prescribed by the 
doctors must be collected at the hospital’s main pharmacy. There are also supplemental 
services related to the clinic that are situated in other parts of the hospital. These services 
include dietetics and social services.        
Since the establishment of the ART roll-out program at the clinic an estimated 7700 adult
16
 
patients have been enrolled into care. This figure does not include the paediatric or maternity 
sections. Approximately 5100 of the 7700 are female, and 2600 are male. An estimated 3000 
of the 7700 total patients enrolled since 2004 have been lost to follow-up or classified as 
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 Roll-out Program: This refers to the Comprehensive Health Care Program for HIV care implemented by the 
government and overseen by the National Department of Health. The rollout program offers HIV services that 
range from pre-diagnosis, wide supply of ART, and palliative care if required.  
16
 These figures were supplied by the data capturers of the clinic.  
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‘defaulting’ patients. These patients have not returned to the clinic over the past year. It is not 
clear how many of these have died as only 170 have been recorded as having demised. 
Approximately 1400 patients have been transferred out to locally situated clinics that are 
geographically closer to the patients’ homes. This transfer to primary health care facilities is 
in line with departmental policy that prescribes that patients should attend health care 
services within their local districts and be referred to higher order facilities if more 
specialized care is required. Currently there are approximately 3100 active adult patients in 
the clinic.  
An earlier study on adherence in the clinic was conducted by Magula (2006), who found that 
sixty per cent of the first 100 patients enrolled in the rollout program had treatment adherence 
levels above 95 per cent for the first three months, but only 41 per cent had the same levels 
after 12 months on treatment. Of the first one hundred patients who were eligible to start 
ART, 30 per cent did not and over half of these were lost to follow-up (Magula, 2006). This 
lost to follow-up presents a particular concern for the ART program in the clinic as it is a 
significant statistic.  
The current research project aims to understand the barriers to accessing ART in this 
particular clinic from a more holistic perspective in order to provide a clearer image of the 
problems patients encounter when attempting to access ART. Understanding the barriers can 







1.9) Moral and Ethical considerations  
 
Ethical permission for this study was a requirement before any data could be collected. The 
first ethical requirement was to obtain a Good Clinical Practice (GCP) certificate. This 
certificate requires a researcher to do a course on human subject treatment and protection in 
the research setting and is mandatory for all researchers in the Health Sciences who use 
human subjects as their research participants. The importance of protecting the participants 
especially those who fall into vulnerable
17
 categories is a key point of the course. In 
protecting vulnerable categories the course hinges on the four pillars of ethics in health care, 
namely: autonomy, beneficence, non-maleficence, and justice (Beauchamp and Childress, 
1994). The certificate was obtained through the University of KwaZulu Natal. 
Permission to conduct the study was then sought and obtained from the Social Sciences 
Research Ethics Committee. Permission was granted and an application was then submitted 
to the Medical Manager of the hospital where the research would be conducted. After 
provisional permission was granted, the application was forwarded to the Provincial 
Department of Health’s Research Unit who gave the final permission to conduct research 
within the Public Health Care sector, using their facilities. Their written permission was then 
once again forwarded to the medical manager of the hospital who granted full permission for 
the research to be conducted.  
The various bodies mentioned above are the official gatekeepers for the research site but final 
permission to begin the research project had to be obtained from the Nursing Unit Manager 
who is in charge of the ART Public health clinic at the hospital. Without her permission and 
assistance this project would not have been possible. 
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 Vulnerable groups: HIV/AIDS infected individuals are considered vulnerable due to high levels of stigma and 
discrimination attached to their disease status.  
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A consent and information sheet was created and given to all participants prior to any data 
collection. Informed consent is one of the main aspects of research ethics and all the 
participants of this project participated freely and were informed that they could withdraw at 
any point. Confidentiality was maintained by using coded pseudonyms for participants.  
 
1.10) Outline of the thesis 
 
Chapter One: Introduction 
This introduction has set the theme for the remainder of the thesis. This has been done by 
providing the background, clarifying the research problem and introducing the aim and the 
objectives of the study. The ethical considerations have been discussed. It also describes the 
research setting and provides a chapter outline for the rest of the thesis.    
Chapter Two: The Meaning of Access to Healthcare and Antiretroviral Drugs 
In Chapter Two, the concept of access to healthcare is defined and its various components 
described.  
Chapter Three: Literature Review and Theoretical Framework 
Chapter Three provides a review of the existing literature conducted in the area of barriers to 
accessing HIV related treatment and care so as to highlight research already done and to 
identify gaps in the literature. The theory of structural violence is also introduced and 
discussed in this chapter and forms an important framework upon which ethnographic 
findings presented in Chapters Five and Six are hinged.  
Chapter Four: Methodology 
This chapter details the methods used to collect the data, and describes the data collection 
process.   
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Chapter Five: The Barriers to Continuous Access to ART Care in the Clinic   
Chapter Five discusses the results from the quantitative and qualitative data analysis 
regarding the main barriers to ART that patients experience in the clinic. Accordingly, it 
addresses the physical, organizational, social and economic barriers experienced in relation to 
accessing ART.  
Chapter Six: The Effects of the Barriers to Accessing ART Care 
Chapter Six discusses how the barriers identified are experienced by the patients and the 
reactions these barriers cause in the patients. The chapter also addresses how these barriers 
impact on the patients’ ability to continuously access their treatment and how the barriers 
influence the main categories of access, namely: availability, accessibility, affordability, 
acceptability, and accommodation.   
Chapter Seven: Conclusion and Recommendations 
The final chapter includes the conclusions drawn based on the research and makes 













CHAPTER TWO: The Meaning of Access to Healthcare and 
Antiretroviral drugs 
 
2.1) Access to Health Care: A Difficult Concept to Define 
 
“The proof of access is use of services, not simply the presence of a facility. Access can, 
accordingly, be measured by the level of use in relation to ‘need’. One should recognize, 
however, that clients and professionals evaluate ‘need’ differently. Further, one must 
distinguish two components in use of service: ‘initiation’ and ‘continuation’. This is 
because different factors influence each, though any one factor may influence both. It is 
hardly necessary to emphasize that barriers to access are not only financial but also 
psychological, informational, social, organisational, spatial, temporal, and so on.” 
(Donabedian in Aday and Andersen, 1974: 219) 
The concept of access to health care has largely been difficult to define and understand (Aday 
and Andersen, 1974, Penchansky and Thomas, 1981). This is evident in the words of 
Gulliford et al., (2002) who state “that access is a complex concept” (Gulliford et al., 2002: 
186), and Penchansky and Thomas (1981) who note that “access is thus difficult to define and 
measure operationally…” (Penchansky and Thomas, 1981: 127). Likewise Clark and Coffee 
(2011) remark that: “Access is an important concept in health policy and health services 
research, yet it is often not defined or employed precisely” (Clark and Coffee, 2011).  
The problem surrounding the use of the concept of access has a long history and to date no 
all-embracing definition has been accepted and the concept has been broadly used. As early 
as 1974 in their seminal work on access to health care services, Aday and Andersen (1974) 
created a framework for the study of access to health care. In this framework they suggested 
that to understand access to health care it is best to “consider access in terms of whether those 
who need care get into the system or not” (Aday and Andersen, 1974: 218). This view 
highlighted two very important aspects involved in access to health care, namely: whether 
people have access, or whether they have gained access. They further clarify these concepts 
in terms of potential and actual entry and utilization of health care services, when they note 
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that access consists of  “those dimensions which describe the potential and actual entry of a 
given population group to the health care delivery system”(Aday and Andersen, 1981: 6).   
Potential realization of access is characterized by the health care system and the population at 
risk and also includes the idea that the availability of services is a central component to the 
concept of access. This aspect of potential access according to Bashshur et al (1994) includes 
the notion that “persons with a regular source of care are less likely to encounter difficulties 
as compared to those without such as source” (Bashshur et al., 1994: 410). Andersen (1995) 
defines potential access as “the presence of enabling resources” and realized access as the 
“actual use of services” (Andersen, 1995: 4).     
Although there exists some confusion surrounding the different meanings of whether a person 
has access, or whether she/he has gained access (Gulliford et al., 2002), Aday and Anderson’s 
(1974) framework does present a useful way to understand how all the varying components 
of the concept of access fit together. They argue that access to health care starts with health 
care policy which then influences the health care system and the population at risk. The 
characteristics of the health care system and the characteristics of the population at risk then 
in turn influence utilization and satisfaction with health care services and access (Aday and 
Andersen, 1974). The two themes highlighted in the literature as having an influence on all 
the other aspects of access are the characteristics of the population who utilize the health care 
services, and the characteristics of the health care system itself (Penchansky and Thomas, 
1981, Gulliford et al., 2002, Aday and Andersen, 1974). These two concepts are discussed in 
more detail further in the chapter.  
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From analysing the Aday and Andersen’s (1974) framework for the study of access to 
healthcare it becomes clear that the various components
18
 of access influence each other and 
have the potential to overlap. This is important to consider since the various components of 
access are often used interchangeably. This synonymous use of the various components can 
then result in the holistic meaning of the concept of access being lost and/or limited to the use 
of one component only. Aday and Andersen’s (1974) Framework for the study of access to 















Figure 2.1 Aday and Andersen’s Framework for the Study of Access to Health Care (1974) 
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 Components of access include: availability, accessibility, affordability, acceptability and accommodation. 
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2.2) Access starts with Health Care Policy 
 
The concept of access to care is embedded within the realm of health care policy 
(Penchansky and Thomas, 1981). In Aday and Andersen’s (1974) framework for studying 
access to health care they note that policy variables are changeable and amendable and as 
health policy has the ability to affect all other aspects of access including the health care 
system and the population at risk it should therefore be the starting point when access is 
considered (Aday and Andersen, 1974).  
Interventions and policies can therefore, Aday and Andersen (1981) maintain, either enable 
or prevent people from accessing health care services. One of the main goals for many health 
care policies, including South Africa’s health care policy, is to improve equal access to health 
care for all (NDOH, 2011a). In the South African scenario the link between policy and access 
has been particularly obvious as for many years all that stood between people in need of ART 
and actually receiving it was policy (Fassin, 2007, Barnett and Whiteside, 2006). Policy 
directly prevented the distribution of ART to those who needed it, but once policy changed, 
access to ART was theoretically available. In this way policy influenced the health care 
system and the population.  
Likewise, policies regarding drug patents have played a major role in the scale up of access to 
ART. (see for example WHO et al., 2010)
19
. After ART showed its efficacy as a viable 
treatment option for HIV and AIDS infection, it became clear that only those who could 
afford the high cost of the lifesaving drugs would benefit from it (Barnett and Whiteside, 
2006).  
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The World Trade Organisation Agreement on Trade-Related Aspects of Intellectual Property 
Rights (TRIPS) was the first major global policy change to improve access to ART (WHO et 
al., 2010). The flexibilities allowed in the agreement resulted in the South African 
government importing cheaper generic drugs that posed competition to the larger 
pharmaceutical companies. This competition resulted in a marked decrease in the price of 
ART drugs in South Africa (WHO et al., 2010). 
In the South African HIV/AIDS setting the effect of inefficient policies was severely felt. 
According to the SAHRC report of 2009, the ministry of health was well informed of the 
devastating effects that awaited the South African public health care service, and the 
population in general, but chose to deny the extent of the problem (SAHRC, 2009). Instead of 
focusing on strategies to combat the coming epidemic, debates were held over the 
effectiveness of ART and the cause of AIDS (Epstein, 2007). This ensuing debate only 
concluded in 2010, and for the critics of the government and those inflicted with the disease 
this was a blatant act by the government to deny the general population of South Africa 
access to health care and to life-saving drugs (Ige and Quinlan, 2012).  
Policy can also be used to target the population at risk by either stimulating change in the 
mutable factors of the population directly or through the health care system (Aday and 
Andersen, 1974) in the form of prevention campaigns that encourage behaviour change in the 
population at risk. Policy however is not always effective in changing behaviour as is 
demonstrated in the failure of HIV/AIDS prevention campaigns especially in the sub-Saharan 
setting. A major contributor to this is the fact that the epidemic is so generalizable and not 
only confined to ‘risk groups’, as mentioned in Chapter One. This fact,  has however eluded 




2.3) Characteristics of The Health Care System 
 
The health care delivery system is characterized into two main components, according to 
Aday and Andersen’s (1974) framework. These two components are resources and 
organisation (Aday and Andersen, 1974). Resources include the capital and human resource 
component; and organisation involves the function and utilization of the resources aspect and 
how well the resources are organised to work towards providing access to patients. 
Organisation also refers to aspects such as gaining entry into the system, travel time, and 
waiting times. The second component of organisation is structure and refers to the path taken 
by the patient once he/she has entered the health care system and from which components of 
the system he/she receives services (Aday and Andersen, 1974).  
The health care system affects utilization and consumer satisfaction directly. It is the structure 
of the health care system itself that causes the effect on access rather than the characteristics 
of the population, but, the health care system can also effect the population at risk by 
implementing health programs such as anti-smoking campaigns, to decrease the risk of 
disease (Aday and Andersen, 1974). 
According to Aday and Andersen (1974), “the time interval for a visit can be expressed in 
terms of contact, volume, or continuity measures” (Aday and Andersen, 1974:214). Contact 
is concerned with the time it takes for an individual to gain entrance into the health care 
facility and also pertains to those individuals who do not gain entry at all. Volume refers to 
the number of contacts and revisits with the health care system in a given time and “reflects 
who gets into the system and how often he uses it” (Aday and Andersen, 1974:214). 
Continuity refers to the coordination and link between health services and the patient. If this 
link is fragmented and poorly organised, a decreased level of access is achieved. Continuity 
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furthers permits the operationalization of the integration of services (Aday and Andersen, 
1974). 
The ART program is situated within the biomedical Western health sector. This view focuses 
on the individual with a particular concern for the biological aspects of diseases. The 
biomedical view argues that diseases are caused by pathogens that are impersonal and have a 
negative effect on the normal functionality of the human body (Pool and Geissler, 2005). 
Pool and Geissler (2005) explain the position of the biomedical system well when they say 
that “biomedicine is seen as mystifying social, economic and political problems by making 
them appear individual, biological, natural. It hides (or ignores) the social causes of 
sickness…” (Pool and Geissler, 2005: 84).  
Foucault (1975) also reminds us about the spatiality of diseases and argues that diseases do 
not only exist within the biological body, but also in other spaces located outside the body 
such as the society in which people live (Foucault, 1963).This is an important point since 
people frequently interpret diseases as illness and understand their afflictions through cultural 
interpretations. People are however not only biological but cultural beings and as a result are 
also informed about illness behaviour from the society in which they live (Pool and Geissler, 
2005). If the health care sector wants to communicate effectively with the population at risk 
and influence behaviour change then a more holistic view of illness is required. 
For the purposes of this study it is important to consider the biomedical view point of the 
health care system as this has implications for addressing adherence to ART. Adherence as a 
concept is constructed in biomedical terms and is focused on the individual person and the 
individual’s own ability to follow instructions given about treatment. However how 
adherence fits into the broader concept of access to health care is seldom considered by a 
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purely biomedical approach. In order to fully comprehend access and the barriers to access 
faced by ART patients, a more holistic bio-psycho-social perspective is required.      
 
2.4) The Population at Risk: Characteristics of those in need of care and 
its influence on access 
 
Characteristics of the population at risk also determine the level of access to healthcare. 
Components of the population at risk include predisposing, enabling, and need factors. These 
characteristics include mutable and immutable factors (Aday and Andersen, 1974).  
The predisposing component includes properties of the patient that exist prior to illness 
manifestation. This includes demographic factors such as gender, age, religion and ethnicity; 
social structure factors; and health beliefs (Aday and Andersen, 1974). Posse et al., (2008) 
further note that predisposing factors could also include marital status, and attitudes towards 
treatment, health care workers and disease. Health beliefs include “attitudes, values, and 
knowledge that people have about health and health services” (Andersen, 1995: 2).  
Social structures such as social networks and social interactions are now also considered as 
important predisposing factors for access to care (Andersen, 1995). Within the ART setting, 
social networks have been shown to be of particular importance in access to ART. 
Henderson’s (2011) account of the troubling time between the unavailability and subsequent 
availability of ART in South African health care facilities highlights the importance that 
social networks and interactions have on a patient’s ability to access ART (Henderson, 2011).   
Social structures, culture, health beliefs and demographic factors such as ethnicity, gender, 
and age are considered immutable predisposing variables in accessing ART since they cannot 
be influenced or changed by health care policy (Andersen, 1995, Posse et al., 2008). Illness 
behaviours and economic factors such as out-of-pocket health care costs are considered to be 
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mutable since these can be influenced and changed to a certain degree by health policy 
interventions (Andersen, 1995, Posse et al., 2008).   
The enabling characteristics refer to “the means that individuals or their community may 
have available to facilitate (or in their absence, hinder) the use of services” (Posse et al., 
2008: 906). This includes resources enabling the patient to reach facilities. The individual, the 
family, and the community in which the patient lives are taken into account as enabling 
factors (Aday and Andersen, 1974). At the individual level these characteristics may include 
finances, health information and family responsibilities, while at the community level social 
support and community resources are included (Posse et al., 2008).  
The need characteristic of the population at risk refers to the immediate need of the patient to 
access health care services according to her\his evaluated illness level (Aday and Andersen, 
1974, Posse et al., 2008). The need component is perceived by the patient and evaluated by 
the health care system and may be assessed differently by the patient and the health care 
provider (Aday and Andersen, 1974, Donabedian, 1972).  
Perceived need of care by the patient is the beginning of the process to accessing health care 
services on an individual level. The health beliefs and attitudes will determine at what point 
each individual considers the need appropriate to seek health services (Gulliford et al., 2002). 
It is at this stage that the patient will first adopt what is known as the sick role. The sick role 
as first described by Parson (1951) suggests that when a person becomes ill she\he adopts the 
sick role that exempts the individual from normal social responsibility but also signifies that 
she\he willingly subjects herself\himself to medical care and advice until a normal level of 
health is regained (van Staden and du Toit, 2003). It is this position that patients assume 
when first engaging with the health care system where they acknowledge that they have a 
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need for health care service. This need is influenced by personal, biological, cultural and 
environmental factors (van Staden and du Toit, 2003, Andersen, 1995, Gulliford et al., 2002).     
Gulliford et al., (2002) also note that the patient’s perceived need for service can be different 
from that calculated by the health care system. This becomes evident in instances where the 
health care system implements interventions to change health related behaviours though 
policy, but the patients’ do not respond accordingly. This can clearly be seen in the 
prevention of HIV/AIDS. Prevention strategies such as safer sexual practices, including 
condom use and monogamous relationships have not materialized as the health care policies 
predicted. This, according to Gulliford et al., (2002) could well be because people and users 
of the health care system simply do not see the need for behaviour change as laid out by the 
health care system (Gulliford et al., 2002).  
 
2.5) The Five Pillars of Access: Availability, Accessibility, Affordability, 
Acceptability, and Accommodation   
 
While Aday and Andersen’s (1974) framework is useful to understand how the various 
aspects comprising the concept of access to health care fit together, Gulliford et al., (2002) 
note that the model is largely based on the availability of services. As a result Gulliford et al., 
(2002) continue, it does not effectively cover the fact that availability does not always result 
in utilization of services because in some instances services are available but difficult to reach 
or under-utilized due to a variety of reasons, and thus the potential ability of access to health 
care services is compromised (Gulliford et al., 2002).  
Penchansky and Thomas (1981) are widely acknowledged for developing a more 
comprehensive definition of the concept of access (Clark and Coffee, 2011, McLaughlin and 
Wyszewianski, 2002). Penchansky and Thomas (1981) recognised that availability of 
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services does not always result in utilization and developed a definition that incorporates this 
fact (Gulliford et al., 2002, Penchansky and Thomas, 1981).  
In many instances access is synonymously used with availability and accessibility of health 
care (Aday and Andersen, 1974, Penchansky and Thomas, 1981, Gulliford et al., 2002). 
Penchansky and Thomas (1981) however argue that this is confusing and misleading since 
availability and accessibility of services forms part of the larger concept of what access truly 
entails. Penchansky and Thomas (1981) therefore proposed that access should be understood 
as: “a concept representing the degree of ‘fit’ between the clients and the system” 
(Penchansky and Thomas, 1981: 128). According to Penchansky and Thomas (1981) “access 
is a measure of the ‘fit’ between characteristics of providers and health services and 
characteristics and expectations of clients, and that this concept includes five reasonably 
distinct dimensions: availability, accessibility, accommodation, affordability, and 
acceptability” (Penchansky and Thomas, 1981: 139). 
Harris et al., (2011) used Penchansky and Thomas’ definition of access in their own 
explanation of the concept when they said that “access is therefore the opportunity and 
freedom to use services, and encompasses the circumstances that allow for appropriate 
service utilization, plus sufficiently informed individual or households (demand-side), 
empowered to exercise choice within the health system (supply-side). The ‘degree of fit’ 
between demand-and supply-sides, rather than each in isolation, determines the degree of 
access achieved” (Harris et al., 2011). Posse et al., (2008) drawing on the original definition 
proposed by Penchansky and Thomas (1981) further define access as “entry to the health 
system and continuation of the treatment process, and is determined by characteristics of the 




The five access dimensions formulated by Penchansky and Thomas (1981) are interrelated 
and influence each other. Furthermore, some dimensions are more relevant for certain 
settings than others. In some settings availability can be an issue, where in other locations 
services may be available but not accommodative to the patients’ specific needs. Due to the 
interrelatedness of the five dimensions they are often synonymously used under the umbrella 
term of access (Penchansky and Thomas, 1981), yet this is somewhat misleading as they do 
not mean one and the same thing but in actuality each component comprises a single piece in 
the access puzzle.  
2.5.1) Availability 
 
Penchansky and Thomas (1981) define availability as: “the relationship of the volume and 
type of existing services (and resources) to the clients’ volume and types of needs. It refers to 
the adequacy of the supply of physicians, dentists, and other providers; of facilities such as 
clinics and hospitals; and of specialized programs and services such as mental health and 
emergency care” (Penchansky and Thomas, 1981: 128).   
The UNAIDS Handbook of Access to HIV treatment and care describes treatment availability 
as services that can be found anywhere in a given community. Harris et al., (2011) further 
note that availability can include distances travelled to health services and the mode of 
transport required and used to reach services. Anyinam (1987) similarly describes availability 
of health services as either the total supply of services or personal and the geographical 
distribution of the services (Anyinam, 1987). Availability of resources and personnel are 
usually calculated as ratios. In South Africa health care resources and personnel are markedly 




South Africa’s political past has left the health care system in a fragmented state (Harris et 
al., 2011). During the Apartheid Regimen health care was segregated according to race. 
Today however the health care system is divided along economic lines between a world class 
private health care sector and a struggling public health care sector (SAHRC, 2009). This 
divide has resulted in great inequality in the availability of healthcare and has resulted in a 
healthcare situation that Barnett and Whiteside (2006) describe as being based upon: “those 
who can purchase well-being and those who cannot”(Barnett and Whiteside, 2006: 6).   
In South Africa there are more health care professionals working in the private sector than in 
the public sector, even though more than seventy per cent of South Africa’s population 
utilizes the public health care sector. Three out of ten doctors, four out of ten professional 
nurses, one out of ten pharmacists, and one out of twenty psychologists work in the public 
health care sector (NDOH, 2011b). In KwaZulu Natal the public health care personnel to 
patient ratios stand at 28: 100 000 for doctors and 111: 100 000 for registered nurses, as 
compared to the private sector where one specialist doctor attends to fewer than 500 patients 
per year (KZNHEALTH, 2010, Harris et al., 2011).  
This great inequality of available health care personnel in the public health care sector has 
major implications for the expanding ART programme since the number of patients are 
increasing but the number of staff necessary to deliver the services are not meeting the 
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According to Penchansky and Thomas (1981) accessibility can be defined as: “the 
relationship between the location of supply and the location of clients, taking account of 
client transportation resources and travel time, distance and cost” (Penchansky and Thomas, 
1981:128). Accessibility here refers to the physical accessibility in terms of location and 
building structure. Clark and Coffee (2011) in a similar stance define accessibility as: “ the 
ease of approach from one location to another measured in terms of distance travelled, the 
cost of travel or the time taken” (Clark and Coffee, 2011: 3). 
Anyinam says of accessibility that: “the capacity of any social service is limited by the 
number of people who can reach and use it” (Anyinam, 1987: 805). According to Anyinam 
(1987) there are three aspects to accessibility, namely: Coverage accessibility that refers to 
the capacity of a service to treat patients, locational accessibility that refers to space occupied 
by the facility and takes into account the physical distance travelled, and revealed 
accessibility which reflects the actual utilization of that service (Anyinam, 1987). 
The patterns of referral for KwaZulu Natal are also a significant contributor to the 
accessibility of health care services. KwaZulu Natal is bordered by the Eastern Cape Province 
and as a result there is a migration of people from the Eastern Cape Province who utilize 
health services in KwaZulu Natal. The larger tertiary hospitals are particularly affected by 
this as they offer specialised services that few centres can provide (KZN Strategic Plan 2010-
2014 KZNHEALTH, 2010). The rural areas of the province provide fewer services than the 
urban centres and this results in the rural areas having less coverage of ART treatment than 
the better resourced and serviced urban centres, but, at the same time, adds to the burden of 
work load in the urban centres (Fried et al., 2012).  
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The natural features of the province are also a factor to consider when discussing 
accessibility. The province is home to mountain ranges, numerous rivers and distant 
homesteads that present difficulties in terms of physically reaching health care facilities. The 
terrain especially presents difficulties for those health care services that are located in the 
deep rural areas that provide services to their local communities (KZN Strategic Plan 2010-
2014, KZNHEALTH, 2010). Despite differences in accessibility between rural and urban 
areas Fried et al., (2011) found that while patients’ experiences of the health care system and 
provision of ART was varied between rural and urban centres the effect on their ability to 
access their ART was comparable between the two (Fried et al., 2012).  
2.5.3) Accommodation 
 
Penchansky and Thomas (1981) define accommodation as “the relationship between the 
manner in which the supply resources are organised to accept clients (including appointment 
systems, hours of operation, walk-in facilities, telephone services) and the clients’ ability to 
accommodate to these factors and the clients’ perception of their appropriateness” 
(Penchansky and Thomas, 1981: 128). These authors noted that long waiting times, long 
travelling times, and inability to get an appropriately timed appointment all affect satisfaction 
negatively. Further, patients with high health concerns tend to be less satisfied with the 
accommodative ability of access to health care as they tend to be more sensitive about their 
health care needs (Penchansky and Thomas, 1981). 
Accommodation thus refers to the extent that the health care service will go to negotiate the 
services offered to suit the individual needs of the patients. The issue of health care protocols 
comes into effect with the aspect of accommodation. In the public health care sector 
following protocols is a standard practice. Patients are classified into groups according to the 
various protocols and are treated according to the instructions of the protocols. Human (2011) 
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related how restrictive following protocols are in diagnosing and providing treatment to 
patients. Protocols do not allow for individual assessment or flexibility in regards to 
providing services to patients (Human, 2011). This inflexibility of the health care system to 
engage on a more personal level with patients has a negative impact on the accommodative 
factor of access to health care.   
2.5.4) Affordability 
 
Affordability as defined by Penchansky and Thomas (1981) is: “the relationship of prices of 
services and providers’ insurance or deposit requirements to the clients’ income, ability to 
pay, and existing health insurance. Client perception of worth relative to total cost is a 
concern here, as is clients’ knowledge of prices, total cost and possible credit arrangements” 
(Penchansky and Thomas, 1981: 129). Affordability is identified by factors such as personal 
income levels, subscription to medical aid schemes, and the expenses involved in transport 
costs to reach health care facilities (Penchansky and Thomas, 1981). Gulliford et al., (2002) 
likewise note that the “availability of services may be measured in terms of the costs to 
individuals of obtaining care” (Gulliford et al., 2002) and may include factors such as 
transport costs, travelling time, and time taken off work to seek medical care.  
As noted in South Africa, healthcare is divided into the private sector and the public health 
care sector. Antiretroviral drugs are provided free of charge in South Africa for people who 
utilize the public health care system. However, the concept that it is free medicine is 
misleading. Out-of-pocket expenses (OOP) present a major challenge for people who are 





Harris et al., (2011) found in their study on inequality in access to health care in South Africa 
that half of their respondents reported that because they do not have to pay for primary health 
care services the public health care sector is their only choice when selecting where to seek 
treatment. However, 21.1% of their respondents said that they had to delay seeking medical 
treatment because of expensive transport costs while the inability to get time off from work 
for those who were employed presented a further challenge in the affordability component of 
accessing health care. (Harris et al., 2011). Thus, despite the fact that Primary Healthcare and 
ART is free in public clinics and hospitals in South Africa, affordability is an important 
criterion that needs to be considered on a number of levels when dealing with access as the 
parameters of affordability extend beyond the boundaries of free healthcare.   
2.5.5) Acceptability 
 
The aspect of acceptability is defined by Penchansky and Thomas (1981) as: “the relationship 
of clients’ attitudes about personal and practice characteristics of providers to the actual 
characteristics of existing providers, as well as to provider attitudes about acceptable personal 
characteristics of clients. In the literature, the term appears to be used most often to refer to 
specific reaction to such provider attributes as age, sex, ethnicity, type of facility, 
neighbourhood of facility, or religious affiliation of facility or provider. In turn, providers 
have attitudes about preferred attributes of clients or their financing mechanisms. Providers 
either may be unwilling to service certain types of clients (e.g. welfare patients) or, through 






Acceptability of care plays an important part in access to health care. It is perhaps the most 
abstract dimension of the concept of access as it is influenced by the patient and the health 
care provider’s ethnicity, culture, religion, economic class, and sex. Other factors are more 
about the facility itself such as the type of service, its location, diagnosis, and extent of 
service coverage (McLaughlin and Wyszewianski, 2002). These factors are largely 
immutable and inform both parties’ healthcare provider and patient, about the extent of 
services offered; female patients might be more comfortable to be examined by female health 
care providers for instance. Acceptability can however also be projected from the health care 
provider’s perspective. In the HIV setting this has often manifested in stigma and 
discrimination towards HIV infected patients in instances where health care providers either 
refuse to treat HIV positive patients or offer limited services, such as withholding surgery or 
denying admission to Intensive Care Units (Timsit, 2005, Sadoh et al., 2009).    
2.6) The Proof of Access is in Utilization of services and User Satisfaction 
 
Utilization of services is often considered as the measure of access to health care. The aspects 
of utilization include the type, site, purpose, and time interval (Aday and Andersen, 1974). 
Type refers to the kind of service, site refers to the location where the patient is treated, 
purpose refers to the reasons behind the care given, and time interval refers to the contact 
time with health care services (Aday and Andersen, 1974).  
Aday and Andersen (1974) highlight three components related to the purpose of service, 
namely: preventive care, custodial (palliative) care and illness-related care.  Preventive care 
includes efforts to stop disease process and custodial care refers to end-of-life type care as 
seen in hospices. Illness-related care concerns curative and chronic care. When access to 
health care is considered, the purpose of care is an important factor to take note of.  
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HIV/AIDS occupies a peculiar place in the purpose of care as it involves all three aspects of 
purpose: preventive, curative, and palliative (UNAIDS and WHO, 2003). Initially, HIV 
infection was treated with a curative stance, but ART is changing this to a chronic, long term 
purpose of care. The importance of this is that the three aspects of purpose of care require 
different demands from the health care system and have different patterns of care linked to 
each aspect. Therefore if HIV/AIDS was initially treated with a curative purpose it would 
have certain patterns of care. One of these patterns of care is the global drive to get all those 
who need ART onto treatment. This places a sharp focus on initial entry into the system with 
a special focus on treating as many people as possible. The changing nature of the epidemic 
to a chronic, long-term, irreversible condition will now result in different patterns of care and 
different demands being placed on the health care system. These patterns of care are linked to 
continuous access to health care, with a long term view. More and more patients will enter 
the system, but unlike most other diseases, HIV patients will remain within the system adding 
an increasing demand on services and resources, and as Stott et al., (2013) note: “There is 
evidence that continued ART scale up may exacerbate the health system crisis in South 
Africa” (Stott et al., 2013).    
HIV infection, at the same time, also requires preventative care, as prevention of infection 
still remains the only hope of ‘cure’. Preventative services require different service from the 
health care sector that can often be seen as falling outside the medical domain. In the case 
with HIV, preventative services seem to have fallen to the volunteers and community 
workers; actors placed outside health care services. However, prevention, that includes 
testing for HIV, has been shown to be instrumental to bring patients into contact with health 
care facilities. Yet under Aday and Andersen’s (1974) model, preventative services form part 
of the concept of health care service utilization, but the biomedical health care system cannot, 
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at this stage, provide a prevention service to those seeking protection from HIV infection 
since there is no vaccine available. 
The time aspect related to utilization of services is another important aspect in accessing ART 
and includes contact time, volume, or continuity of utilization (Aday and Andersen, 1974). 
Contact time refers to the amount of time it requires for people to enter and use the services 
while volume refers to the number of appointments, and reflects if people get into the care 
system and how often it is used (Aday and Andersen, 1974). Continuity of service is 
particularly important in the ART setting since much depends on continuous service 
delivered to patients. Continuity refers “to the degree of linkage and coordination of medical 
services associated with a particular illness experience or episode – important because if the 
process of receiving care is fragmented and poorly organised, people may be considered to 
lack appropriate access to the system” (Aday and Andersen, 1974: 215)   
Gulliford et al., (2002) however notes that just using utilization of health care services as a 
measure for access can be misleading, and states that: “poor-quality services may be 
associated with high levels of utilization” (Gulliford et al., 2002:187). They suggest that other 
health outcomes such as consumer satisfaction should also be considered when access is 








2.7) Access is an Issue of Equality 
 
As noted equitable access to HIV treatment remains an unmet challenge globally (UNAIDS 
2012). Several studies have shown that the availability of the drugs does not automatically 
translate into accessibility or utilization of the treatment (UNAIDS 2009). According to 
UNAIDS (2012), the global target is to have 15 million people on ART by 2015. Currently it 
is estimated that 8 million people are receiving anti-retroviral therapy globally but a further 7 
million are in need of treatment (UNAIDS 2012).  
According to Mottair (2012), “HIV/AIDS related service delivery in South Africa is 
inextricably linked to socio-economic rights…” (Mottiar in Ige and Quinlan, 2012: 84). 
Further to this, the UN notes that “in many parts of the world the spread of HIV/AIDS is a 
cause and consequence of poverty” (UNAIDS in Mottiar, 2012: 89).   
Inequality in access to health care is increasingly drawing attention to the unethical aspect 
about peoples’ inability to receive health care when they need it. Common principles of 
equity to health care access include: “equal access to health care for those in equal need of 
health care; equal utilization of health care for those in equal need of health care; and equal 
(or equitable) health outcomes” (Oliver and Mossialos, 2004: 655).  
Aday and Andersen (1981) define equity of access to care as “when services are distributed 
on the basis of people’s need for them… and the inequality exists when services are 
distributed on the basis of demographic variables, such as race, family income, or place of 
residence, rather than need” (Aday and Andersen, 1981: 6). 
Jones (2010) highlights in his study investigating access to ART that the rights-based 
approach alone does not always result in the best understanding or operationalization of 
access to care, even though access is placed within the rights-based movement. For access to 
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be realized as a human right, he argues, a more multi layered and complex understanding of 
the concept is necessary. Once all the aspects of access have been considered a more holistic 
understanding of the concept of access is achieved without which, access as a human right is 
prone to failing at the implementation stage. Jones (2010) further notes with regard to 
understanding access to HIV/AIDS related services that: “elaborating on the meaning of 
‘access’ to treatment, and by implication a rights-based approach, produces a more rounded 
picture of the dilemmas, anxieties, community, and institutional and contextual pressures – 
the grey areas – that the people-living-with-AIDS encounter” (Jones, 2010: 34).    
Barnett and Whiteside (2006) further add to the discussion on the importance of equity in 
healthcare and this is evident in their words: “With the development of antiretroviral 
therapies (ARTs), the epidemic defines who is saved – and who is left to die from the disease 
and its impacts. In its distribution across the continents and in relation to access to drugs that 
can save lives, it is a global epidemic that defines the excluded of the world – the wretched of 
the earth. Above all, HIV/AIDS defines those who can purchase well-being and those who 
cannot” (Barnett and Whiteside, 2006:6). 
Equity of access to health care services is thus perhaps the ultimate level of measure of who 
gets treated and who does not. But equity, like access, remains a complex concept to both 
define and measure. According to Gulliford et al., (2002) “equity introduces the notion of 
fairness or social justice” (Gulliford et al., 2002: 189). A common measure is that there 
should be equal access to equal need, and it uses the utilization and needs ratios. However 
Gulliford et al., (2002) note that “analyses have shown surprisingly little evidence of 
horizontal inequity in utilization of care, even in countries where access to care is considered 
to be severely rationed to income” (Gulliford et al., 2002:189). Gulliford et al., (2002) further 
argue that inequality is more readily shown when availability and health outcomes are added 
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to the equation and argue that conclusions based on utilization alone should be interpreted 
with caution (Gulliford et al., 2002). 
Universal access is not necessarily something that can be achieved in all local contexts as 
within the local context barriers to accessing health care services may be present that 
constrain patients’ ability to fully engage and utilize their treatment (Jones, 2010, Penchansky 
and Thomas, 1981). In this chapter the comprehensive concept of access to healthcare has 
been explored. As is evident from this chapter and the literature, access to healthcare is a 
broad concept that consists of five dimensions that are interrelated but also independent. 
Often in the medical literature the comprehensive term of access is synonymously used with 
one of its constituent dimensions that results in a constricted understanding of the broader 
concept. It is therefore important that when access to healthcare is discussed that it is 
understood from all its dimensions, and not just one of them independently.   In the next 
chapter the barriers to accessing healthcare will be defined and the four categories of barriers 





















CHAPTER THREE: Literature Review and Theoretical 
Framework 
 
Having outlined the problems associated with the concept of access in the previous chapter, 
this chapter now focuses directly on the relevant literature pertaining to the barrier to 
accessing antiretroviral therapy in the context of the HIV/AIDS pandemic.  
3.1) The Importance of Continued Access in the ART setting. 
 
“‘The clinic is your last option.’ He nods. ‘A cure is better.’ 
‘Is that the problem with the clinics? They don’t offer a cure?’ 
‘I have three problems with the antiretrovirals,’ he replies crisply. 
‘First, people do not know about them. We don’t know them here. Second, it seems you 
must get sick before they give you the antiretrovirals. You must wait until you are sick. I do 
not like that. Why must you get sick first?’… ‘The third reason is the biggest reason. I feel 
terrible for the people living with this disease inside them. It is there for their whole 
lives…I wonder… whether anyone can cope with that. A cure is much better.’” (Excerpt 
from Three Letter Plague, 'Sizwe Magadla' in Steinberg, 2008: 74).   
 
It would appear that the initial struggle to get people onto ART has been won, but now awaits 
perhaps the biggest challenge yet to keep all those patients who started on ART enrolled in 
the ART program and to ensure that access to health care is not compromised in any way. 
Fox and Rosen’s (2010) systematic review of retention in ART programs in sub-Saharan 
Africa is extremely significant in this respect as their review revealed that at 2 years there is 
an average retention rate of only 60% in ART programs in the region (Fox and Rosen, 2010).  
Continued access to HIV care and treatment is however essential for the HIV program to 
succeed (UNAIDS, 2012).  Ideally, these drugs should be supplied in a simple and efficient 
way to ensure the transition of HIV from a deadly infectious disease to a chronic manageable 
one (Rossouw et al., 2013). This stated, the increased workload in the public health sector in 
many resource poor countries along with poor policies, unsupported health care workers, 
poor organization, unreliable supply of drugs, and limited specialized services has resulted in 
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barriers that make it difficult for patients to access their ART (Posse et al., 2008, Gari et al., 
2013). 
The literature reveals that little attention is being paid to the large group of virologically 
stable people who attend ART clinics on a monthly basis (Wilkinson, 2013). Currently the 
rate of retention for people on ART in the public health sector in South Africa is less than 
70%. Fried et al. (2012) report that “nearly one in six in a recent study- at some point 
interrupt treatment, becoming so-called ‘defaulters’ or lost-to-follow-up” (Fried et al., 2012: 
147), and according to Brinkhof et al., (2009) nearly 40 % of people started on ART in sub-
Sahara Africa drop out of their ART programs in the first two years, and are lost to follow-
up. Ware et als., (2013) observation that an estimated one in six patients enrolled onto an 
ART program were not taking treatment after a two year period (Ware et al., 2013), presents 
a similar picture.  
These findings , and the fact that not much attention is being given to this group of people, is 
worrying in the face of rising ART drug resistance that is now becoming a reality in many 
clinics across South Africa  (Rossouw et al., 2013). The main focus of the ART program at 
this time is to initiate people onto treatment regimens without much consideration for the 
long-term retention in the ART program. This focus is embedded in the vague usage of what 
access to health care really means
21
 and as a result using availability of ART drugs is 
frequently used interchangeably with access to treatment.  
One of the major concerns for this need for continuous access to ART is the fact that sub-
Saharan Africa still imports more than eighty per cent of ART drugs that are needed 
(UNAIDS, 2012). This has major implications for the longevity of the program since global 
funding is already receding (Barnett and Whiteside, 2006, Fox and Rosen, 2010). In addition, 
                                                 
21
 The issue of access: This has been extensively discussed in Chapter Two 
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Mukherjee et al.,(2006) found that in resource poor settings like South Africa “the context of 
poverty factors such as lack of access to transport, food insecurities, and user fees for medical 
care, posed more significant barriers to adhering to long-term therapy than a patient’s 
individual behaviour” (Mukherjee et al., 2006: 123).  
3.2) The issue of barriers to continually accessing ART 
 
As Reuter (2008) cited in Steinberg (2008:87) succinctly points out “…whether a person 
embraces a health-care service is determined primarily by the accessibility of that service”. 
This statement draws attention to access as being a broader concern which supersedes the 
more limited issue of adherence. This is similarly explored by Penchansky and Thomas 
(1981) who specifically state that problems with any component of access will influence 
patients and the health care system in three ways: “1) utilization of services…will be lower; 
2) clients will be less satisfied with the system and/or services they receive; and 3) provider 
practice patterns may be affected.” (Penchansky and Thomas, 1981: 130).  
Barriers to accessing care, as highlighted in the literature, are regarded as crucial in 
understanding ART. Posse et al., (2008) define barriers to accessing ART as: “any factor 
occurring at the population level or health system level that restricts patients’ initiation of and 
continuation into ART” (Posse et al., 2008: 905). In keeping with Aday and Andersen’s 
(1974) framework they also recognise that both health system factors and patient factors 
influence barriers to accessing ART, and that barriers affecting the patient level are related to 
predisposing, enabling, and need factors. (Posse et al., 2008, Aday and Andersen, 1974).  
Posse et al., (2008) further highlight that barriers are context specific and that health care 
facilities should explore the barriers that are more pertinent to their specific community in 
order to influence policy changes and provide more effective, quality care that will ensure the 
continuation of ART service accessibility (Posse et al., 2008).  The generalized epidemic in 
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resource poor settings, or developing countries like South Africa, presents unique challenges 
to providing access to ART (Posse et al., 2008, Jones, 2010). Mukherjee et al., (2006) further 
note that: “a multitude of structural barriers prevent access to health care and the regular 
supply of antiretroviral drugs” (Mukherjee et al., 2006: 123). Posse et al., (2008) remark: 
“developing countries… the nature of their generalized HIV/AIDS epidemic and of their 
often fragile health system poses different problems when compared with developed 
countries” (Posse et al., 2008: 905).  
The UNAIDS (2003) Handbook on Access to ART identified the types of healthcare systems, 
economic and political factors, as well as the stage of the epidemic in a specific region as 
factors that can affect the extent to which people living with HIV/AIDS (PLWHA) can access 
treatment and care (UNAIDS and WHO, 2003, Mukherjee et al., 2006). Further to this 
Mukherjee et al., (2006) highlight that these barriers can also include medical care costs, lack 
of integration of primary health services with HIV services, long distances that contribute to 
transport costs making it difficult to attend the clinic monthly, family responsibilities and the 
expense of transport (Mukherjee et al., 2006). 
Posse et al., (2008) reviewed the barriers to accessing ART and found that lack of awareness 
of ART, patient level barriers including stigma, perceived high costs of ART and services, 
and lack of financial means were cited most commonly while fear of side effects and 
permission from a husband or partner were cited less frequently (Posse et al., 2008). Health 
system level barriers most commonly cited include length of travel time and distance to 
health facility, lack of consistency and coordination of services, and the “limited involvement 
of the community in the programme planning process”(Posse et al., 2008: 908). Posse et al., 
(2008) further note that health system barriers were less cited in the literature reviewed due to 
the fact that patient level barriers were more frequently investigated.  
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The barriers to accessing care, the literature reveals, affect the five components of the concept 
of access
22
. Physical barriers influence the accessibility and availability dimensions; 
organisational barriers affect the accommodative, acceptability, accessibility, affordability 
and availability dimensions; social barriers impact the acceptability, affordability and 
accommodative dimensions; and economic barriers can influence the affordability and 
accessibility dimensions. What is evident though is that the barriers, like the five components, 
are interlinked and affect each other as well. The various barriers identified in the literature 
can be classified into four broad categories namely; physical, organizational, social, and 
economic (UNAIDS 2003, UNAIDS 2009). 
3.2.1) Physical Barriers  
 
Physical barriers as discussed in the existing literature include factors such as distance to 
healthcare services; long travel distances and transport costs; difficult terrains to negotiate; 
limited transport availability; and danger (UNAIDS, 2003; Mukherjee et al., 2006; Harris et 
al., 2011). 
 
Transport and long travelling distance have been identified as some of the more significant 
physical barriers encountered by patients seeking ART treatment and care. Mukherjee et al., 
(2006), van Dyk (2010), and Jones (2010) mention that the physical distance between the 
location where people live and where the clinic or health care service is situated impacts on 
people’s ability to access their treatment especially if it results in increased transport costs 
(van Dyk, 2010). Ware et al., (2013) also found that travelling distance and increased expense 
resulted in disengagement with HIV services.    
 
                                                 
22
 The five components of access were discussed in the previous chapter. 
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Jones (2010) however presents a different perspective on physical barriers. In his study about 
access to ART he uses a geographic perspective to understand the barriers that people face 
when they want to access their treatment. Jones (2010) argues that a more geographical 
perspective allows for a broader understanding about the concept of access to health care and 
also about the barriers to access. Jones (2010) highlights in particular the geographical 
boundaries drawn around municipalities creating theoretical separation between areas. These 
boundaries capture the local people within a certain radius and according to primary health 
care policy prevents them from seeking health care in other districts. This in some cases can 
be very limiting, especially if some clinics in certain areas provide better quality service as 
compared to others (Jones, 2010). These administrative boundaries affect the concept of 
universal access to health care for all in particular since some people who fall within certain 
boundaries will be limited in their ability to access ART (Jones, 2010).  
A further concern about the locality of health services expressed in the literature is the fact 
that it does not accommodate well for the mobile population (Jones, 2010). The health policy 
states that people should seek health services that are situated within the communities where 
they live, a fundamental aspect of primary health care aimed at reducing the impact of 
distance on access to care (KZNHEALTH, 2003, Dennill et al., 1999). However, in the ART 
and mobile community setting this can present a challenge for individuals who are often 
away from their local community. Since the healthcare system, and especially the primary 
health care system, is fragmented patients are not able to collect ART at any other clinic, but 






These boundaries mentioned by Jones (2010) have a further effect on access by confining 
people to a certain area. In light of a highly stigmatised disease such as HIV/AIDS, this can 
be problematic for access since some patients feel self-conscious and are not willing to be 
seen at the local clinics for fear of gossip and discrimination among the community members 
(Jones, 2010).  
3.2.2) Organisational Barriers 
 
Organisational barriers, as highlighted in the literature, are factors such as lack of healthcare 
services; poor organisation and administration of healthcare services; lack of integration of 
services such as Tuberculosis and women’s health services; staff shortages; unreliable 
supplies of materials and drugs; lack of information about policies to support effective 
treatment; poor referral systems; long delays and time consuming procedures that result 
because of poor administration and record keeping; lack of confidentiality; inadequate 
counselling; lack of follow-up and the politicization of HIV and AIDS (UNAIDS, 2003; 
Sanjobo, et al., 2008; Mukherjee, et al., 2006).  
Barriers in the organisation can also be caused by national policies that inform protocols in 
the health care setting. Protocols are tools used to standardize treatment and care. These are 
particularly used in the public health care sector. Due to the generalized HIV epidemic in the 
country the department of health has standardized the treatment regimens for the general 
population. These standardizations are presented in protocols that are then operationalized at 
the local clinic level. However, policies and protocols are developed by government which is 
removed from the local ground level setting, and which does not always have the best 
understanding of the actual daily activities of the life in the clinic setting. This is evident in 
the work of Blaauw in Ige and Quinlan (2012) who mentions that “A national official noted: 
‘Some of the weaknesses inherent in any national programme… (are) that you are slightly 
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removed from the implementation level and essentially… you’re creating guidelines and 
policies and standards for something you are not involved in every single day” (Ige and 
Quinlan, 2012: 92).  
Human (2011) moreover documented how strict adherence by clinic staff to protocols can 
create barriers to accessing care. In his account Human (2011) captures the difficulty 
encountered by patients to be correctly diagnosed and prescribed appropriate medications 
when they fall out of the protocol guidelines (Human, 2011). Similarly protocols can be so 
strictly adhered to by clinic staff that little flexibility is given to address individual needs that 
might be related to factors other than biological disease.     
Sadoh et al., (2009), further document the effect that poor staff attitudes have on creating 
barriers to accessing HIV care by creating stigma and discrimination within the healthcare 
system. Further, Abdool Karim & Abdool Karim (2010) as well as Barnett & Whiteside 
(2006) point out that the expansion of the ART programme increases the volume of patients 
that the public healthcare system has to cope with while Brinkhof et al., (2008) indicate that 
facilities are unable to monitor defaulting patients closely or follow up on their adherence to 
treatment.    
The South African Human Rights Commission led a public inquiry into the accessibility of 
health care in South Africa. In their report released in 2009 they state that “The SAHRC has 
received many complaints with regard to poor service delivery in the public health care 
system in all provinces of South Africa. These complaints point to the lamentable state of 
many public hospitals in the country due to many factors, including a shortage of trained 
health care workers, a lack of drugs in clinics, lengthy waiting periods that patients endure 
before receiving treatment, poor infrastructure, a disregard for patients’ rights, a shortage of 
ambulance services and poor hospital management” (SAHRC, 2009: 4). The report further 
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notes that “access to health care services, especially for the poor, is severely constrained … 
by long waiting times at clinics and other health care service providers” (SAHRC, 2009: 6).  
Long waiting lists and waiting times have in fact, been cited as the most common complaints 
against the administrative aspect of organisational barriers (Gulliford et al., 2002). The 
monthly visits required by the ART policies are also a major barrier for people to continue 
their treatment as is the treatment by clinic staff. Ware et al., (2013) reported that one of their 
respondents remarked:  “they [staff] told me, ‘‘you are late.’’ Now, there are problems 
people face. I don’t know how they perceive it but for me this thing is very difficult. Attending 
clinic every month is very difficult, because you have to leave your work, sometimes report 
[to work] late—reasons like these. Everyone has problems. They are supposed to solve these 
problems with love, not harshly like they do. Until people are afraid of their words—abusive 
words. They behave as if we are there to beg for meds. It’s our right to get the meds. 
[Female, age 34] (Ware et al., 2013: 5). Ware et al., (2013) thus found that once patients 
have defaulted their treatment they become reluctant to return to the health care facility due 
to fear of being reprimanded by health care workers. They identify the reluctance to return to 
health services as a barrier to continuous access to care.   
These administrative barriers are important to consider as they can have real consequences on 
access to health care services. Gulliford et al., (2002) remark that: “organisational barriers to 
access may result in delays in treatment, which can cause dissatisfaction among users and 






3.2.3) Social Barriers 
 
Social barriers outlined in the literature include personal beliefs; attitudes towards treatment; 
the stigmatising category of ‘risk group’ identification and labelling; false cures; lack of 
social and family support; lack of education; community attitudes towards PLWHA; religious 
beliefs; and culture (UNAIDS, 2003). In addition Sanjobo et al (2008) identify factors such as 
side-effects; pill burden; forgetfulness; lack of emotional and social support; and general 
improvement in health as barriers to adherence.  
The patient’s own health and illness beliefs have also been identified as key aspects that 
could influence access to HIV related health care services (Jones, 2010). In Jonny Steinberg’s 
account about HIV services in the Eastern Cape, he captures the resistance of ‘Sizwe’ to have 
an HIV test and to engage with the HIV health care system (Steinberg, 2008). ‘Sizwe’s’ fear 
of ART is not limited to him alone. Many patients access ART when it is too late, and their 
CD4 count is already too low. Furthermore, limited information about ART, the literature 
indicates, has led to widespread rumours about the drugs. These rumours are closely linked to 
the assumption in the communities that ART is synonymous with dying (Jones, 2010). When 
patients commence ART at such a late stage of disease progression, the drugs are ineffective 
or cause the life-threatening Immune Reconstitution Inflammation Syndrome (IRIS) and 
when they die the families and communities associate it with the usage of ART drugs 
(Steinberg, 2008, Jones, 2010).    
The fear of the side effects of ART has been influenced by the damaging reviews of the 
effectiveness of ART by the South African government. The fear and doubt about the toxicity 
of the drugs expressed by the political leaders, including the national minister of health, has 
spread to the population (Jones, 2010, Ige and Quinlan, 2012, Steinberg, 2008). Jones (2010) 
reports that in his study patients expressed concern about the government’s perception of the 
57 
 
drugs and some felt that the “government was deliberately hiding information from them” 
(Jones, 2010: 32). Even though the political leadership has changed and the government, 
along with the minister of health is now in favour of using ART, the unfortunate messages 
about ART are embedded within the living memories of the people in local communities 
(Fassin, 2007). While it was relatively simple for political leadership to change the policy 
regarding supply of ART to the general public, it remains a lasting challenge to change 
formed perceptions that people now have about the drugs (Fassin, 2007). Jones (2010) reports 
that one respondent in his study said that: “our leaders should not say negative things about 
ARV’s. People were going to go for ARV’s freely without fear. But we are not free” (Jones, 
2010: 32).  
Social responsibilities have also been identified as barriers to accessing ART services (Ware 
et al., 2013, Merten et al., 2010, Gari et al., 2013). In some instances patients are obligated to 
attend to family matters or engagements which results in them missing their appointments at 
the ART clinics (Ware et al., 2013).  Gari et al., (2013) and Ware et al., (2009), however, 
found that social relationships and ties are vital for patients to be able to access their 
treatment by providing social and financial support. These social relationships create a sense 
of obligation to improve their health which further helps with adherence to ART (Ware et al., 
2009). However in instances where social support does not exist, patients experience greater 
difficult in accessing their ART (Gari et al., 2013).     
Gender as a social phenomenon has implications on accessibility to HIV related treatment 
and this is given much attention in the literature. Women make up more than 50% of all 
people infected with HIV, and HIV is now the leading cause of death for women between the 
ages of 15-49 years worldwide (UNAIDS, 2010). This statistic indicates that females are less 
able to access ART for a host of reasons including economic oppression; disempowerment; 
limited education and lack of decision making power. Their role as primary caregivers in the 
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family structure often means that females are not able to attend to their own illness (Murray 
et al., 2009). Being female was furthermore found to be a barrier to accessing ART (Gari et 
el., 2013). Merten et al. (2010) in their meta-ethnography reviewing barriers to adherence 
found that women often do not have the power to decide over household resources which 
limits their ability to access ART. Further to this men can deny them access by withholding 
resources or by blaming them for infection with the virus (Merten et al., 2010).  
Gender does however also impact upon men. In the literature the discrepancy between the 
female and male ratios is noticeable. Jones (2010) noted is his study that the ratio between the 
female and male patients was 60 per cent females as compared to 40 per cent males. The lack 
of men coming forward to start treatment has been identified as being a point of concern is 
other ART clinics (Jones, 2010).  
Stigma is another social barrier that has been identified by UNAIDS (2010) as one of the key 
social barriers to accessing HIV-related health care (UNAIDS 2010). Stigma not only 
prevents people from testing but can also prevent them from taking their treatment. This is 
evident in the words of Abdool Karim et al., (2010) who point out: “Stigma, and its 
concomitant discrimination, are some of the most critical reasons for the failure of prevention 
programmes providing a major barrier to accessing HIV prevention, care and support 
services” (Abdool Karim and Abdool Karim, 2010: 588).  
The main area where patients experience stigma is in their local communities. Jones (2010) 
noted that a lack of accurate information about the ART drugs and a skewed message from 
the government has contributed to the discrimination that patients feel. Stigma has 
implications for access because of the heavy focus on adherence and counselling. Patients are 
encouraged to have a treatment supporter, someone whom they can confide in and share their 
disease burden with. Although it has been found that a treatment supporter can greatly assist 
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with adherence and access to ART, it does require disclosure of a patient’s HIV sero-status 
(Jones, 2010, Van Dyk, 2012). Disclosure of HIV status has implications for accessing ART. 
Some patients are too afraid to disclose their status and, from a lack of accurate information 
supplied by the department of health to communities, some patients assume that a ‘treatment 
buddy’ is a necessary requirement (Jones, 2010). This assumption is however often founded 
on reality as Jones (2010) points out that some patients are actually turned away from health 
care facilities if they do not have a treatment supporter (Jones, 2010). Their fear of disclosure 
does not only hold relevance in the initial access to ART, but has implications for continuous 
care as well. If a patient does not feel secure enough to disclose her/his status and share the 
disease burden with a family member or trusted relative, then life-long commitment to an 
ART regimen is in jeopardy. This discrimination and fear leads to behaviours such as hiding 
ART drugs from family members (Van Dyk, 2012, Jones, 2010). Discovery of the drugs can 
have devastating consequences for some patients who live in stressful and highly stigmatized 
environments, thus limiting their ability to continue accessing their ART (Jones, 2010). 
Stigma and discrimination is not limited to the communities where the patients live. Stigma is 
also found within the healthcare sector itself. This has consequences for access to health care, 
in particular HIV related services and treatment (Jones, 2010).  
Jones (2010) notes that confrontation of stigma and discrimination can start as soon as the 
patient enters the health care facility, where they firstly have to face the hospital clerks 
(Jones, 2010). This is the first point of entry into the health facility and as a result also 
represents one of the most important operational aspects of access to treatment. Jones (2010) 
found that patients felt discriminated against by hospital clerks who gossip about their HIV 
positive status amongst themselves and with other patients and staff (Jones, 2010). This, 
according to Jones (2010), has implication for access to ART since HIV positive patients feel 
too afraid to return to the same health care facility for fear of discrimination (Jones, 2010).  
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Fear and guilt imposed onto the patients for missing visits or not complying as they were 
initially instructed to do also creates barriers for patients to remain and return to care (Ware et 
al., 2013). Terms such as defaulter and lost to follow-up that are used within the clinics to 
identify those patients who have interrupted their treatment visits further perpetuate the 
discrimination of HIV positive patients by health care workers.  
Ware et al., (2013) further report that patients are often treated harshly by health care workers 
if they do not comply exactly as they are instructed. One male participant in their study 
remarked “I felt humiliated. I felt very bad. After receiving the services I was full of pain. 
After that incident I didn’t go back to the hospital. I decided to leave everything and opt for 
fruits and food…and until now I am not taking it [ART].” [Male, age 60] (Ware et al., 2013: 
5). This finding is likewise expressed by Jones (2010) who reports that patients are often 
judged by health care workers, not only because of their HIV status but also by their inability 
to adhere to treatment regimens; this judgment will often result in decreased levels of care 
being offered to the patients (Jones, 2010).   
Sadoh et al., (2009) found that health care workers were far more agreeable to treat patients 
who are HIV positive than to receive care by a colleague whom they know is HIV positive 
(Sadoh et al., 2009). This is a significant finding for stigma in the health care sector since 
health care workers are supposedly best educated regarding the modes of HIV infection 
(Sadoh et al., 2009).  
Even more important than the perpetuating discrimination by such attitudes is the limit that 
health care workers are willing to place on the extent to which they are prepared to provide 
care for those patients who are HIV positive. Holzemer et al., (2006) found that the 
healthcare sector provides an opportunity for stigma since: “they are primary settings in 
which stigma can be triggered and also where stigma can manifest” (Holzemer et al., 2006). 
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This opportunity for stigma has resulted too often in the denial of care to those patients 
identified as being HIV positive, as Holzemer et al., (2006) further noted: “sometimes the 
patient is denied the right health care simply because he/she is infected with the HIV virus” 
(Holzemer et al., 2006: 546).     
The literature moreover identifies certain cultural practices and beliefs about HIV/AIDS and 
its related treatment as a barrier. Some of these cultural barriers include myths about HIV and 
AIDS, ‘false cures’, cultural concepts of health, traditional healing methods and treatments, 
and HIV/AIDS as a taboo subject (UNAIDS, 2003).   
3.2.4) Economic Barriers 
 
The strong economic emphasis in the literature further suggests that the fight against 
HIV/AIDS has also become the fight against poverty as there is a clear link between 
HIV/AIDS and poverty in the literature. Barnett and Whiteside (2006) thus highlight the 
effects of the commodification of health in terms of “those who can purchase healthcare and 
those who cannot” (Barnett and Whiteside, 2006: 6). This link between HIV/AIDS and 
poverty is clearly articulated in the words of Brundlant in Schwartlander et al., (2006) who 
state, “Does anyone deserve to be sentenced to certain death because she or he cannot access 
care that costs less than US$2 a day? Is anyone’s life worth so little? Should any family 
become destitute as a result? Should children be orphaned? The answers must be no, no, no 
and no! Yet this is what is happening. Every day.” (Brundtland in Schwartlander et al., 2006: 
544)                                                                                                                                                      
The literature further states that for drugs to be available four key factors need to be met, 
namely: Firstly, good quality, safe, and effective drugs need to be selected. Secondly, the 
drugs must be affordable enough for the governments and the people who need them. 
Thirdly, the financing for these drugs needs to be sustained to ensure a continuous supply of 
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drugs. Fourthly, healthcare systems need to have policies in place that ensure that the drugs 
are made available at healthcare facilities, especially where they are needed most (UNAIDS, 
WHO, UNDP, 2011; UNAIDS, 2003). 
Cost of drugs presented a major problem for developing countries to provide ART in the 
earlier years of the epidemic when ART was first made available. Indeed, one of the reasons 
given by the South African government for the delay in providing ART to the general 
population was due to the high cost of the drugs. The government claimed that it was unable 
to afford the costs to supply ART to the general population (Govender in Cullinan and Thom, 
2009). 
Since then major efforts by the international community, global organisations, and 
governments have resulted in reduced cost prices of the drugs and flexibilities has been 
created in terms of patent laws. In South Africa a ruling by the Constitutional Court and an 
earlier victory by the South African Government over pharmaceutical companies’ restrictive 
prices, and the provision to allow for cheaper generic drugs to be imported along with the 
more expensive drugs, has resulted in the cost of ART in South Africa being  remarkably 
reduced. This has resulted in the free provision of ART to the general population who rely on 
the public health care sector for treatment (WHO et al., 2010).  
However, there still remain some monetary expenses involved when patients access their 
ART and Fried et al., (2011) note, that costs involved in accessing ART services presents a 
barrier for continuous access and retention in care. Posse et al., (2008) further note that: “The 
cost of drugs seems not to be the most important constraint of access to ART, as many of the 
drugs are provided free of cost to eligible patients through combined efforts by countries and 
bilateral and multilateral partners” (Posse et al., 2008: 904). Financial expenses for the 
patient, known as ‘out-of-pocket’ expenses, refer to those costs that are not thought of when 
63 
 
discussing free medical care. These costs may include paying a fee for the hospital cards, 
pharmaceutical products, or specialised services related to their illness (Gulliford et al., 
2002). Further to these cost of transport, frequent trips to the clinics for medication refills, 
and cost of appropriate food to eat may present additional financial problems (Mukherjee et 
al., 2006, Posse et al., 2008).  
Jones (2010), Merten et al., (2010), and Ware et al., (2013) all found that food, money and 
transport costs were concerns mentioned in their study when it came to the economic aspect 
of access to ART. Hunger and food insecurity remains a major concern as poverty continues 
to have a devastating effect on HIV positive patients. Hunger can present a very important 
barrier to accessing ART if money is scarce in the household. Patients have reported that they 
would have to sacrifice ART transport money for food money (Jones, 2010).  
Jones (2010) further notes that a participant mentioned to him that: “she ‘skips’ treatment 
appointments because of lack of travelling funds” (Jones, 2010: 33). The cost of transport to 
clinics is proving to be a serious barrier for patients. Most participants in Jones’ (2010) study 
complained that lack of money for transport presents a very real challenge for them to 
continually access their treatment. Gulliford et al., (2002) also notes that travelling costs and 
time off work also contribute to the financial expense to access ART, even though it is 
indirectly incurred. 
However the economic costs are not just limited to the out-of-pocket expenses. Monthly 
visits can affect job security as well, thereby further contributing to the poverty cycle in 
which most HIV positive patients already find themselves. Jones (2010) noted how one 
participant in his study told him that: “she had lost her job because of the lack of flexibility in 
the system for treatment provision and subsequent need for time from work spent queuing” 
(Jones, 2010: 33).  
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The strong economic focus on access to ART in the literature skews the belief that access is 
merely a case of affordability and availability. This is further exacerbated by the use of 
quantitative research that only lists the barriers without contextualizing them with more in-
depth understanding. Often in the literature about access to healthcare and ART the focus is 
shifted to adherence and there clearly is a need for these two concepts to be considered 
independently. This shifting of classification has resulted in the inappropriate use of the term 
access and on focusing only on the availability of actual ART drugs without considering the 
wider understanding of what access means. This further results in misclassification and 
incorrect use of the term barriers to access, which is limited most often to focus on the patient 
instead of considering the role that the healthcare system plays in creating and perpetuating 
the barriers to accessing ART. This study thus uses the broader definition of access to 
healthcare to better understand the meaning behind the barriers and the structural drivers that 
create barriers to access, as opposed to merely zooming in on factors related to adherence 
only.   
Having outlined the key themes in the literature in terms of the barriers to accessing ART and 
the interrelatedness of the barriers; in the remainder of the chapter I now focus on the key 














3.3) Structural Violence Theory  
 
“Violence is present when people are prevented from reaching their potential” (Galtung, 
1969: 168) 
 
If we consider Aday and Andersen’s (1981) definition of access to health care as the potential 
and actual entry into the health care system, then using Galtung’s Structural Violence Theory 
becomes relevant in the pursuit of understanding the causes behind barriers to access.  
In 1969 Johann Galtung asked what constitutes violence. According to Galtung (1969: 168) 
“violence is present when human beings are being influenced so that their actual somatic and 
mental realizations are below their potential realizations ”. He further defines violence as “the 
cause of the difference between the potential and the actual, between what could have been 
and what is. Violence is that which increases the distance between the potential and the 
actual, and that which impedes the decrease of this distance” (Galtung, 1969: 168).  
In his work, Galtung (1969) argues that the definition of violence should be extended beyond 
mere physical violence. He describes distinctions between different types of violence with the 
most important distinguishing factor being the subject who enacts the violence. For Galtung 
(1969) when there is an actor that commits direct violence it is described as personal or direct 
violence, but where there is no actor present it is defined as structural or indirect violence 
(Galtung, 1969).  
Galtung (1969) further explains that if there is a situation where harm is experienced but it is 
avoidable then violence is present. He uses the example of a limited lifespan. During historic 
times a limited lifespan would be unavoidable and expected. In today’s time with all the 
medical advances and technology available to increase lifespan, a limited lifespan is a result 
of structural violence. Similarly we can compare those who are infected with HIV. HIV is a 
preventable disease but people are infected daily. Moreover there is effective treatment 
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available that can restore the lifespan of those infected back to normal yet there are people 
dying because they do not have access to treatment, or they gain access which is then 
interrupted by obstacles that are caused by larger structural forces. Suffering and violence is 
brought into action everyday by those who suffer under these forces. 
Structural violence can therefore be characterized by the structures that are present within 
society such as economic, political, legal, religious and cultural that prevents people from 
achieving their potential (Farmer et al., 2006). The violence is found in peoples’ subjection to 
structures that create ways of being that have a negative effect in their lives. These processes 
are ubiquitous and mostly invisible, yet their frequent occurrence makes them ordinary and 
acceptable. For the person subjected to the violence there is no perceived threat. The violence 
is so embedded within the fabric of everyday life that those subjected to the violence are not 
aware of it.  
Pool and Geissler (2011) further explain the concept of structural violence and highlight the 
importance of gender, socio-economic standing and race when they note “the constraints on 
behaviour and options imposed by institutionalized inequalities in wealth and power on those 
who are underprivileged: mainly women, the poor, and those of colour” (Pool and Geissler, 
2011). Examples of structural violence include racism, poverty, sexism, ageism, pollution, 
under and unemployment, military invasions, and medical inequalities such as disparate 
access to healthcare services (Farmer et al., 2006).  
By using this expanded definition of violence to include structural violence, a broader 
understanding can be gleaned about how the barriers to accessing HIV related healthcare 
prevent people from reaching their potential by limiting their ability to continually access 
ART drugs. The disruptions that these barriers cause, results in physical suffering in the form 
of opportunistic diseases that could lead to premature death.  
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Besides the physical disease threat, the structural barriers enforced by the healthcare 
institutions through policies that are not well informed, result in other suffering such as 
perpetuating poverty. HIV/AIDS has long been associated with poverty, and the link between 
the two phenomena has been established, (see for example Barnett and Whiteside, 2006). 
Most people who suffer from HIV infection live in poverty. This creates difficulties for them 
to access ART and to remain in the ART programs. Financial barriers pose a major problem 
for people especially in terms of reaching the healthcare facilities to collect their drugs as 
well as taking the treatment at home. Food insecurity is a problem for many of the PLWHA, 
and can result in difficulties in accessing ART and in remaining adherent due to the fact that 
they do not have enough food to eat.  
Structural violence theory then can be used to identify the reasons behind inequalities to 
accessing healthcare services. Farmer (2001) has used this theory extensively in his work in 
Haiti and argues that HIV/AIDS is interlinked with social processes and therefore that the 
driving factors behind the epidemic must be understood from a structural point of view. 
Structural violence can be used to understand how forces such as poverty and sexism impact 
and fuel the epidemic, and it can help identify those people who are marginalized and suffer 
the greatest (Paul Farmer, 2004).   
South Africa has one of the highest rates of inequality in the world and the healthcare system 
reflects this situation as it is sharply divided between those who can afford quality health care 
and those who cannot (Barnett and Whiteside, 2006). Farmer (2003) refers to this situation as 
the commodification of healthcare which further exacerbates the destructive forces of poverty 





Adherence in the clinic and ARV-programs is often understood as a personal and individual 
activity. The risk then to default on treatment is consequently also explained in individual 
terms. Ware et al., (2013) elaborate on this when they remark that “lost to follow-up connotes 
clinics’ difficulties in keeping track of patients, while patient-centred terms –the currently 
preferred ‘disengagement’ or the African term ‘defaulter’ –imply that missed visits result 
from patient choice” (Ware et al., 2013). This stance of placing the onus on the patients for 
missed visits stems from the biomedical viewpoint that the individual is responsible for 
her/his own health; a view which is supported by the commodification of healthcare. The 
individualistic model frequently overlooks the fact that heath is situated in the broader 
context of culture and society. This skewed view contributes to the mystification of 
biomedicine and thereby places the blame on the patients while protecting the health care 
system and those involved in producing policies and protocols related to functions of the 
health care system.   
If we return to the definition of violence as proposed by Galtung (1969: 168) as being 
“present when human beings are being influenced so that their actual somatic and mental 
realizations are below their potential realizations” we can appreciate that people have it in 
them (the desire and personal ability) to be adherent and comply with their treatment 
regimens, but there are forces around them that can prevent them from realizing this goal. 
Policies guiding the implementation of the ART program are constructed away from the 
reality of the setting and, quite often, those who make the policies do not have a thorough 
understanding and appreciation for the plight of the patients and the everyday constraints of 
the public health care system (Ige and Quinlan, 2012).  By using structural violence theory 
we can try and understand that this ‘individual risk’ actually forms part of much larger socio-
political and economic structures that create risk. Individual behaviours are embedded in the 
social settings and must therefore be understood and explained within these structures.   
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Hunter (2010) criticizes the use of structural violence in the HIV/AIDS setting by saying that 
the theory’s main focus is on the larger socio-political forces that marginalize people but fails 
to address the daily-life inequalities that people experience, especially those who suffer from 
HIV and AIDS. Hunter (2010) further suggests that the use of structural violence in the 
context of HIV/AIDS fails to make a clear distinction between the victim and the victimizer 
(Hunter, 2010). Another critique of Galtung’s definition relates to the invisibility of the 
violence. Galtung (1969) argued that because the violence subjected onto people is invisible 
it is difficult to act against it. Winter et al., (2012) however argue that the invisibility of the 
violence lies in the “normalcy of everyday violence that allows it to be inherited across 
generations and renders it ‘invisible’” (Dilts, 2012). Dilts (2012) further argues that 
“structural violence’s invisibility is more likely because of violence’s ceaseless repetition in 
the open rather than because it has been hidden away in a dark or subterranean place” (Dilts, 
2012: 192). It is however this ‘normalcy in everyday violence’, as first described by Scheper-
Hughes (1992) that is manifested in the public healthcare setting, albeit difficult to identify, 
that presents barriers for patients to access their ART treatment.  
In this chapter the various barriers to accessing ART healthcare have been highlighted. 
Further to this the use of structural violence theory has been discussed as a theory to 
understand the barriers to accessing ART for people living with HIV/AIDS. The barriers can 









CHAPTER FOUR: Methodology  
 
4.1) The Ethnographic Approach in Health Care Research 
 
This research was conducted using an ethnographic approach that falls under the broader 
classification of qualitative research. The aim was to obtain a holistic view of the people and 
place where patients collect their anti-retroviral treatment. More specifically the aim of this 
project was to elucidate the barriers to accessing HIV/AIDS related health care services in a 
public sector clinic. The objectives were to identify the most important barriers, as perceived 
by the patients once they have been on ART for some time, to assess the impact that these 
barriers have on the patients’ ability to continually access their treatment and to capture the 
patients’ reactions to the perceived barriers in the clinic. 
The ethnographic approach allows for the research to be situated within the context of the 
collected data and is used to gain deep insight into the subjects studied. By using ethnography 
to describe the group or culture in detail the anthropologist makes use of thick description
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to produce ethnographies. In-depth research reveals information that is hidden from mere 
surveys and questionnaires. The detailed analyses produced about the subjects and their 
interactions with their environment reveals the meaning and inter-related webs behind 
behaviours (Fetterman, 1989). The approach allows for data to be collected in a structured 
and logical manner. The holistic approach, the hallmark of ethnography, allows for the 
‘insider’ and ‘outsider’ view to be taken into consideration and thereby facilitates a more 
robust understanding of a certain group of people and their behaviour (Pool and Geissler, 
2005, Hansen, 2006).   
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connected contexts that are relevant for understanding the phenomenon in question’ (POOL, R. & GEISSLER, 




A central feature of ethnography is thus the use of the insider’s perspective, also known as 
the emic perspective (Pool and Geissler, 2005). This perspective is integral to understand 
why certain members of a group behave in a certain way. Those researchers who prefer emic 
data tend to be more idealistic and phenomenological in their perspectives. Although post-
modernism theory argues that one can never truly adopt the perspective of another, 
ethnographers acknowledge this situation and thereby attempt to be as open-minded about 
their fieldwork as possible (Bernard, 2002). The etic perspective, in contrast, is the external 
view of the scientific researcher into the culture of the group studied (Pool and Geissler, 
2005). This stance is materialistic and positivistic in philosophical terms. This viewpoint 
favours that of the researcher and scientific theory over that of the subject being studied. The 
aim of the anthropologist is to gather as much data as possible from the emic perspective but 
then to try and understand and explain it from the etic perspective. This shift between the 
emic and etic perspective is therefore very important in ethnography.   
Ethnography has been used successfully in healthcare settings to conduct research. Although 
research in the health care setting is generally not conducted over as long a period as 
traditional anthropologists ascribe too, it remains a valuable method to use (Willis, 2010). 
Ethnography has been used to develop health focused interventions, to investigate illness 
behaviours and cultural practices dictating health behaviours, and has brought to light the 
specific health care needs of various populations. Despite the range of subjects that can be 
investigated using ethnography it has also been found to be a useful measure of the 
effectiveness of quantitative methods within healthcare research (Savage, 2006).  
Gifford (1996) stated that “qualitative… health care research has the ability to describe in 
depth the experiences of the peoples’ lives and the social context that strengthen, support and 
diminish health. It has the ability to humanize the research process and to lead the context 
specific strategies for the individual and collective change” (Gifford in Hansen, 2006: 47).  
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Increasingly qualitative research is being recognised for the value that it can add to healthcare 
research. In some instances it is mandatory to conduct a qualitative study prior to a 
quantitative study in order to obtain more detailed information about the research setting and 
to understand the problem in greater detail. Ethnography with its various and multiple 
methods of data collection and detailed descriptions then becomes one of the best qualitative 
methods to collect data when the research subject is new or unfamiliar (Savage, 2006).  
The usefulness of ethnography in the healthcare setting is found in the perspective it offers on 
research problems. Quantitative methods of inquiry are removed and distant from the 
researched and often ask the ‘wrong questions’, according to participants, and miss what is 
actually happening in the healthcare setting (Savage, 2006, Greenhalgh, 2010). Ethnography 
allows for close interaction between the researcher and the researched and provides a unique 
insight into the setting. Its main strength in healthcare research lies in its ability to explain 
instead of merely just measure a problem. It also provides deep insight into problems 
identified and creates hypotheses to test. As Savage (2006) points out “it can reach the areas 
that quantitative research cannot reach” (Savage 2006: 391). 
Although ethnographic research presents many positives in the health care setting there are 
however a few drawbacks when conducting an ethnographic study. As with all qualitative 
research, ethnographic evidence is not generalizable, is subjected to biases, is difficult to 
evaluate and is generally not very reliable in terms of repeatability. Time is another important 
factor. Traditionally ethnographies were conducted over lengthy periods of time. In the 
healthcare setting, as noted, this has presented as a challenge and as a result ethnographies 
have shortened; however these time-bound problems are not just confined to ethnographic 
accounts but affect all research done within this setting. Besides this problem, the rapidly 
changing healthcare system poses a threat to the validity of ethnographic accounts (Willis, 
2010). In addition, testing ethnography remains a problem for those who wish to establish it 
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as a research method in the health care setting as due to the varied nature of ethnography 
there is no rigorous ‘check list’ available with which to test the results  produced 
(Greenhalgh, 2010).   
However, despite these drawbacks, ethnography has made and continues to make major 
contributions to the study of health care settings. The importance of the approach is evident in 
the words of Scheper-Hughes (2004: 4) following her use of ethnography in health care 
settings: “I wonder if any other discipline is better suited or situated than anthropology to 
interrogate values and practices from a position of epistemological openness and to offer 
alternatives to the limited pragmatic utilitarianism that dominate medical bioethical thinking 
today” (Scheper-Hughes, 2004).  
There are two types of ethnographic viewpoints in the healthcare setting. One, being 
ethnography within the healthcare setting; the other being ethnography about the health care 
setting (Pool and Geissler, 2005).This research project’s focus is about the health care setting. 
Van Dyk (2010) has criticized previous studies on access and adherence to treatment because 
of the ‘artificial environment’ that such studies have created (van Dyk, 2010). She further 
argues that for this reason a skewed image about access to treatment and adherence has been 
produced. In order to present a more holistic analysis an ethnographic approach that included 
mixed method techniques to collect data was employed. While the study was largely 
qualitative in nature, some quantitative data collection was also done to correlate some of the 
findings. This ethnographic research project therefore utilized a triangulation of research 
methods to collect the data required. Triangulation in qualitative research is common and 
often recommended. According to Thurmond (2001) triangulation of research methods 
consists of a combination of more than two data collection techniques, investigators, 
analytical methods, methodological approaches or theoretical approaches (Thurmond, 2001). 
Four different methods were used to gather the data required for this project. Participant 
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observation, focus groups, semi-structured interviews, and questionnaires were used to 
collect the data. The strength of triangulation provided support for the findings where one 
method alone would not have sufficed. Triangulation therefore allows for a more holistic 
view and increases the validity of the findings (Thurmond, 2001).     
Combining qualitative and quantitative methods provided the opportunity for two 
perspectives of the research problem to be gained.  The qualitative methods allowed for the 
identification of the barriers that people experience and it also provided a deeper insight into 
the extent that these barriers impact upon peoples’ lives. The quantitative method provided a 
confirmatory perspective which showed how relevant the particular problems are to the 
clinic’s adult population.  
To identify the barriers and assess the impact that they have on the patient’s ability to access 
their treatment, focus groups, semi-structured interviews and questionnaire were conducted. 
To capture and explore the patients’ reactions to their perceived barriers, participant 
observation was done. The behaviour that was noticed in the clinic as a reaction to the 












4.2) Study area, population and inclusion and exclusion criteria 
 
Patients were recruited for this study from the public health clinic that provides HIV/AIDS 
related services at the hospital. Only patients were included in this study since they are the 
users of the health care system and are thus best placed to evaluate whether they have access 
to health care services or not. As mentioned previously the clinic is located at a large public 
sector hospital in Durban that falls in the province of KwaZulu Natal. This particular clinic 
provides ART services for paediatrics, obstetrics and adult patients. The services include 
screening of eligibility to commence ART, adherence counselling, examination by a nurse 
and a doctor, referral to social services and referral to a dietician if required. Referral to 
specialised services, such as dermatology, is facilitated by the fact that the clinic is located 
within a large tertiary hospital.  
The participants of the study reflected that of the clinic’s adult population and consisted of 
adult men and women aged between 18 years and 65 years. The adult population in the clinic 
ranges from ages 18 to 65 years and mainly consists of isiZulu-speaking patients. Reflecting 
the national demographics of the epidemic, women make up more than half of the population 
of the clinic.  
This project investigated barriers only experienced by the adult patients of the clinic. Adults 
are classified in the South African health care system as any person over the age of 18 years, 
which corresponds with the Children’s Act of 2005 which states: “a child, whether male or 
female, becomes a major upon reaching the age of 18 years” (The Children’s Act of 2005, 
Act no 38 of 2005). This age is significant since the clinic offers services to both paediatric 
and adult patients. Once paediatric patients turn 18 years old they are transferred over to the 
adult side of the clinic.  
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Criteria for patients to participate in the research project had to be uniform across the 
research methods. It was not possible to observe one category of adult patients as separate 
from another. A key reason for this is that all the adult patients are serviced in a particular 
area of the clinic and it was not possible to know, just from observation, which age categories 
they fall into, or to observe the male patients separately from the female. The focus groups 
and the semi-structured interviews also comprised of a variety of participants spanning the 
adult age range from 18 years to 65 years.  
The inclusion criteria for the study then comprised of adult patients aged 18 years and over 
who were already enrolled in the ART programme and receiving anti-retroviral treatment for 
a period longer than one year. A period of one year on ART was chosen since this projected 
aimed to investigate the barriers to continuous access to ART health care services. New 
patients experience a different set of barriers that can overlap with the barriers that patients’ 
experience who have been in the system longer, but, the focus of the study is on the barriers 
experienced over a longer period of time. Also, patients tend to experience more side-effects 
and complications due to the ART drugs within the first year of starting treatment. Exclusion 
criteria included any patient who did not voluntarily agree to participate. Patients were also 











4.3) Sampling and size 
 
Non-probability, purposive sampling was used for the qualitative data collection. This form 
of sampling is consistent with sampling when using qualitative data. Purposive sampling is 
appropriate for sampling key informants required for interviews. Key informants are 
participants in a research study that can provide in-depth data, but does require good rapport 
being established between the researcher and the participant (Bernard, 2002). Good rapport is 
essential for ethnography as a whole. Having worked at the clinic for four years I have come 
to know some of the patients in the clinics well by working closely with them. Two of these 
patients became key informants for the study and they participated in the semi-structured 
interviews.  
Initially during the questionnaire piloting phase sampling for the quantitative data was done 
using simple random sampling techniques, but this proved structurally difficult to do. The 
primary reason for this is that even after careful explanation about the research project some 
patients were suspicious as to why their particular file numbers were selected and others felt 
left out and insisted on participating in the project; this created some tensions amongst the 
patients.  Bernard (2002) notes, that it is sometimes difficult to conduct random sampling in 
the real research setting, especially when the research involves humans. Bernard (2002) 
suggests that in such cases, “use a nonprobability sample and document the bias”(Bernard, 
2002: 180).  
The sampling method was then changed to convenience sampling to collect the quantitative 
data so as to avoid further complications in the setting and to ensure that the data would be 




4.4) Data Collection Instruments and Process 
 
4.4.1) Participant observation 
 
“Participant observation means that you try to experience the life of your informants to the 
extent possible; it doesn’t mean that you try and melt into the background and become a 
fully accepted member of a culture other than your own” (Bernard, 2002: 368) 
Participant observation is one of the core methods of data collection for ethnographic studies. 
It gives the researcher the opportunity to interact on a more intimate level with the people 
being studied. This vantage point allows for a closer approximation to the real, everyday truth 
of the condition in which the subjects find themselves. Participant observation is an 
observational technique that is used to gain an insider’s perspective into the community being 
studied. As an essential method in any ethnography, it provides the insight and perspective 
required for ethnographic approaches.    
Participant observation is advantageous for placing the researcher in the research setting. This 
viewpoint allows for first-hand experience and the opportunity to observe what is actually 
happening instead of merely being told.  This allows for a deeper understanding of the 
research setting, the population, and the problem being investigated. This further gives the 
researcher the opportunity to contextualize the data. Furthermore participant observation is 
very useful in establishing rapport with research participants, especially where rapport is 
essential for in-depth semi structured interviews. Another practical advantage is that little 
funding or equipment is required to collect the information.  
Participant observation is useful for studying topics where little or limited information is 
available, where there are differences in the view points of ‘insiders’ vs. ‘outsiders’, where 
the problem is somehow obscured from outsiders, or hidden from public view. It has 
particularly usefulness for exploring and describing problems and the data collected. It is a 
relatively unobtrusive method by which to collect rich, detailed information from the 
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insider’s point of view. What people say they do and what they actually do are often two 
different realities. For this reason, being present and participating in the research setting 
provides the researcher with the opportunity to see things for what they really are and 
approximate the data closer to the truth. 
Participant observation was the first research method used for this research endeavour. This 
provided a better understanding of the clinic’s population and the setting and continued until 
the end of the data collection period. In total participant observation was conducted for a 
period of six months. 
Careful field notes were taken on a daily basis detailing the events of the clinic. Participant 
observation was not structured and this allowed for the natural flow of the clinic to unfold on 
a daily basis, however, some clear topics were outlined that assisted with observing. These 
topics included observing the flow and movement of patients throughout the clinic and 
detailing their interactions with the various health care personnel and their general actions 
when collecting treatment. Participant observation took place during the operating hours of 
the clinic from 07:00am to 16:00pm. Participant observation was conducted for an average of 
five hours every day during the six month period.   
The data obtained was compiled in systematic field note entries into a journal and was then 
analysed and this provided a deeper understanding of the setting and the people who played a 
part in it. It provided me with the opportunity to experience on a daily basis how the clinic 
functions, how all the characters interact with each other, what processes are adhered to and 
how these factors influence access to treatment and health care services. The use of 
participant observation thus provided me with an insight into the everyday interactive 
experiences between the patients and the health care sector and their endeavour to access 
health care services. Participant observation was also the data collection method for 
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observing the patients’ reactions to perceived barriers. These reactions were further explored 
by the focus groups and semi-structured interviews.   
Participant observation further provided me, as a researcher, with the opportunity to develop 
close interactions with some of the patients of the clinic. This rapport was particularly helpful 
during the semi-structured interviews which were conducted post participant observation.  
Participant observation can however be challenging and like most data collection tools has 
certain disadvantages. One major difficulty that I was confronted with was that I could not be 
everywhere simultaneously. Only one event could be observed and/or participated in at any 
given time. This forced me to be selective about where I wanted to be which introduces bias. 
Another major dilemma that I experienced is the dual role that I had to adopt while 
conducting participant observation. The method requires for the researcher to be both a 
participant of the group and a researcher. This became problematic when I wanted to write 
and record data that I had observed but was constrained by my role in participating with 
patient care. The presence of a researcher in the setting does influence the behaviour of the 
population being studied. The patients and staff of the clinic knew from the beginning that I 
was the ‘research nurse’, and not one of the clinic staff. This I felt changed their behaviour 
towards me somewhat. For those patients who came to know me I became an extra source of 
help. When they were facing some problem in the clinic, such as a lost file, or if they were in 
a hurry to get back to work and needed a script or note, they approached me for assistance. 
Some patients also felt the need to share information with me regarding their experiences 
with the ART clinic without me asking them. This I can only attribute to the fact that the 
patients understood that I occupied a unique role within the clinic. The staff also treated me 
differently. Some members of the staff were reluctant to interact with me while others chatted 
more freely to me, possibly because they saw me as a researcher and not a person of 
authority. While I could not participate fully in the activities of the clinic because of the 
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researcher role that I already occupied, this role did however allow me to adopt a unique 
position in the clinic and allowed me to observe and participate in the functioning and daily 
activities of the clinic rather unobtrusively.  
When conducting research, and particularly ethnographic research, it is also essential to bear 
in mind that the viewpoint of the data collected will also be influenced by the researcher’s 
own cultural and world views. Thus, while objectivity is always the goal, subjectivity is a 
reality of all research.  
4.4.2) Focus groups 
 
Focus group can be defined as a planned group discussion about a particular research topic 
that is used to collect data through a group discussion (Hansen, 2006). Focus groups should 
be used when a researcher is interested in a range of opinions, wants to achieve a better 
understanding of the cultural and social norms of the group, and want more information about 
the influences and motivations behind certain behaviours (Hansen, 2006).  
The group dynamic is used to obtain insight into beliefs and attitudes of a particular group. 
Groups should ideally include between six and eight participants and the members should 
ideally be homogenous as homogeneity assists with the flow of information (de Vos et al., 
2002). It is a particularly useful method of collecting data about needs assessments, for 
developing or refining instruments for interventions for further research, or to enrich data 
collected by other methods (de Vos et al., 2002, Hansen, 2006). Information is gained from 
the participants’ common experience and is not individual-based (de Vos et al., 2002).  
This insight that focus groups provide about the population group is particularly useful when 
a researcher is interested in the power dynamics between different actors in the population 
being studied (Hansen, 2006). An example of this is the power dynamics between healthcare 
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workers and patients. In my research project I was interested in this relationship because it 
affects the experience of accessing treatment at the clinic and it reveals the hidden structural 
violence that lies within these relationships.  
By conducting focus groups the researcher obtains rich data from various perspectives. 
During the focus group attention must be paid to both what is said as well as how it is said 
and by whom (de Vos et al., 2002). Focus groups are useful for discovering new information 
that might be hidden, for gaining different perspectives, for gaining insight into why people 
behave in a certain manner; for gaining insight into the influence of group interactions and 
for exploring topics holistically (de Vos et al., 2002, Hansen, 2006).  
In focus group discussions it is important to ensure that participants are well informed about 
the topic that is under discussion and they should ideally experience the particular topic 
during their everyday lives in order for them to provide the deep and rich information that the 
researcher wants (Hansen, 2006). If the participants do not share a common interest with the 
research topic the participants’ ability to converse freely will be compromised (Bernard, 
2002). 
Despite the many positives of focus groups there are certain limitations to focus groups and 
the researcher must be aware of these. Firstly bias and influence of the researcher must be 
acknowledged and all attempts must be made to avoid this (Bernard, 2002). The moderator of 
the focus group must also be careful to avoid leading the group in a particular direction that 
produces biased answers (Hansen, 2006). Furthermore the effect of the group should also not 
be underestimated. Some participants will be more outspoken than others. This might cause 
the shyer participants to withdraw from the conversation or simply agree with everything that 
is being said (Hansen, 2006). This gives rise to the problem of individual views being 
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portrayed as group views where the timid participants are too afraid to voice their own view 
points.  
In addition focus groups are limited in their ability to generalize the data gained from them to 
the entire population to which they belong because it is not possible to get a totally 
representative group (Bernard, 2002). So, while we might gain deeper insights into a 
particular issue, the findings might not apply to the population as a whole. There are also 
some physical limitations to focus groups. Groups are demanding and require ample time to 
prepare and conduct the interviews (Hansen, 2006). They can also become costly when the 
issue of reimbursement is raised or when food and drinks are provided.  
For this particular research project an initial pilot focus group was held prior to the main 
focus groups to assist with formulating the questions for the actual groups and to assist with 
the formulation of my interview schedule. The pilot group consisted of 6 participants, who 
were female, isiZulu-speaking, and over the age of 18 years.    
In total four focus groups were conducted, each comprising of 6 participants. Three of the 
groups consisted of females and one of the groups consisted of males. The groups were 
divided according to gender to facilitate the flow of the discussion and to avoid unnecessary 
tensions. 
Participants were selected on a voluntary basis and the group sessions were conducted in the 
clinic where it was most convenient for the participants. The focus groups were run by a 
research assistant who understood the purpose of the project well. The groups were 
conducted in isiZulu which is the preferred language of the participants. The focus groups 
were audio-recorded and notes were taken by the researcher during the group session. Focus 
groups were used to gain a comprehensive perspective about the shared problems people 
encounter when they are accessing their treatment. It was useful to elicit a range of opinions 
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about the shared experiences of the clinic’s patients and to uncover the social and cultural 
norms that underlie their responses and behaviours.                
The data from the focus groups aided in identifying the themes relevant in developing more 
concrete questions for the semi-structured interviews and the questionnaires. The semi-
structured interviews were used to gather more in-depth information on an individual patient 
level. The qualitative data was used to formulate the questionnaire and contextualize the data. 
The quantitative data was used as a measure to check the validity and reliability of the 
qualitative data collected.   
4.4.3) Semi-Structured interviews 
 
The semi-structured interview is based on an interview guide that ensures that the 
information that is required is collected. The use of the interview guide also assists with 
uniformity of the information obtained from the various participants and allows for reliable 
and comparable information. The interview guide offers clear instructions for the researcher 
to follow and is particularly helpful when there is more than one interviewer.  
Ten semi-structured interviews were conducted with attendees of the clinic who were willing 
to discuss their thoughts and feelings with me in detail. The semi-structured interviewees 
consisted of four isiZulu-speaking males and six isiZulu-speaking females ranging in ages 
from 24 to 45. These participants were also interviewed during the focus groups. By using the 
same participants I was able to revisit some of their earlier comments and to explore those 





The semi-structured interviews were conducted in a consulting room at the clinic where it 
was most convenient for the patients. On average each interview lasted one hour, was audio-
recorded and a research assistant was available when the participant wanted to communicate 
in isiZulu instead of English.  
These interviews provided a deeper and more personal account of problems around access to 
ART. The questions for the semi-structured interviews were derived from the participant 
observation data, the focus group data and the literature reviewed and was used to explore in 
more depth and detail some of the issues raised. Participants were asked to discuss their 
experience colleting treatment, what difficulties they faced, if they were adherent to their 
treatment and what factors have affected their adherence to their treatment regimens. Besides 
the four categories of barriers
24
 that remained a theme throughout the data collection process, 
other barriers to accessing ART were also explored in more detail such as the specific issues 
that present challenges for patients to continually access their treatment.  
A particular advantage of the semi-structured interview is that the time spent on the interview 
is more controlled as compared to unstructured interviews (Hansen, 2006). In my particular 
setting this was helpful as the patients were always in a hurry to leave the clinic. Following 
an interview guide allowed me to be more focused on the topics that needed to be covered, 
although discretion was used when participants wanted to talk more about certain points.  
Direct contact with participants has certain advantages. The information obtained is often 
detailed and can offer unique insights into the research problem. It also allows for a high 
degree of validity as responses can be checked for accuracy and relevance during the 
interview. Some participants found the experience therapeutic, although it was stressed that 
the purpose of the interview was for research.  
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 The four categories of the barriers were discussed in Chapter Three: The Literature Review.  
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By listening to the participants’ ideas and opinions some participants reported that they felt 
appreciated and acknowledged, and enjoyed the opportunity to talk about the issues that they 
faced.   
Semi-structured interviews do however have some limitations. While they are useful for 
gathering in-depth information, obtaining that information requires skilled interaction 
between the researcher and the participant; it requires cooperation from the participants to 
dedicate their time and share their insights with the researcher (Hansen, 2006). This could 
prove to be a mammoth challenge if the researcher does not have good rapport with the 
participants.  
The effect that the researcher has on the interview must also be taken into consideration. This 
situation is particularly important when the researcher is a healthcare provider and the 
participant is a patient. There is an unequal power relationship between these two actors that 
can potentially have an effect on the data collected (Arber, 2006). Unless there is good 
rapport between the healthcare researcher and the patient participants there is always the 
chance that the patients will tell the researcher what they think they should say (Bernard, 
2002). The participant may also feel vulnerable in this situation and may participate in the 
research purely because of the power dynamic. The healthcare researcher must be aware of 
this situation and must make every effort to neutralize this dynamic.  
Another important aspect to remember during the healthcare research interview is the purpose 
of the interview (de Vos et al., 2002). Some participants may confuse this opportunity to 
discuss their opinions as a counselling session. This could lead to awkward situations where 
the participant is revealing very sensitive information in expectation that the researcher can 
intervene with their problems and provide solutions, therefore it is important that the 
researcher make it very clear, and constantly remind the participant that the interview is for 
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research purposes and not for clinical reasons (de Vos et al., 2002, Hansen, 2006). As noted, 
participants in my study did express that they appreciated the opportunity to express their 
feelings and concerns, and although this is an important step in the establishment of rapport, I 
constantly reiterated that the information they provided was for research purposes.  
Finally reliability of the participant’s answers is a point of concern for any interview 
(Bernard, 2002). The interviewer effect, inhibitions by the participant to share sensitive 
information, and the context in which the data is collected make almost every interview 
unique (Hansen, 2006). This can make it difficult to ensure reliability of the data as each 
participant will add her/his own unique information.  
4.4.4) Questionnaires 
 
To increase validity and reliability of the qualitative data collected quantitative data was also 
collected. A simple questionnaire that covered the themes that were raised during the focus 
groups and semi-structured interviews were incorporated into an interviews schedule.  
The questionnaires consisted of three sections that comprised of 61 items. The participants 
were asked about their demographic information, reasons for attending this particular clinic, 
time spent in the clinic, treatment regimen and date of commencement of ART, and whether 
they have missed any appointments. They were also asked about their own beliefs regarding 
the treatment and how they foresee themselves remaining on ART. Goals for taking ART 
were also covered as this reflects insight into their condition, and the effect of adherence 
counselling. Self-reported levels of adherence were also asked about since barriers to access 
can influence adherence.  
The questions relating to the barriers that were identified in the literature as well as the data 
from the focus groups and interviews centred on the four categories of the barriers. Barriers 
were highlighted and the respondents were asked to rate the effect of the barrier on their 
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ability to access their treatment. Barriers were scaled form 1 to 5 where 1 equals no problem 
(this is not a problem for me); 2 equals a small problem (it can be a problem but I manage), 3 
equals (I am neutral about this/ don’t have an opinion); 4 equals a big problem (this is a 
problem for me); and 5 equals a very big problem (this is a big problem that can result in me 
not coming to the clinic). Careful note was taken of which barriers were most significant in 
the clinic. However, those barriers where a 5 or ‘very big problem’ was selected as an option, 
even when the percentage was low, was considered to be significant since these barriers can 
result in the discontinuation of ART drugs.  
Questionnaires were handed out to any adult patient who consented to voluntarily participate 
in the questionnaire and who had been on treatment for a minimum period of one year. 
Participants were fully informed about the research project and its aims.  
The total number of completed questionnaires returned to the researcher was 156, 82 
consisted of isiZulu copies while 74 were English. More females than males responded to the 
questionnaires. This demographic inequality could have resulted from two separate causes. 
One, the clinic has a larger female population as compared to males; and two the female 
patients were more enthusiastic to participate in the study as compared to the males.  
The questionnaire consisted of closed ended questions, Likert- scale type questions and a few 
open ended questions. The Likert-scale
25
 questions required the patients to rate the effect of a 
certain barrier on their ability to access their treatment. Some open-ended questions were 
included to allow the patients to provide more comprehensive answers. The questions were 
arranged in such a way that the more easy to answer questions came first, with the more 
difficult or sensitive questions featuring towards the end of the questionnaire. This is in line 
with Behr’s advice that said: “the questionnaire should start with simple factual questions 
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 Likert-scale:  This is a close ended question that requires the participant to scale their responses, usually 
consisting of five points (Bernard, 2006).  
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which can be answered without much difficulty. Complex or awkward questions should come 
toward the end (Behr, 1988: 157)”.  
The questionnaire took approximately 30 minutes to complete. The questionnaires were 
handed out to the patients at the beginning of their waiting time in the clinic. This was the 
first queue that they sat in while waiting for their clinic files. After the questionnaires were 
handed out the participants were instructed to either drop their completed forms in a labelled 
box at the entrance of the clinic or to return the questionnaire to the researcher or the research 
assistant. Most patients completed the questionnaire by the time that they reached the front of 
the queue.  
The questionnaires, information sheet
26
 and the consent were available in either English or 
isiZulu. The researcher and the isiZulu-speaking research assistant were always close at hand 
for those participants who had difficulty understanding certain questions or who were 
illiterate. Anonymity was ensured by assigning numbers to each questionnaire answered and 
keeping the consent separate from the questionnaire. There were no personal identifications 
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 Information sheet: This is mandatory for healthcare research and explains to the participant in the language of 
her/his choice about the study and the extent of each individual’s involvement. It also covers important aspects 
such as confidentiality, voluntary participation and the contact details of the ethics committee that granted 
permission for the study to be conducted. The information sheet also provides an additional confidentiality 
factor by covering the questionnaire itself.  
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4.5) Data Analysis 
 
The data gathered from the qualitative methods was analysed using thematic coding. The 
themes were constructed around those themes identified by the literature, namely: physical, 
organisational, social, and economic barriers. Thematic analysis uses inductive coding
27
 to 
analyse the qualitative data (Hansen, 2006, Bernard, 2002). The literature provides some 
ideas about the themes that might be elucidated from the data but the researcher largely 
follows a process of continually returning to the data and analysing the data to uncover 
further themes. This iterative process is useful for a study about access barriers as it is 
recognised that barriers to access are embedded within the local context and that researchers 
should investigate the local barriers affecting the clinic’s population (UNAIDS and WHO, 
2003). Coding was used to group the data into the main themes of the barriers, namely: 
physical, organisational, social and economic barriers. Coding of the qualitative data was 
done using NVIVO 10 software. In NVIVO 10, queries were run that included word 
frequency and coding.    
Comments about the distance travelled to the hospital, transport, or physical issues with 
accessing the clinic were coded as physical barriers. Further comments about local clinics and 
the referral patterns were also included under this group. Statements mentioning the hospital 
and clinic, including waiting times, administration, services by health care personnel and 
comments about infrastructure were labelled as organisational barriers. Social barriers 
included any comments about the patients’ own personal factors that had an influence on 
their ability to access the clinic. Such statements included comments about any stigma and 
discrimination experienced in the local community, family and treatment support, religious 
beliefs, traditional cultural beliefs and the patient’s own belief about the concept health. 
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 Inductive coding: Analysing qualitative data by coding for themes as they emerge (Hansen, 2006).   
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Economic barriers were coded by statements about any patient or organisational cost 
involved in accessing treatment. From the data collected only costs experienced by the 
patients could be evaluated. Data regarding the health system finances were gleaned from the 
pre-existing literature. Any answers or comments regarding financial aspects or costs were 
coded for. This included employment issues and time factor issues.   
The recordings that were collected in isiZulu during the semi-structured interviews and focus 
groups were translated and transcribed into English. To check for validity and reliability the 
transcripts were back translated
28
.  
Themes that were coded for in the qualitative data were then re-worked and incorporated into 
a questionnaire schedule. The quantitative data was analysed using SPSS software. Basic 
statistical tests were performed on the quantitative data including testing for the mean, mode 
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 Back translation: This is the final step in validating the transcribed data. The translated data is re-translated 
into the original language in which the interview was conducted to check for accuracy.  
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4.6) Bias and limitations to the data 
 
The data showed some bias towards organisational barriers more than the other barriers that 
were highlighted in the literature. However, with comments about the counsellors, stigma 
does become an important barrier, since the counsellors could have their own stigma towards 
the patients. However, this project did aim to investigate the barriers to accessing ART in the 
healthcare setting and therefore organisational barriers will be more apparent and abundant in 
the data than social or behavioural barriers, although these were inquired about. The focus on 
organisational barriers is an attempt to fill the information gap in the literature about barriers 
to accessing healthcare. 
The conclusions from this study were largely based upon the results gleaned from the 
qualitative data, and as a result, is not generalizable to the general population. 
Generalizability is not an aim of qualitative research; instead the point of conducting 
qualitative research is to obtain detailed information about the research problem.   
In this chapter the research methods that were used to conduct the study was discussed. The 
value of conducting ethnography in the healthcare setting was examined and the use of 
triangulation of research methods was discussed. The four different research methods, 
namely: participant observation, focus groups, semi-structured interviews and questionnaires 
were explored in detail. In the following chapter, the results from the data analysis is 








CHAPTER FIVE: The Physical and Organisational Barriers that 
Impact Upon Continuous Access To Antiretrovirals   
 
“When we fail to listen to our patients’ stories, we lose the opportunity to discover what 
truly ails them” (Campo, 2006: 1678).  
 
In this chapter I begin with an analysis of the main and most frequently mentioned barriers 
that arose from the quantitative and qualitative data analysis. These barriers to accessing 
health care are classified into four main categories, namely: physical, organisation, social 
and economic barriers. It is important to stress at the outset of this chapter that although the 
barriers are neatly teased out into specific categories in this thesis, as is the case in much of 
the literature, in reality the various categories frequently blend, transverse each other and 
indeed cause each other - thus producing an inter-related, fused set of barriers that individuals 
need to transcend in order to access ART in the public health care sector.  This noted, in this 
chapter, I tackle the physical and organisational barriers, while in Chapter Six I turn my 
attention towards the social and economic barriers.   
In order to set the scene, I begin the chapter with an overview of a typical day in the clinic as 
seen through the eyes of one of my research participants, Sandy.  Sandy’s story reveals many 
of the challenges that patients face on a monthly basis when accessing ART treatment at the 
clinic, and the inclusion of her experience in this chapter provides the reader with a personal 
feel for the patients’ experiences. In addition, the portrayal of Sandy’s experiences, clearly 
illustrates the inter-related nature of the barriers patients face as they attempt to access ART 
therapy at this particular clinic.  The remainder of this chapter then goes on to address the 





5.1) A Typical Day at the Clinic  
 
Sandy has been on ART for the past two years. She was initially diagnosed with HIV when 
she became ill with a Tuberculosis infection and was admitted to the hospital. Sandy is 27 
years old and identifies herself as an isiZulu-speaking African woman who is unmarried and 
has two children under the age of five. Currently she has a job as a cleaner, but the position is 
only temporary. She has come to the hospital today to collect her monthly supply of ART 
drugs.  
On a typical collection day Sandy first arrives at the hospital at around 06:00am. The card 
office is not yet open but there is already a very long waiting line. On the side of the card 
office’s door is a piece of paper that reads: “Waiting time between 07:00am and 11:00am is 
30 minutes. If you have waited longer than this time please inform the manager.” The paper 
is dirty and torn, it has clearly been stuck to the wall for some time, long forgotten and 
ignored by both the card office staff and the patients. Both the patients and the clerks know 
that the paper is merely a formality, a requirement from the hospital management, and its 
promise no longer holds any significance at the hospital.  
At 07:00 am the long line finally begins to move and people get to sit down inside the card 
office. One of the clerks takes the first batch of small blue identity cards that contains a 
patient’s name, hospital number, follow-up appointment dates and which clinic is responsible 
for the follow-up treatment and care. After approximately 20 minutes two clerks return each 
holding a stack of orange coloured files filled with papers that contain all the medical 
information, test results, diagnostic information and treatment since the patient first entered 
the healthcare service. Some files are thin and new but others are thick and slightly dirty with 
notes and papers spilling out of them, held together by staples or elastic bands. The clerks 
start calling out names and the patients who are sitting in the two front rows hastily get up 
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and shuffle along, desperate to collect their files and move on to the next point of service in 
the hospital, which is the cashier’s desk.  
When the patients are sent to open a hospital file at their initial visit, they are asked a series of 
demographic questions that are captured on the files. These details include full names of the 
patient, home and contact details, employment details, financial tier, and the specific hospital 
number allocated to the patient. The financial tier and employment details are used to classify 
the patients into income brackets that will determine the amount that each patient will pay for 
hospital services. If a patient is unemployed she/he is required to supply an affidavit 
indicating the status, but even the unemployed will be required to pay the basic fee of twenty 
rand at each contact with the hospital. For some patients the twenty rand is a significant 
amount to pay, and presents a major barrier to continuous access to the health care facility.  
The payment is accompanied by a stamp from the cash register clerk and permits the patient 
entry into the health care facilities where treatment and care is received.   
The cards of the patients sitting in the next two rows then get taken and the clerks disappear 
into the filing room. After 20 minutes they reappear and their stacks of files disappear into 
the hands of the owners. Again the snaking line moves forward, every patient in turn filling 
those two front rows. Finally Sandy gets to move into the actual card office building where 
she can take a seat. There are four rows of chairs before her but at least now she can sit.  
Eventually she reaches the front row and the clerk asks her for her blue card. Sandy’s blue 
identity card looks slightly different from the cards of the other patients at the hospital. Her 
card contains two numbers, one for her hospital file and the other for her file at the ART 
clinic. This small difference identifies her as a patient of the ART clinic, and automatically 
divulges her confidential disease status. Her blue identity card gets taken by one of the clerks 
who once again disappear into the filing room, and once again after approximately 20 
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minutes reappear with piles of hospital files. Names get called out, people eagerly get up, 
take their files and rush off to which ever clinic in the large hospital will provide them with 
treatment.  
Sandy’s name is not called. She knows what lies ahead now. Arguments with the clerks about 
where she had left her file last and ‘yes I did drop it in the box’ and ‘yes it was returned there, 
I know where to drop it by now’. Sandy’s hospital file has been misplaced, or as the clerks 
will simply say, ‘lost’. The delay will cost Sandy another hour while she waits for another 
clerk to make her a duplicate file. Sandy feels terribly angry and irritated, both by the attitude 
of the clerks who blame the patients for losing their files, and the fact that all her medically 
related information is now lost.  
Eventually Sandy receives her new file, a duplicate of her old file but this one is thin and 
clean and empty of three years’ worth of medical information and test results. She heads 
down to the cashiers office where she pays her twenty rand and gets her stamp. 
With her new file in hand Sandy is feeling less angry and heads for the ART clinic situated at 
the top end of the hospital. The day is already progressing and the long walk in the bright sun 
is making her feel hot and uncomfortable. At the end of the day after Sandy has completed 
her entire visit to the hospital, she would have walked approximately one kilometre within 
the hospital complex alone
29
. When she reaches the clinic she is confronted with the second 
queue of her day. She pushes her way past the over-filled passage and walks to the end of the 
line. At least there are enough chairs here for everyone and she gratefully sits down once 
again. Appreciatively she looks up at the big air-conditioner that blasts cool air onto her face.  
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 Path distance analysis was performed using Google Earth (www.googleearth.com)  
97 
 
An administrative clerk, known in this particular clinic as a support services officer, walks 
down the passage and once again collects her blue identity card, this time to go and retrieve 
the clinic file that contains all her HIV related medical information and treatment scripts. The 
nurses follow with their register and record her name in it. Sandy knows that this wait will be 
a long one and she opens her bag to take out a piece of fruit. Every so often she moves up a 
place, inching forward to the front of this very long and slow moving line.  
The crowd around her is starting to get rowdy and agitated. People begin to complain about 
the long wait for their clinic files. “How much longer must we wait just to get our files?” 
asks a young man sitting a couple of places ahead of Sandy. He is getting agitated and 
complains bitterly when the nurses walk past. His complaints are not just directed at the 
nurses but he also blames the new patients for holding up the queue.  
Finally Sandy gets her file and moves to the nurses table. The table is large and old and on it 
is the clinic register that captures all the adult patients for the month. One nurse is writing in 
the file while the other nurse weighs Sandy on a scale. She has to take her shoes off before 
the weighing and now sits down on a chair to fasten the strap of her sandal. She hurries 
because she wants to get to the treatment room before someone can push in front of her.  
In the treatment room there is a short queue and it moves rather quickly. The male nurse is 
very friendly and he asks Sandy, the first healthcare worker to do so, how she is feeling 
today. She tells him the story of her lost file and the long wait in the card office. He is 
empathetic and agrees with her that it is unacceptable for the hospital files to get lost, but that 
she should not feel too bad about it since she is not the only patient here today whose file has 




From the treatment room Sandy moves to the next waiting queue. This queue is where she 
can sometimes wait the longest and where people complain the most. She is waiting to see an 
adherence counsellor. After about half an hour of waiting the line stops moving. It is tea time 
and all the counsellors come out of their rooms and go to the staff tea lounge where they will 
stay for at least thirty minutes. Now the patients are just left sitting, watching their day go by 
as the clock continues to tick.  
At the other end of the building are the three rooms where the doctors who work purely with 
adult patients are located. But none of the three are currently inside their rooms. They are also 
waiting. “This is absolutely ridiculous. The clinic is full and we are just standing around. It is 
past ten and we have hardly seen any patients. How are we supposed to function like this? 
We will be working until late this afternoon when the counsellors are all gone”- says Dr 
Victoria, the senior doctor. The delay at the counselling office delays the whole process. In 
fact a delay anywhere, be it the card office or the counselling office, has a knock-on effect in 
this clinic where there is such strict adherence to the protocols that dictate the process of care. 
Two hours pass and Sandy eventually gets her chance to enter the counsellor’s room. The 
room is small, cramped and divided into two sections by a curtain. Behind the other curtain 
sits another counsellor with another patient, counting tablets. There is a desk and opposite the 
desk sits the counsellor. He is not friendly but also not rude. Sandy knows what is expected 
of her. She opens her purse, removes the old containers and hands them to the counsellor 
opposite her. He counts the remaining tablets and then begins to ask her a long series of 
questions. “Is she coughing, or having any night sweats? What about any side-effects of the 
treatment?” He further reminds her about the importance of adherence and that she must not 
stop taking her tablets under any circumstances. Sandy nods and agrees with him and thanks 
him for his advice. He writes down all that they had discussed during the session and hands 
her back her clinic file. In total the counselling session takes about ten minutes.   
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From the counselling room Sandy walks to the next queue. This is the queue for the doctors 
and because it is her day to see the doctor and collect treatment she will have to wait here as 
well. Luckily Sandy knows that it is not her date to have routine bloods taken
30
 When she 
looks at her watch it is past 12:00am. She will have to remember to ask for a sick note from 
Dr V, because she will not make it to work today. Sandy is feeling worried about this, every 
month since she has started with these tablets she has had to take one day off from work to 
collect her treatment. Without the treatment she will get sick again, and there is a chance that 
she might die, but if this continues her job is threatened. Her manager has already issued her 
with a warning for taking too many sick days. He has threatened to deduct days off work 
from her pay from now on.  
Luckily the wait for the doctor is not too long and she enters the room after the nurse had 
shouted: “who is next in the line?” The nurse is friendly and takes her file and asks her for 
her blue card, the one she gave to the clerks in the morning to find her hospital file. On the 
blue card is a collection of dates. The nurse begins to fill in the next set of empty lines for the 
next three months. These are her clinic visit days, her booked appointment days. To 
systematize things the clinic book people per day. Thus if treatment was started on a Monday 
then the patient will always be booked for the Monday that is twenty eight days from the 
current visit. It is for this reason that when the patients reach the desk where the nurses take 
their weight they are asked if today is their “appointment day.” If it happens to not be the 
allocated appointment day, that is to say that the patient came on a different day to collect 
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 Routine bloods: In the ART program protocol, it is mandatory that blood analysis get performed. Currently 
every six months liver function and kidney function tests are performed along with whole blood analysis. The 




her/his treatment, she/he is then sent to the back of the waiting line to be helped last
31
. In this 
situation the patients are punished for not adhering to the strict rules of the clinic. 
The visit with the doctor does not take long as Sandy has no physical illness complaints and 
Sandy finally heads to the last queue of the day. She reaches the pharmacy queue at 13:00 
pm, lunch time. Here she waits half an hour before the pharmacist returns. The queue does 
move rather quickly and eventually she reaches the pharmacy cubicle and collects her refilled 
bottles of tablets.  
After collecting her treatment, Sandy walks to the entrance of the clinic to drop her files at 
their respective places. Before she leaves she reads another paper stuck on the clinic’s wall. 
This one reads: “Time for collecting treatment is 1 hour. Time for seeing the doctor and 
collecting 2 hours. By Order, Management” Sandy looks down at her watch; she has spent 
her entire day at the hospital to collect her treatment. She is done for the day but in twenty 
eight days she will have to endure this process again, and after that she will have to repeat it 
every twenty eight days for the rest of her life.  
Sandy’s trip though the hospital complex is indicated in Appendix 2 and the flow and layout 
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 One male patient recalled a day when he came on an un-booked day, only to be told by the clinic nurses that it 
was not his day to collect and that he must return the following week. 
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In the literature, see for example Ware et al., (2013), Harris et al., (2009), Merten et al., 
(2010) transport is often mentioned as posing a major barrier for patients to access their ART 
treatment and related healthcare services. Transport at the clinic did not however present as 
being as big a problem as presented in the literature. This stated, problems of transport were 
more linked to the costs of transport involved as opposed to a physical lack of transport, 
something that Harris et al., (2009) also found in their research conducted in South Africa 
about barriers to accessing healthcare. Questionnaire respondents were asked to indicate their 
primary means of transportation to the clinic, and the result are shown in Figure 5.1 below. 
 
Figure 5.1: Means of Transportation  
 
As Figure 5.1 above shows, over 80% of the questionnaire participants stated that they use 
public transport to get to the clinic and only 7% said that they have their own transport. In 
addition to this, 52% of the participants said that transport to the clinic was the most 


























respondents said that if they don’t have enough money to afford transport, they borrow 
money from relatives and friends to afford the transport costs to attend the clinic. 
Just over half the respondents (55%) indicated that they did not consider transport to be a 
particular problem to accessing treatment, while 45% stated that it posed a problem of 
varying proportions. This is illustrated in Figure 5.2 below. 
 
Figure 5.3: Perceived Problem of Mode of Transport 
 
Clearly then, the participants did not perceived transport in itself to be a problem. Rather, 
they indicated that the cost of transport posed a more significant barrier. The problem of costs 
involved in transport to the clinic is supported by the words of the research participants. As 
one male research participant, Shawn, noted “The reason [why people miss their visits] could 
be shortage of bus fare”. Lauren, a key research participant, added: “for others it is not 
having transport money to hospital,” to which Steven, a male participant explained: 
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Another significant physical factor influencing the ability of patients to access treatment is 
the distance of the clinic from their homes. Respondents were asked how far the clinic was 
from their home. The question specifically tested the respondents’ perceived view of 
distance, rather than absolute distance. The results of the analysis are illustrated in Figure 5.3 





Figure 5.3: Distance of the Clinic from Home 
 
In the literature the distance between a patient’s house and the clinic was identified as a 
significant barrier to accessing ART. However, in this particular clinic quantitative data 
suggests that distance does not feature as a significant barrier. Just under half of the 
respondents who answered the question on the questionnaire indicated that the distance 
between their house and the clinic was not a problem, while just over half reported this to a 
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Figure 5.5 Reasons for patients using this particular clinic for treatment 
 
One of the major motivating drivers behind the concept of primary health care is to bring 
healthcare closer to where people live. Primary health care policy dictates that people should 
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care closer to people is a basic principle of primary health care and is an attempt to decrease 
the distance barrier between those who need medical care and the health care facility itself.  
In this study, as shown above, the quantitative data revealed that distance between a patient’s 
house and the clinic did not feature as a major barrier. However, qualitative research revealed 
that patients attend the clinic primarily because it is situated more closely to their place of 
work or because they perceive the quality of care to be better and are thus prepared to travel a 
distance to get to the clinic.   
The clinic is situated in a large hospital, and technically should not be considered as a ‘local 
clinic’ by any of the patients. Interestingly enough however, in the questionnaire, 30% of the 
respondents said that it was their nearest clinic to their home. This percentage is somewhat in 
question. From working in the clinic, and having personally opened new files for patients 
initiating ART therapy, I have come to notice that many patients list a false address so as to 
access healthcare services at this particular hospital and clinic. These addresses usually have 
the same road name as the one in which the hospital is located.  Since the clinic only operates 
during working hours, it does make it difficult for patients who are employed to collect their 
treatment. From the interviews and focus groups it thus became clear that the distance from 
work was more of an issue than having a clinic situated closer to home. This is evident in the 
words of the research participants. 
Neville, a 50 year old male participant who has been on treatment since 2008 said: “No it’s 
not nearby, just that things are much easier here”, when he was asked about the distance 
between his house and the clinic. These sentiments were reiterated by Neville who stated 
“this Hospital is closer to my work” and by Joseph who stated, “this hospital is closer to my 
work and I am only allowed one day off per month to get to the hospital. That is why I need to 
106 
 
get in and out from the hospital quick as possible so that I don’t have to be delayed and 
request another day off from work”. 
 
It is thus clear that an anomaly exists in this case between the quantitative and the qualitative 
research and this highlights the importance of qualitative research endeavours.  While the 
quantitative research reveals that patients attend the clinic due to proximity to their 
residences, and many indeed falsify addresses to indicate close residential proximity to the 
clinic, the qualitative research indicates that patients have a preference for clinics closer to 
their workplaces.  This is significant as policy clearly dictates that patients should attend the 
nearest clinic to their places of residence as their first port of call in the quest for health care 
services, and that they should utilise these primary health care facilities for their primary 
healthcare needs.  If the primary healthcare facility cannot provide the necessary treatment to 
the patient, only then should referral to a more equipped facility be validated (KZN 
HEALTH, 2013).  However if the patient does not want to attend the local clinic then there is 
no alternative option available, the patients are forced to attend the clinic or stop the ART 
drugs. When policy conflicts with patient desires, such as the desire to attend closer to work 
rather than home, patients develop innovative strategies, such as falsifying addresses, so as to 
attend the clinic of their choice.  In doing so, patients appear to be supporting the imposed 
policy framework, when in reality they are not. 
 
In addition to proximity to work as a reason for attending the clinic, 31% of the patients said 
that they attend this clinic, because in their opinion, the quality of services provided are better 
than at their local clinics. The patients indicated that they are happy to travel a distance to 
attend this clinic because they perceive the quality of care to be better than in their local 
clinics. This finding is contrary to what is presented in the literature, for example Harris et al., 
(2009) who found that the majority of public healthcare sector users choose their facilities 
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due to the close proximity of the public healthcare facility to their homes. This response from 
the participants is significant since the patients are constrained by healthcare policy to utilize 
healthcare services from their local clinics, but in reality choose not to.  Reasons cited for 
opting to use the services of clinics closer to work rather than home are numerous, and are 
captured in the words of the research participants. 
 
Steven, explained “I think it’s because of the stigma around HIV.  Well it’s because people are 
trying to avoid stigmatisation. Most people take treatment however they would rather keep it 
to themselves which is why they travel all the way to the hospital. They feel they are somehow 
safe and cared for at the hospital. At the hospital doctors are always available, when one 
feels sick you get your treatment and you can speak to a counsellor at the same time so all 
that motivates us in taking our treatments. Also people are afraid they are trying avoiding 
isolation from negative people and to those who are not taking treatment.” 
 
Steven mentioned three very important reasons for why patients choose to travel the distance 
to attend the clinic. Firstly he mentions the stigma related to HIV healthcare, secondly, he 
describes that there are a range of healthcare services available at the hospital that are not 
available at the local clinics, and thirdly, he comments on the anonymity that the large 
hospital offers. It is clear that there are some advantages for attending the ART clinic that is 
situated at the hospital, and can explain why the patients prefer coming to this clinic.  
 
The availability and quality of healthcare services thus plays an important role for keeping 
and drawing patients to this particular clinic; this is evident in the words of Neville a male 
participant who as explained to me during the focus group: “this Hospital was the first 
hospital that provided ARV’s. When the other health institutions started rolling ARVS; I was 




Lauren, a key informant explained this issue further: “We are very satisfied with this 
Hospital’s doctors because you get all the assistance you deserve.  Especially if you have 
another sick problem besides HIV issue they write on your card and refer you accordingly. If 
it is something that the doctor is familiar with doctor simple prescribe you with medication 
for that problem and problem is solved. Yet at our local clinics there is no such service, 
doctors are not available at those clinics.’ 
 
Veronica, also a key informant agreed with Lauren’s explanation. She told me that: “I prefer 
this Hospital because there is patient care. All the specialists are available everywhere you 
look there is a doctor to help you with your diagnosed condition. Everything is close 
including skin clinic. We don’t mind even if we have to pay. That is why I love attending at 
this Hospital patient care is 100%. If you have another separate condition besides HIV 
problem that gets seen too and you go home smiling. Whereas at our local clinic there is no 
confidentiality everybody knows that you are an HIV patient and no treatment for your 
problems.” Betty, a 27 year old female patient added to this “I don’t mind because here I get 
treated and there are always doctors available.  If I have any other sicknesses the doctor 
would give me script and I would get treatment. Doctors and nurses are always there for us 
and yet at our local clinic we get treated as if being HIV positive is a punishment.” 
 
A female Linda, age 31 described how the availability of the ART drugs at the hospital 
changed her life: “I am now relieved that we can access treatment because before people 
were dying like flies due to the fact that there was no education about treatment and 
treatment was not available at our nearest clinics. However, I wouldn’t collect my treatment 
at our local clinic because they are always out of stock. Most local people know me so I don’t 
want them to know about my status.” 
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The hospital offers a sense of anonymity that the local clinics fail to provide. The anonymity 
factor is related to the healthcare and social stigma in the local communities. The aspect of 
anonymity was also reported in the data from the questionnaires, where 13% of the 
respondents reported that they chose to attend this clinic because they did not want to be seen 
in their local clinics collecting ART. This anonymity that the hospital unintentionally provides 
plays a vital role in protecting the patients from perceived harm. However as mentioned 
earlier, healthcare policy threatens this protection by forcing patients to attend their local 
clinics even if they will be subjected to social discrimination and potential physical harm due 
to their HIV-positive status.  
 
Chris, a male participant explained: “Firstly I didn’t want to collect my treatment closer to 
home because I didn’t want people to know about my status besides it is not comfortable 
collect HIV treatment in your area. You end up meeting up with your local neighbours whom 
you don’t want them to know about your status because they talk too much. It is preferably to 
collect from this Hospital because it’s away from home. Also you meet different people from 
all walks of lives.” 
 
Prudence, a 24 year old female patient said “It is better to collect at this Hospital you all join 
the same queue. Thereafter you have collected your card and you go to the clinic nobody 
worries about where you go. You don’t disturb others that have other sick problems. What I 
have noted why people love coming here is because people are separated. No body worries 









A male participant, Phil, in the focus group said of this: “This Hospital is much private for all 
patients especially for HIV patient we meet with other patient at the card office to collect and 
pay once all that is done each one goes to different direction. None of us worries about who 
goes where. The people that we walk the same direction and attend the same clinic that is 
obvious to me that they are also on the same boat as me.” 
Another participant, Roger, agreed with him: “Yes we agree to that. A person that meets you 
at this Clinic is a person that is collecting treatment. At Poly clinic is not a good idea 
because everyone knows what you are there for and they would start talking about you.” 
All these comments about not wanting to be seen in the local communities are due to poor 
quality service by the healthcare system, stigma and discrimination which are tantamount to 
structural violence. The healthcare system through insisting that  patients attend clinics 
closest to their residences is perpetuating discrimination by inadvertently disclosing HIV 
positive patients’ statuses and by denying patients the basic human right of choice.  
 
5.3) Organisational Barriers 
 
 
In order to ascertain the extent to which organisational barriers were considered a significant 
hindrance in accessing treatment, patients were asked about a range of organisational issues 
and how much of a problem these presented on a scale of 1 to 5, where 1 represented no 
problem and 5 represented a very big problem. The results of this are shown in Figure 5.6 and 
Figure 5.7 that follow. In Figure 5.6, those that indicated some kind of problem (i.e. small 
problem to a very big problem) were grouped and shown against those that indicated no 




Figure 5.6: Organisational Problems 
 
 
Figure 5.7: Extent of Organisational Problems 
 
Figure 5.6 and 5.7 clearly indicate that the biggest organisational barrier experienced by 
respondents is the length of the queue for counselling and counting tablets, followed by the 
attitudes and service of the counsellors. Generally, the attitudes of the other healthcare 
workers (doctors, nurses and pharmacists) did not feature as a significant problem. In the 






































































































5.3.1) Card Office – Administration 
 
Poor administration has serious implications for healthcare service delivery and patient 
satisfaction (Penchansky and Thomas, 1981). Clerks and administrators are the front line of 
hospitals or clinics and the patients’ first encounter with the healthcare service is usually with 
the administrative aspect of the hospital. The quality of their services often sets the tone for 
the rest of a patient’s visit. One of the most important functions of the administrative section 
is the keeping and maintaining of hospital records and files. Hospital files contain all the 
valuable information gathered over a period of time and documents all the points of care with 
the healthcare service. The hospital file represents time, treatment, services, and money spent 
on the health care of a patient. It is one of the most valuable documents within the healthcare 
facility. This study found that more than half, 53%, of the participants’ hospital files have 
been lost or misplaced by the card office at some point (see Figure 5.8 below).   
 
Figure 5.8: Extent of Card Loss 
 
Besides the economic and service implications of a lost file, the issue of confidentiality is 
also of concern. Hospital files contain all the patient’s relevant test results and summaries of 
consultations or admissions. A lost file compromises the patient’s right to confidentiality. 











participants’ files had been lost at the card office. All eight women replied in the affirmative. 
The paper-based recording and keeping of medical information thus seems to be a major 
problem for many people. Lauren said of the system that “it is still very old fashion and it is 
an un-structured process and I hate it”.  
The lost files at the card office are a significant problem. 53% of the respondents who 
completed the questionnaire said that their hospital files had been lost by the card office. This 
has implications for the patients as well as the running of the clinic. Some participants in the 
focus group said that it made them so angry when their files got lost that they did not feel like 
returning to the clinic because they had to repeat all the tests again. The repetition of the tests 
is both expensive and time consuming, and one responded said that: “losing my card (file) 
made me very angry. I felt so angry that I did not feel like returning to the hospital or clinic.” 
In addition, lost files also impacts negatively on the entire clinic and the processes involved 
in running the clinic. This is evident in the words of one of the doctors who deals only with 
adult patients, Dr Victoria said: “as you can see, we (the doctors) are just standing around. 
The clinic is full and there are many patients but because of the delays in the card office we 
are now also delayed. Some of these patients arrived at the hospital at 04:00am this morning 
to stand in the queue, but no one seems to pay attention to this. It is frustrating because the 
patients get tired and hungry and we, the doctors, only see the patients later in the day.”    
Patients’ concerns over issues of lost cards are further evident in the words of Maggie, a 
female participant: “How is this possible that such a thick card can go missing from card 
office?  Why cards disappear every month? How one can explain this? This is really shocking 




Janet, another female participant shared her story about the card office losing her file: “Our 
card goes missing at the card office. Previously I was pregnant and I was seen by a 
gynaecologist and had a miscarriage. After that I was scheduled to see a gynaecologist in 
Room 6; my card with my previous notes went missing. Room 6 doctor didn’t have any clue 
of my previous history, meaning the finding from my previous miscarriage and so forth. That 
is really a challenge. I am now offered a duplicate card which has no previous notes 
regarding my previous pregnancy etc. To date my old cards have not been found.” 
Another female participant, Rose, agreed with the previous comments: “I have also 
experienced the same problem. Many times I have come to card office looking for my clinic 
card they always say that they can’t find it. I would suggest that cards should be filed and 
sorted alphabetically. Or the other option; HIV patients should be allowed to take their cards 
home and return them during their appointment date, pay by the cashier and go to the 
clinic”. 
Lauren further added to the problem of lost cards by noting that missing cards not only cause 
a problem in terms of valuable medical information that is lost, as well as major time delays 
but also exposes patients to unnecessary pathogens. This is evident in her words, “You sit in 
very long lines with people coughing on you getting infected with their sicknesses. For me the 
process is not streamlined and not user friendly. It’s an old way of doing things probably this 
is caused by the fact that this is a government institute.” As she explained she mentioned that 
because of the long wait due to a missing file they (the HIV positive patients) are exposed to 
a range of infectious diseases, and it presents a situation of potential harm.  
Betty, 27, also complained about the delays of the card office and suggested that patients 
keep their files: “Collection of card delays us a lot due to the fact that they are lost, so we 
would prefer to keep our cards together.” Veronica, a 29 year old female participant, also 
115 
 
commented on this and said that patients’ files are safer at home with them: “I would say the 
waiting period while collecting cards. The missing cards with all our important history. My 
opinion would be rather to allow us to take our cards home to be safe. Do away with 
duplicates they are of no use to doctors they have no previous patient notes.” 
The above quotations clearly indicate that patients consider missing files to be a major 
problem at the clinic and that this primary concern of missing files has the opportunity of 
transferring into a number of other related concerns including exposure to infection because 
the waiting times if increased.  
5.3.2) The Counsellors 
 
The adherence counselling at the clinic was identified as a problematic area and presented the 
most significant barrier to accessing ART of all the service providers at the clinic. Only 11% 
of the respondents said that they had not experienced any problems with the counsellors in 
contrast to the 75% who said that the counsellors presented a major barrier for them. During 
the analysis of the qualitative interview transcripts, the word counselling was mentioned 
more than any other word.  
A significant result from the questionnaires showed that over half of the respondents felt that 
the attitude of the councillors is a problem. 21% of patients scaled the problem as being 
catastrophic. This statistic is the most significant barrier to continuous access to ART in this 
particular clinic and the statistical data was corroborated by the qualitative data. The result 




Figure 5.9: Attitudes and Service of the Counsellors 
 
The fact that the counselling itself is the most significant barriers to accessing ART in this 
clinic is cause for concern and stems from the fact that policies are often misguided and out 
of place. The purpose of the adherence counselling is to provide a supporting service to the 
patients who are on life-long treatment. It is a medical intervention to ensure adherence to the 
ART drugs. However as was discussed earlier, biomedical interventions are not always well 
equipped to handle problems that are situated beyond the individual patient as the issues that 
are discussed with the counsellors are beyond the narrow view of the biomedical system. It is 
in line with this individualistic biomedical model that counselling is referred to as adherence 
counselling, because adherence focuses solely on the individual patient’s ability to take 
treatment as prescribed. If the patient cannot comply with the strict adherence required by the 
ART program, then the counsellor is trained to label that patient as a ‘defaulter’, despite the 
fact that the reasons for defaulting are often beyond the control of the individual. While the 
distinction between adherence and access is often overlooked in the public healthcare system, 
the literature too frequently confuses the situation. Ware et al., (2013) says of adherence that 
“since adherence means not only following dosing regimens but also being able to refill 















No problem Small Problem Neutral Big Problem Very Big
Problem








barriers to adherence and retention overlap” (Ware et al., 2009: 2). These authors further state 
that the term ‘defaulter’ is exclusively African and “imply that missed visits result from 
patient choice” (Ware et al., 2009: 4). However, a patient’s ability to refill medications is not 
a matter of adherence, or at least should not be seen as one, since patients seldom miss their 
visits or ‘default’ from sheer personal choice. Instead refilling medications should be seen as 
part of the concept of continuous access to healthcare services. By erroneously using the term 
adherence synonymously with the concept of access to healthcare, discrimination and stigma 
is perpetuated in both the literature and the healthcare setting because most often patients are 
subjected to structural violence that creates the situations in which they miss their 
appointments. This is evident in the words of Gloria, a female research participant, who 
stated, “The counsellors need more training.  If one has not come on their appointment date 
it does not mean that they have defaulted treatment”.   
Another female participant, Doris, likewise said of this situation: “it’s a waste of time to meet 
with counsellors. I collect my tablets because I want to get better. They insist on counting my 
tablets, in their minds checking whether I have defaulted or not. For me that is a waste of 
time. They are also abrupt they have no time for us. In fact they need counselling 
themselves.” Further to this another female participant, Joyce, remarked: “They do not even 
look up but just demand your pill bottle so rudely. Then if you have extra pills they will write 
‘defaulter’ on it even though you have taken all your pills. They won’t even ask why there is 
extra. They do not listen to us. They expect us to just sit quiet and listen to them shouting at 
us.” 
A male participant, Jack, also commented on the attitudes and services of the counsellors, he 
said that: “Counsellors are not 100% sure about what they should do for patients. They make 
you feel as if you owe them something by attending at the clinic. Or by being there you 
irritate them somehow. I really don’t like to be seen by counsellors. Yes they did help me at 
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the beginning when I knew nothing about treatment but now I feel as if I am more 
professional then them”. 
Nelly a female patient aged 32, who has been taking ART drugs since 2009 recounts her 
experience of being labelled a ‘defaulter’ in her attempt to prevent social stigma and 
discrimination. “One month I decided to put the tablets together because some tablets make 
lots of noise when in the container. Even in the taxi when you move your bag they make a 
noise. If someone knows these tablets they will know what tablets you are carrying. I showed 
my tablets to the counsellor and she said she will take as if I did not bring them since they are 
not in their container.  She wrote on the card that I had defaulted and sent me to the doctor 
even though I had these tablets.” Nelly also felt that the counsellors needed further training in 
how to deal with patients, she said that: “The counselling is so bad. Those counsellors, they 
need counselling themselves!” 
 
Regarding this matter of having to attend the adherence counselling at every monthly visit the 
patients have no negotiating power. They are forced to endure the protocol out of fear from 
being labelled a ‘defaulter’ or for fear of having access to their drugs prevented because they 
did not follow the rules. As Mary, a female participant stated: “They threaten us.  According 
to my knowledge a counsellor should be someone friendly, someone you can easily talk to. 
The way these counsellors are they make it difficult to talk freely.  We even hide some things 
from them,” Another female participant, Janet, added, “We do not talk to counsellors except 
when they want to know about tablets and ask you the usual questions. Other than this we do 
not spend time with them.”  Adding to this, Sindi stated “They do not listen, we cannot talk to 
them about our problems,” while Priscilla further stressed, “They supposed to be there for 
you but they don’t care about us. Some of them they ignore you, continue with what they are 
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busy with or play with their cell phone. Some patients they count their own tablets and sign 
the book and leave”.  
Gloria who has been on ART since 2008, told me her story about being afraid to disclose her 
HIV status at work and how the counsellors ‘punish’ her for trying to access her treatment 
without following their rules. Gloria stated, “I informed my manager that I have to collect 
treatment monthly. Of late she does not like the idea. At the same time I cannot disclose my 
status to my boss because she is the type which will tell the entire world.  I reported this to 
the counsellors and the doctor. Sometimes I cannot make my appointment because of this. 
When that happens I call my child to come for my treatment but to my disappointment the 
counsellors refuse to give my treatment. My card is even written that “we told you that we 
will not give treatment to your child, come when you have time”. Even when you call and say 
but you do know my child they tell you the same. If you have missed your appointment you get 
told that you defaulted even if you know that you still have enough pills.  They tell you rudely 
that they will not help you until you go to the doctor and they throw the card at you. They tell 
you they can’t help you if you do not want to help yourself. I tell them that I will see the 
doctor because they can’t help me anyway. You end up being rude yourself.” 
 
Chris, a male participant aged 39, and on ART since 2010, explained how he got into trouble 
with the counsellors when he attempted to prevent discrimination from some of his 
community members. “One day I came without my treatment because I had gone pass 
somewhere and did not want that person to see my treatment.  The counsellor said next time 
she will not give me the treatment – I asked myself what does this got to do with it because I 
had come on my appointment date. If you are explaining the story to a counsellor she has to 
understand because she is also human.  There are times whereby you can’t take your 
treatment with you for certain reasons.”   
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These comments highlight the discrimination that the patients are subjected to by the 
healthcare system. Despite the negative treatment that patients are subjected to by the 
counsellors, they lack negotiating power and therefore have no choice but to endure the 
adherence counselling to be able to access their ART drugs. If they decide that they cannot 
endure the counselling any longer and leave the clinic, they face a certain death. Of particular 
concern is that most patients consider this clinic’s service to be superior to that of the local 
clinics and thus if they leave the clinic as a result of the negative treatment they receive, they 
are unlikely to seek services elsewhere.   
Besides the poor services offered by the counsellors to the patients, it was suggested by some 
participants that the counselling was no longer required and that they thought of it as a time 
wasting activity. This was particularly reported by patients who had already been on ART 
treatment for some time, particularly over two years. Participants often mentioned that the 
counselling was helpful in their first year on treatment, but that after they became accustomed 
to taking their tablets daily the need for counselling decreased.. As Shawn told me during a 
group discussion: “No, we don’t want to be seen by counsellors especially we as old patients. 
Joining counsellor’s queue is a waste of time especially if one is rushing back to work. That 
takes about two to three hours it is really time consuming”.   
The need for healthcare service is therefore frequently evaluated differently by the patients 
and the healthcare system .This difference in need perception was mentioned by both 
Penchansky and Thomas (1981) and Aday and Andersen (1974) in their definitions of access 
to healthcare and utilization of service. The changing perception of need for services must 
accommodate the changing perception of the patients’ needs to further ensure continuation of 
utilization of ART services.      
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In addition to the problems already noted, the waiting time to be seen by the counsellors is 
also longer than at any other point of service in the clinic and most patients clearly view this 
as an unnecessary step in the process of attaining medication. This is evident in the words of 
Michael, a male participant, “I have been here very early in the morning however I have 
spent so much time waiting to see a counsellor for nothing. Therefore I don’t need them”. 
Another male participant, Luke, agreed with the previous statement, he added that: “If we 
could just come in the morning weigh ourselves check blood pressure and go straight to the 
doctor. We don’t really need counsellors”.  
The adherence counselling has been implemented by healthcare policy as a strategy to ensure 
that patients remain on their treatment. However, as is evident from the above data and 
discussion, this service becomes less relevant the longer the patients remain in the system. 
Not only is it considered a time wasting and/or unnecessary activity but also contributes to 
the suffering that patients already endure in the form of perpetuating stigma and 
discrimination. This is a clear example of structural violence since the process is created by a 
social structure in the form of policy and its effects are often invisible, but leave the patients 
powerless.   
5.3.3) Attitudes and services of the rest of the health care workers in the clinic 
 
 
The pharmacists in the clinic scored the highest percentage of satisfaction with 67% of the 
respondents saying that they had no problem with their attitudes and service. The doctors 
came second with 60% and the nursing staff third with 54% of the participants saying that 
they had not experienced any problems with their service. 
The higher scores obtained by the other healthcare professionals in the clinic might be related 
to the associated need that the various actors serve and fulfil. The nurses provide and 
administer care and treatment, while the pharmacists dispense the actual drugs. The doctors 
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attend to any reported illness and prescribe the required treatment regimens. The doctors play 
a particularly significant role in this clinic as they are often considered to be the gatekeepers 
of extra medical attention, such as specialised services. They are also responsible for filling in 
the social disability grant forms and therefore hold a particular power over those patients who 
seek to apply for financial assistance.  
5.3.4) Monthly Visits 
 
Monthly visits to collect ART drugs are mandated in the ART program policy with a 
motivation to ensure adherence
32
. This policy has caused some of the greatest upset at the 
clinic amongst the patients, as is presented in Figure 5.10. In the questionnaire only 35% of 
the respondents who answered the question regarding monthly visits said that the monthly 
visits were not a problem while 65% said that monthly visits do present a problem for them. 
A significant proportion, 20% of the respondents, reported that the monthly visits presented 
such a big problem for them that it could result in them not returning to the clinic or not 
remaining in the ART program.  
 
Figure 5.10: Scaling the problem of monthly visits to collect treatment. 
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The problem of monthly visits was succinctly noted by research participants in the qualitative 
research. One female participant, Sindi, said during a focus group: “Two months is 
preferable. Please don’t keep us waiting just to collect treatment. You need to separate repeat 
and new patients so that everyone is comfortable and not delayed.” Another member of the 
group, Joyce added to this: “It is really uncomfortable for me to collect treatment every 
month”. Jack, a male participant simply stated that: “Coming here is time consuming and it 
interrupts my work.”  
The problem of monthly visits was also clearly articulated in the words of Lauren a key 
informant who said that: “I hate this process, for me it is long and a tedious process. For me 
the process is not streamlined and it’s an old way of doing things. The process takes you 
away from your daily life. I don’t like collecting my treatment every month. I would prefer to 
collect my treatment every six month and six month after that I should be allowed to see the 
doctor and get my blood pressure checked, not to check my blood pressure every month for 
me that is a waste of time”. Adding to this Lauren suggested that: “Perhaps you should have 
different quadrants of patients that would identify those who need more attention. Walking 
patients can collect and leave. This is a suggestion to make the collection times faster.  Those 
who are normal and healthy just there at the hospital to collect treatment should be also 







Figures 5.11 and Figures 5.12 below shows the time spent per visit to collect treatment, as 




Figure 5.11: Time spent per visit including the doctor visit.   
 
 
Figure 5.12: Average time spent, excluding consultation by the doctors 
 
The majority of the patients indicated that they spend on average between three and five 
hours at the clinic per month to collect their treatment and see the counsellors. This time 
bracket remained roughly the same for visits that included being seen by a doctor. However, 
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a significant proportion of participants (25%) reported that they spent between six and seven 
hours in the clinic per visit when visiting the doctor and collecting treatment.  
The reported statistic that there is little difference in the time spent at the clinic when the 
doctor’s visit is included is significant. This could result from the increased patient load in the 
clinic which places time pressures on the doctors to see to all their patients thus limiting 
contact time between doctor and patient. Penchansky and Thomas (1981) highlight that with 
an increase in barriers to accessing healthcare services, there is a decrease in the time spent 
when a patient consults the doctors, and contributes to deceasing the quality of services 
offered by the doctor.  
While the monthly visits have been identified as a major barrier to accessing ART treatment 
at this clinic, the monthly visits have likewise been identified in the more recent literature as 
an obstacle to accessing ART drugs (see for example Wilkinson, 2013). Some interventions 
have been created to decrease the number of visits such as the adherence clubs that are run in 
the Western Cape with the help of Médecins Sans Frontières (MSF)
34
. The clinic where this 
research was conducted follows national policies and provincial protocols diligently. As a 
result there is little room for questioning whether the protocols benefit the patients in the long 
term, or what effect the decisions taken at policy level will have on the lives of the patients.  
The ART program is expanding, and as was highlighted in the literature earlier, the 
government aims to double the number of people receiving ART by 2015. This in effect 
means that the population of the clinic will only increase. The burden on the healthcare 
system will also increase and the expansion will be felt by the healthcare workers, but more 
so by the patients who utilize the services.  
                                                 
34
 Médecins Sans Frontières (MSF): “is an international, independent, medical humanitarian organisation that 
delivers emergency aid to people affected by armed conflict, epidemics, natural disasters and exclusion from 
healthcare. MSF offers assistance to people based on need, irrespective of race, religion, gender or political 
affiliation”. For more on MSF see http://www.msf.org 
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The time delays created by the increased volume of patients in the clinic due to their monthly 
appointments is however not the only problems that the monthly visits create. One of the 
most significant effects of the monthly visit is the economic implications on the patients. The 
economic factors that result in barriers to accessing ART are further discussed in Chapter Six 
and demonstrate the interrelatedness of the barriers.    
5.3.5) Operating times of the clinic 
 
Operating times have been found to be a significant factor in satisfaction of services in the 
literature (see for example Penchansky and Thomas, 1981 and Donabedian, 1972), and can 
pose a major barrier to the availability dimension of accessing health care. This ART clinic 
operates from Monday to Friday from 07:00am to 16:00pm, and is closed on the weekends. 
Respondents were asked if this was considered to be a problem and the results are indicated 
in Figure 5.13 below. 
 
Figure 5.13: Indicating the extent of the clinic’s operating hours.  
 
 
According to the quantitative data, roughly a third of the participants said that the operating 
times of the clinic did not present a problem, while approximately two thirds said that it was a 
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that it presented a catastrophic problem. Not surprisingly, when queried whether or not it 
would be easier to collect treatment on a weekend, almost half of the respondents indicated 
that this would be easier, as indicated in Figure 5.14 below. 
 
Figure 5.14: Collection over weekends 
 
41% of the respondents said that it would be easier for them to collect their treatment over the 
weekends. 39% said that it would not make a difference and 20 % said that it might make 
things easier. These responses can be linked to the employment and unemployment of 
participants.  
The operating times of the clinic impact the accommodative aspect of access to healthcare 
services. There are two main reasons why the operating times present a problem for patients. 
Firstly, for those who are employed, the fact that the clinic only operates during working 
hours has a negative impact on their employment. The second reason is stated by Michael, “I 
came here at just after 13:00pm, after work. But when I got here the nurses scolded me and 
asked me why I came so late. They said that they will not help me on this day because it was 
too late and I was told to return home and come on another day. I do not understand why I 











The healthcare workers in the clinic, guided by policy and an increased demand for services, 
insist that the patients attend the clinic early in the morning. This places further strain on the 
participants, especially those who are employed. It also indicates the unaccommodating 
stance of the healthcare system towards the patients’ needs, which in turn impacts negatively 
on the patients’ ability to access healthcare.  
In this chapter the first two categories of barriers were discussed, namely: the physical 
barriers that include transport and physical distance; and organisational barriers that include 
administrative issues, attitudes of the healthcare workers, the counsellors and counselling, 
and monthly visits to the clinic. Following Sandy through her day at the clinic provided a 
glimpse of the process involved for the patients to collect their treatment. In the next chapter I 












CHAPTER SIX: The Social and Economic Barriers that Impact 
upon Continuous Access to Antiretroviral Therapy 
 
 
Chapter Five outlined the physical and organisational barriers to accessing healthcare that 
were identified in this particular clinic through the use of both qualitative and quantitative 
methodology. This chapter, in turn, focuses on the barriers to accessing healthcare, but the 
emphasis is now placed directly upon the social and economic factors that impact upon the 
ability of patients to adequately access antiretroviral treatment at the clinic in question. 
6.1) Social Barriers  
6.1.1) Gender 
 
As previously indicated, the majority of the respondents in this study were female, 70%, with 
males comprising 30% of the study population. This skewed representation was expected 
since it reflects the gender dynamics of the clinic’s population. The ART program has a 
particular focus on women because females comprise more than 50% of the people living 
with HIV/AIDS in the world, and in sub-Saharan Africa (UNAIDS, 2012). In South Africa 
pregnant women were the first people to receive any form of ART drugs for the prevention of 
mother to child transmission. This focus on women has led to a ‘feminisation’ of the 
epidemic and in the focus of the ART program. Men have largely been excluded from the 
ART focus, especially in the earlier years of the program when they were not eligible to 
receive ART drugs (Tersbøl, 2006). 
This particular clinic also commenced with the Prevention of Mother to Child Therapy 
(PMTCT) programme and expanded from there. However, at the outset of the ART 
programme it was assumed that pregnant women would attend the clinic and bring their male 
partners with for treatment of opportunistic infections, and that these male partners would 
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commence with ART therapy when the policy change allowed for it. However, in reality this 
did not transpire and the ART program continues to be dominated by women. 
While the PMTCT program has been very successful, it is a preventative strategy that fits in 
well with the medical model. The reason why it has worked well under the medical model is 
because a drug can be prescribed that results in the prevention of HIV infection (Abdool 
Karim and Abdool Karim, 2010). Biomedicine is far more in control of prevention in this 
scenario, especially considering that most women deliver their babies in a healthcare facility 
(NDOH and HST, 2012). Even the latest ART policy favours the treatment of pregnant 
women above all other categories as the policy states that if a pregnant woman tests positive 
for HIV she should be commenced on triple ART on the same day as HIV diagnosis, 
regardless of her CD4 count (NDOH, 2013). This policy change greatly facilitates the access 
of pregnant women into the ART program and this is mirrored in the clinic study population 
where 23% of the study population indicated that their pregnancy status was the reason why 
they entered the ART program. 
6.1.2) Personal Health beliefs  
 
The personal factor of forgetfulness played a significant part at the clinic in terms of both 
adherence and access. Forgetfulness was cited as the most common reason for having missed 
a dose of drugs. Forgetfulness was also identified by van Dyk (2010) as a barrier to 
adherence. Forgetfulness, further dealt with in Aday and Andersen’s (1974) framework for 
understanding access to health care, demonstrates how the personal illness behaviour of the 




A patient’s own belief about the treatment and cause of disease does affect ability to access 
treatment and remain adherent. 93% of the respondents said that they believed that ART 
improved their health. 70% said that they did not believe that traditional remedies work for 
HIV infection; and correspondingly 91% of the respondents said that they are not taking any 
traditional remedies concurrently with their ART drugs.  
During participant observation at the clinic I often found myself sitting alongside patients in 
the queue. While conducting unstructured interviews I was sitting in the queue for the 
pharmacy when a patient Janice began talking to me. Janice stated that every month she 
endures the long queues, rude staff and painful process of collecting ART drugs, but Janice 
does not take the tablets at home; instead she throws them away in the nearest bin outside the 
hospital. “I come here every month to collect these tablets. But they have side effects; they 
shape your body and make you ill. I was never ill until I started with these tablets. So I now I 
just come here but I do not take them. The doctors made a mistake they simply did not know 
what else to diagnose me with so they just said HIV.” 
As is evident in the above conversation, the patient’s own illness belief as well as the illness 
beliefs of the supporting families plays a vital role in whether ART is accessed and used 
correctly. If people do not believe in the drugs, or do not believe they have HIV/AIDS; they 
will not use the drugs. Conversely, if patients believe that ART drug therapy has health 
benefits, as in the case of 93% of the research participants, then theoretically they will take 
them.  This however, is not the case as a host of factors prohibit people accessing ART 





This noted, religious belief can also influence patients to stop taking ART. In accordance 
with this, Betty mentioned an experience she had had with some members of her community: 
“Born again Christians they make us believe that if they pray for us you would get healed 
from HIV. They tell you to stop it for a while, they pray for you and see what happens after a 
period of 3 weeks or more after prayer. That causes lots of frictions between doctor and 
patient because patient end up defaulting with no proper explanation. Some patients end up 
back to the hospital admitted probably for a month or more.” 
Another female participant, Nelly came up to me one day at the clinic and held out a bottle of 
water with a sticker of a pastor printed on the label. She told me that this particular pastor 
was preaching that his holy water and prayer can cure HIV infection. She claimed that some 
of her friends, who were HIV positive had gone to his services, had consumed the water and 
now they are no longer HIV positive. These women had taken ART previously but have since 
stopped because they are now supposedly ‘cured’. Nelly’s concern was not unfounded. 
Recently a pastor in the Durban area has been reprimanded for selling his ‘holy’ water that he 
claims cures HIV infection. The local government along with the national department of 
health was quick to renounce his claims and reprimand the pastor for falsely leading 
desperate people to believe that they could be cured of infection (Peters, 2013).    
Like religious beliefs, cultural beliefs and traditional medicines can also impact on access to 
ART drugs. Steven drew a link between traditional medications and stigma in the 
community: “Some people would prefer to take traditional medicines instead of accepting 
that they are HIV positive, they should be on treatment. At Government hospitals treatment is 
reasonable, not expensive, sometime free of charge, however people would rather pay R100 
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to a traditional healer for Imbiza
35
. I still feel that people from rural areas of all walks of life 
should be more educated about ARVs and they must stop to say they have been bewitched.”  
6.1.3) Disclosure and Family Support  
 
Disclosure and non-disclosure have been identified as factors that can influence access to 
ART services as either a facilitator or an inhibitor to access (van Dyk, 2010). 80% of the 
respondents said that they had disclosed their status and use of ART to a family member, 
while 15% said that they had not. 5% of the respondents did not answer this question. Further 
to this 55% said that their treatment supporter was essential to help them access their ART on 
a monthly basis. The importance of a treatment supporter is indicated in the Figure 6.1 below. 
 
Figure 6.1: Treatment supporter 
 
Family support, or any form of social support, is undeniably one of the most important 
factors for facilitating access to care and treatment. Zoe, a female participant told me that: “I 
have told everyone at home and they support me. I have also disclosed to my immediate 
families including my children and people that I socialise with. I do take my treatment and I 
do receive lots of support from home.” Victor, a male patient, likewise stated: “In my 
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 Imbiza: Imbiza refers to a traditional herbal drink that has medicinal properties and is made by a traditional 
healer (http://ndr.org.za/indigenous-knowledge/stories/182). Veronica explained that the drink is made to “clean 
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community I am very lucky because people around there are very supportive. They support 
you as long as you are aware of your status and you are taking treatment regularly. They 
even advise you that there is life after HIV.” 
Positive social support can motivate patients to stay adherent and can simultaneously hold 
patients accountable. This is evident in the words of Veronica: “My sister knows that I take 
ARV’s. She knows what my times are, and she will always ask me if I have taken my 
treatment. This helps keep me motivated to know that she is also in it with me. She is my 
support. I can’t stop anytime because she will know and ask.”  
On the flip side of the coin, however, several patients mentioned the effect that a lack of 
social support can have on a patient’s ability to access treatment. The lack of family support 
can be detrimental for accessing ART. One of the male participants, Samuel, is 20 years old 
and is co-infected with Tuberculosis. The double burden of disease has taken its toll on the 
young man’s body and he is thin and emaciated. Dr Victoria referred him to a dietician to 
assist with regaining his weight. He was commenced on ART and referred back to his local 
clinic for follow-up.  
Three months later he returned to our clinic for a check-up. He had visibly lost weight and 
looked even more emaciated than he had before. At this visit Samuel came alone whereas he 
had previously been accompanied by one of his uncles. When asked about the nutritional 
supplements and porridge that the dietician had prescribed for him, as it is unusual for a 
patient to continue losing so much weight after three months on TB treatment, Samuel 
confessed the painful truth that his uncles and brother with whom he lives drink consume 
copious amounts of alcohol on a daily basis. He claimed that they do not bother buying any 
food but spend all the household money, the little that there is, on alcohol. Samuel further 
noted that when their money runs out they visit their friends and the drinking continues. 
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Samuel said that on most days he only has a slice of bread to eat in the evenings. When I 
probed about the supplements he had received from the dietician, he continued: “Well, the 
lady had given me some milk to drink. She gave me plenty bottles of milk but then I had to 
take them home. Those guys that I live with, they drank all my milk before I could. They 
always eat all my food and I have no way of keeping it safe and from them. So now I don’t 
have any more milk. I have an appointment with her next week again.”  
When I then asked Samuel who assists him when collecting his treatment from the clinic, 
Samuel responded: “No one. They just leave me on my bed. I have to get the energy somehow 
and walk to the clinic. The clinic is not far, but it is too far for someone who is sick like me. 
My chest pains when I have to walk the distance. My feet burn and is painful too.”   
Samuel’s story is not unusual but does capture the importance of family support for those 
who are ill. In Samuel’s case there are numerous physical and structural barriers that create 
obstacles for him to access his ART, but it is his lack of family support that presents his 












The attitudes in the local communities towards people who are HIV positive and receiving 
ART was furthermore identified as a major social barrier to accessing ART drugs. 
Participants were asked whether or not they perceive the attitudes of their community 
members towards people on ART to be a problem and 29% of the questionnaire participants 
stated that this is not a problem, but, 71% said that stigma is a problem of varying 
proportions. A total of 19% said stigma is a small problem, 16% were neutral, 15% said it is a 
big problem, and 22% identified stigma as a catastrophic problem. The results are presented 
in Figure 6.2 below. 
 
Figure 6.2: Attitudes of the community 
 
6.2.1) Stigma at the family level 
 
A male participant, Roger, stated that stigma on the level of family is a major problem: “I met 
a ‘gogo’ the other day at the clinic who is 60 years old lives in Umlazi  who have been ill-
treated by her mother who doesn’t allow her to use her utensils, dishes etc. When they have 
visitors after she has eaten or used their dishes etc. she is requested to wash up everything 













No problem Small Problem Neutral Big Problem Very Big
Problem
Attitudes of your community members towards 




them HIV. This is very sad to find that there are still people out there who ill-treat their own 
family members badly just because they are HIV positive”. 
 
Another patient, Jenni, is a 26 year old female who started her ART in 2010. Jenny told me 
her story about accessing her ART. Since I have known Jenny she has been very enthusiastic 
about her treatment and improving her health. Prior to being diagnosed with HIV Jenni 
developed a Tuberculosis infection and was then diagnosed with HIV. Tuberculosis is the 
most common cause of death for patients infected with HIV and the two combined have often 
been referred to as the co-morbidity challenge in South Africa (NDOH and HST, 2012, 
Rossouw et al., 2013). In this case the TB infection provided a good ruse for Jenni to attend 
health care services frequently, especially since her family is very judgemental of HIV 
infected people and Jenni was too afraid to disclose her status to them. Jenni, like so many of 
the clinic attenders, is unemployed. She relies heavily on her family for social and material 
support.  
Jenni managed to continue with her ART drugs even after her TB infection cleared two years 
ago. “I just tell them that I still have the TB and that the doctor wants to check up on me 
because I am still very sick”.  Jenny continued, “It would be so much easier for me if I could 
collect maybe every three months. Then at least I would not have to borrow the money for 
transport every month and they would not ask all the questions about where I am going.”  
The fact that Jenni was hiding her HIV status and ART from her family, ultimately affected 
her ability to access her treatment in the long term. According to Jenni’s clinical notes and 
blood work she had a high level of adherence, but one day she simply stopped coming to the 
clinic to collect her tablets. When I contacted her to find out what had happened to her there 
was no response from her. Eventually I managed to get hold of her and she stated: “My father 
found my ARV’s. He was cleaning the house and found them under my bed. He threw them 
138 
 
out, and then when he asked me what they were for I told him I am positive. He chased me 
out. I now live far away on the farm. There is no ARVs here.” Her father, as a result of stigma 
surrounding HIV/AIDS, cut off her ability to access her treatment. Jenni is a thus a victim of 
various forms of structural violence. Her gender makes her vulnerable to HIV infection and 
her economic status contributes to her vulnerability and places her in a particularly volatile 
situation. Once her economic support was withdrawn her ability to continue accessing her 
treatment was exceedingly limited. Her suffering has been further exacerbated by the policies 
that drive the services in the ART clinic enforcing monthly patient visits to collect treatment. 
All of these larger societal forces have contributed to Jenni’s discontinuation of ART 
treatment, indicating that on-going ART therapy is far broader than the individualistic 
assumptions of the biomedical paradigm and policy framework that stress adherence alone as 
an individual endeavour that can be simplistically equated with an individual action, devoid 
of the wider social and structural context and ramifications.    
To the health care sector and health care providers working in the clinic Jenny just became 
another ‘defaulter’, but her story shows the importance of family support and disclosure for 
continuous access to ART as well as the fact that it is imperative to look beyond individual 








6.2.2) Community and workplace stigma 
 
Family stigma thus clearly plays a significant role in continued access to ART therapy, but 
community and workplace social stigma also impacts negatively upon the continuation of 
ART. 
This is evident in the words of Lauren who told me that: “Communities are still very shunting 
about treatment and the HIV stigma and they try by all means to keep away from the HIV 
subject.” Chris shared this view as his reason for attending this particular ART clinic and not 
the one closer to his house: “I prefer to come here because I do not know anyone here and 
nobody from my community is here. People talk in the communities, in the clinics out there. It 
is so bad in the other clinics. When you go there, everyone they will know that you have this 
HIV.” 
An interesting observation that arose from the focus groups was that the patients felt that the 
healthcare sector could intervene and assist with decreasing the levels of social stigma 
present in their local communities. They felt that educating the communities is key to 
decreasing the stigma. One male participant, Micheal, reiterated: “Communities are always 
negative and positive, they really have different views.  Surely it is important to attend classes 
so that one can be educated about treatment and their status. Education is important so that 
you can be counselled about treatment before starting treatment.  Those who discourage 
treatment are those who are naïve about HIV treatment.” 
While stigma in the community can impact upon access to ART, stigma in the work setting 
can also present a barrier to accessing treatment. One of the female focus groups participants, 
Mary. told me that: “It’s a problem to ask for day off every month at work and they don’t 
understand. 3 months was better. Other employers don’t understand if you have HIV. The 
employers don’t want to share the cup with you. They tell you they will call you but they don’t 
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because they afraid you might infect their children.” The stigma tus results in fear and 
psychological harm, as Steven explained:  “The problems that I have experience are that it is 
difficult to keep asking for day off from work to since I am employed. This raises an eyebrow 
from my employers and at the same time you don’t want to tell them about your status since 
you are afraid of being isolated. Therefore it would be better if we could be supplied with two 
months treatment.”  
6.2.3) Healthcare Related Stigma 
 
 
Stigma is however, not only confined to the local communities, families and workplace but is 
also situated within the healthcare setting itself. The literature has covered this topic 
extensively (see for example Holzemer et al., 2006, Sadoh et al., 2009, Parker and Aggleton, 
2002). Stigma has been identified as a significant barrier to accessing ART, especially in the 
local clinics where confidentiality is often undermined. This is evident in the words of 
Veronica, Lauren and Gloria “Local clinics don’t have patient care and confidentiality. When 
you go collect treatment at the local clinic everybody knows that you are HIV positive,” 
reported Veronica. Gloria further explained, “At our local clinic they don’t have 
confidentiality. After you have discussed your issue with a nurse she would simply share it 
with others.” Lauren further expanded on the situation in the local clinics: “At the local 
clinics it is even worse because for some reasons they have new rooms painted white for TB 
and HIV patients. The minute you enter the gate at the local clinic you enter one of those 
rooms everybody already knows your diagnoses.  I am not sure how the government came up 
with this idea of special isolated rooms for HIV patients; I really don’t appreciate that. For 
me I think the government is promoting stigmatisation around HIV. Township clinics are 
painted in white to identify the HIV positive. I wouldn’t want to be collecting at my local 
clinic. People still say you are going to die and are still gossiping about ARVs.”  
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Veronica explained how this stigmatisation that is caused by ill-informed healthcare policies 
affects access to ART. “For some it could be the issue of collecting treatment at the local 
clinic, being afraid that their friends and neighbours would see them and mock them. To 
prevent being seen by friends and local street neighbours some would prefer not to collect 
treatment at all. And fear to be mocked by neighbours if treatment is collected from the local 
clinic.”  
Lauren and Veronica’s statements clearly demonstrate the disengagement between the 
patients and the healthcare system. Although the healthcare system is providing an essential 
service, they are inflicting harm on those whom they serve. It is thus clear that healthcare 
related stigma often forces patients to seek ART services elsewhere, which has in turn 
contributed to the financial burden of accessing ART drugs. The structural force of stigma 
becomes evident in the above mentioned data. It remains a problem for people living with 
HIV/AIDS, and influences other aspects such as employment and faith in the healthcare 
system, which further threatens the patients’ ability to continually access ART drug.  
6.3) Economic Barriers 
 
6.3.1) Employment and Unemployment 
 
 
Nearly half (43%) of the participants who answered the question relating to their employment 
indicated that they are unemployed, while 49% of the participants reported that they engage 
in some sort of income generating activity, be it casual work, part-time work, or full time 
employment. The lack of funds for the unemployed did present some problem, but most of 
those who responded as being unemployed said that unemployment did not hinder their 
ability to access treatment due to social support networks or reliance on the social disability 
grant. Approximately half the sample indicated that the most expensive factor in collecting 
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their treatment on a monthly basis was, as noted, transport. The employment/unemployment 
scenario is indicated in Figure 6.3 below. Despite the fact that quantitative research does not 
reveal a significant correlation between unemployment and ability to access ART, the 
qualitative research revealed underlying links between economics and access. 
 
Figure 6.3: Employment 
 
The monthly visits and the lengthy waiting times have been identified as being particularly 
pertinent barriers in the clinic for those who are employed. These barriers are all interrelated 
and quite often the one affects, or sometimes causes, the other. Being employed can be an 
obstacle to collecting ART drugs as patients require time off work on a monthly basis in 
order to access treatment. One of the reasons cited why participants are asking for a longer 
time between collection dates is because of the economic impact that monthly visits have on 
them. The monthly visits create job insecurity among those who are employed in the clinic, 
especially those patients who have semi-permanent jobs. Thea, a 35 year old female patient 
said: “What I see as a problem is for example, I am employed on contract and my boss 
complains if I am not at work every month to collect treatment. When you send someone else 
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male participant, Shawn, added:  “Sometimes I feel bad to keep asking for a day off because 
where I am employed I am temporary and I don’t want to lose my job. Sometimes I couldn’t 
collect because my boss did not allow me to come and collect.” 
The double-edged sword between needing both treatment and employment to stay alive 
sometimes has devastating consequences for patients. The physical harm is as a direct result 
of the structural violence that is embedded within the healthcare system’s policies to collect 
treatment every month and the employment sector’s unwillingness to allow time off work to 
collect treatment. Many patients are in positions of employment where time off from work is 
not possible because the patients are lacking in skills and education and therefore are in 
structurally poor positions; especially those patients who hold temporary jobs. One of the 
female respondents in the focus group, Barbara, said the following: “I know one case of my 
neighbour and she ended up dying because she could not pick up her treatment. Her boss use 
to give her warnings.” Another female patient, Nelly, also mentioned that it is a problem: 
“Getting your treatment every two months is time saving. It is difficult for people who are 
employed to take off monthly as managers do not like this. Sometimes you find that you attend 
different clinics or different doctors in one month, managers do not like this. This may lead to 
patients defaulting”. 
It is important to note however that it is not only under-employed or those in lower ranking 
employment positions that experience problems with access to ART. This is evident in the 
words of Shawn, a male participant: “There is a problem that may prevent me from 
attending. Due to employment for example today I am going to Mpumalanga next month I 
will be away for the July month. It would be advisable that you give us two months treatment. 
I work for contactors, I travel around the world. It would be preferable if we could be 
allowed to be issued treatment for two months”.  
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After the initial interview I had with Shawn I saw him again late one afternoon at the clinic. 
He came over to me and asked me to help him to get a two month script. He told me: “my 
boss told me that if I take another day off I will lose my job. Without my job I cannot afford to 
come here.” Shawn’s situation is not unique. His comments however highlight that difficulty 
in collecting treatment while employed is not always an issue of economic powerlessness but 
can also be attributed to physical constraints placed on the patients but the nature of their 
work. This adds another dimension to the complication of being employed and having to 
collect treatment every month i.e. that patients may not be in the vicinity of the clinic on the 
day when the appointment has been allocated and there is no flexibility in the public health 
system for such considerations. 
Like Shawn, many of the employed patients reported being faced with job loss if they 
continued to take their treatment. The patients are thus left to make very difficult decisions, 
either they can remain on their treatment and lose their jobs, or they can stop their treatment 
and remain employed. This quagmire experienced at the grassroots level is purely because 
broader level policy states that patients must attend the clinic monthly on the day that has 
been specified.   
Employment, while necessary for sustenance, can thus create barriers to accessing ART 
especially at this clinic which only operates during the week days.  Unemployment, likewise, 
although not clearly indicated in the quantitative statistics, presents a major barrier to 
accessing ART. Most of the patients indicated that the lack employment, and therefore 
money, presented some problem for them and that they had to rely on others in order to have 
the ability to access their treatment. This is evident in the words of Joyce, a female participant 
who told me: “I would prefer to be supplied by two months treatment due to the fact that I am 
unemployed. I don’t randomly have money to travel up and down to the hospital. Also we get 
odd appointments during the middle of the month. In that case I have to borrow money from 
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people and I hate it. For example my next appointment is on the 19
th
 and I won’t have money. 
Again I have to borrow from someone and yet if I am given 2 months’ supply that would help 
me because I would be able to plan in advance for my next collection date”.  
Roger, a male participant, noted: “My cousin who is a pastor assisted me financially to pay 
for my treatment the entire year.” However, constantly relying on family for support can 
cause strain and threaten continued access to ART, as Sarah a female participant explained: 
“I have money issues, for example today I borrowed money to come here from my 
neighbours. Eventually you become an irritating person to your friends and families for 
asking for money each time you attend the clinic.”  
Both employment and unemployment are thus major factors in terms of accessing ART in the 
present public healthcare system. This is evident in the words of a male research participant, 
Chris who stated: “Companies don’t have time for people who take off from work often. So 
when it’s time for retrenchment those who have been taking off from work are the first ones 
who are identified for retrenchment which I think that is unfair for me and that is also 
discrimination and like I mentioned before also patients who are employed they are able to 
eat well and look after themselves those who are unemployed in most cases they default their 
medication because they have no food.”  
Chris highlights a crucial point about the struggle within which the patients find themselves. 
Their lives depend on their ability to access their ART, but at the same time the process of 
collecting their treatment threatens their employment, which is just as crucial for them to stay 
alive. On the flip side of the coin, those who are unemployed frequently lack the necessary 





As noted, food insecurity presents a particular problem for those who were unemployed. One 
female participant, Yvonne, who is 26 years old, sent me the following message: “Hi, I’m 
very sorry for not come and take my medication my problem is that I can’t have my pill cause 
it so difficult to take pill while you don’t have job or food in the table it not like I don’t care 
about my life it the situation I’m facing. Thank you very much.” Yvonne thus had to sacrifice 
collecting her ART drugs because she didn’t have food. Prudence, a 24 year old female 
participant added to the food problem: “I guess to those who are unemployed it is difficult 
because the rule says you must take food before taking your tablets. What happens if you 
don’t have food, how are you expected to take your tablets? Sometimes there is no food at 
home and you not sure how you can take treatment.” 
Lauren had the following to say about this: “The other reasons could be short of food at 
home. One must eat before taking medication, if there is no food how can the patient not 
default taking their treatment? Being on chronic medication you need to up your game and 
eat well. Not everyone has money to buy vegetables.” What is interesting to note in Lauren’s 
comment is that she highlights that those patients who ‘default’ on their treatment due to food 
shortages cannot to be blamed since they are powerless in their decision. Their powerlessness 
is as a result of larger economic and policy structures that perpetuate the patients’ suffering 
by imposing strict rules in order for them to access ART. If the patients cannot manage to 
comply with the rules due to larger forces such as unemployment, poverty, stigma and food 







6.3.2) Social Grants 
 
While conducting participant observation in the clinic a female patient named Janet, called 
me and asked me to sit down next to her. She handed me a small piece of paper, with this 
message on it: “I’m Janet from Westville. I’m 38 years old and I am not working my CD4 is 
170. I’m the mother of 3 children and one I support for my brother, her mother died a long 
time ago and now she is 13. So, I need a favour. As a poor person I am taking my treatment 
difficultly the way of the situation is very bad. Yes, can’t you do me a favour for the pension, 
because I am surviving with a grant for my 2 children and my son is 19 he won’t collect a 
grant even I came here I borrow a bus-fare. Every day I wrote a letter to give you else can I 
come and see you for now I am waiting for my treatment. Thank you.” 
Leclerc-Madlala (2006) examined the significance of the social disability grant within the 
ART setting and found that it was both a facilitator to accessing ART and also an obstacle. 
She also highlighted the difference in need assessment between the patient and the healthcare 
system that determines who is eligible for the disability grant and who is not. In line with 
what Leclerc-Madlala (2006) found, many of the patients who attend this clinic feel that they 
are eligible for the grant. During my work in the clinic I often receive requests like Janet’s, 
and one female participant, Betty, told me: “We would appreciate it if we could be met half 
way by the government. Receive some sort of food support so that while we are taking 
medication we would have something to eat and regain our strength.”  
The participants’ comments highlight the presence of structural violence embedded within 
the healthcare system where policy is a structural force that is created by officials who are 
removed from the local setting. Their detachment results in limited consideration for the 




In summary to this chapter it was noted that a range of barriers influence the patient’s ability 
to continuously access their ART drugs. Many of these barriers are situated within the 
healthcare system itself, but others such as stigma are located in the local communities, in the 
patients’ families and in their workplaces. What is evident from the data is that the healthcare 
system perpetuates the patients’ suffering by enforcing policies that were created at the so-
called ‘centres of power’ (Inda and Rosaldo, 2002), yet these are removed from the periphery 
where the patients are situated. The imbalance in the power dynamic further contributes to 
the patients suffering.  
In the following chapter the effect of these barriers will discussed. In particular, the power 
struggle between the patients and the healthcare system will be explored, as will the patients’ 
















CHAPTER SEVEN: Antiretrovirals, public health and structural 
violence: A melting pot of inequality  
 
 “The system reminds you how sick you are and how poor you are and how black you are”. 
– Lauren, female key informant   
 “But little concern has been shown by the South African actors about the fact that 
biomedical theories do not take into account the structural components of the development 
of the epidemic or the realities of the majority of the populations’ daily lives, which are of 
crucial importance for grasping the gravity of the disease and its spread” (Fassin, 2007: 
location 457 of 5420 [Kindle version]) 
 
In Chapters Five and Six the results from the data collection tools were presented and 
discussed. The discussion focused predominantly on identifying the most relevant barriers 
and qualifying them. In this chapter I discuss how these barriers are interrelated and the effect 
that they have on the patients of the clinic.  
7.1) The power struggle between the patients and the healthcare system 
 
 
Despite the barriers that have been addressed in Chapters Five and Six, a fair number of 
patients indicated that they are satisfied and happy to collect ART drugs at this particular 
clinic. Those who utilize the public health care system have become so accustomed to the 
barriers they face that these barriers have been internalised, normalised and accepted.  While 
patients are largely satisfied with accepting poor service, what is especially worrying is that 
the poor service is perceived to be better than the service they receive from their local clinics.  
The invisible violence and its effects are embedded within the everyday routine and 
procedures of the hospital and the clinic. These routines and procedures are created and 
instituted by health care policy, and usually by people who have very little experience or 
insight in the daily challenges experienced by both the patients and the health care providers 
who attempt to ensure that access to health care services is maintained. The patients have 
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come to accept that they will just have to endure these obstacles in their attempt to recover 
their health and reclaim their lives.  
One of the most prominent inequalities within the healthcare system is the difference in the 
power balance between the healthcare workers and the patients.  This powerlessness is 
recognised by some of the patients but they frequently feel unable to change their situation. 
As one male patient, Roger told me: “I don’t want to be punished for that just because it is 
not my clinic date. The staff at the clinic needs to know that they are here for us patients not 
to make us feel like we owe them something.” Another male patient, Derek, added to this: “It 
is important that we must be informed about new changes at the clinic. This clinic exist 
because of us patients.”  
 
According to Farmer (2004: 315) “Structural violence is both “structured and stricturing. It 
constricts the agency of its victims. It tightens a physical noose around their necks, and this 
garrotting determines the way in which resources - food, medicine, even affection – are 
allocated and experienced”. Those who utilize the public healthcare system have constricted 
agency, that is to say they have very little control over their own health and decision in their 
own healthcare plan. They do not participate, they obey, and if they do not obey they are 
punished by the very system and people who are supposed to protect them in their time of 
vulnerability and need. 
 
Activities such as the enforced repeated counselling are indicative of the mistrust that the 
public healthcare system has in the patients. The patients have to be seen every month so that 
they can be closely monitored. Farmer (2003) argues that this mistrust in the poorer public 
patients is a result of commodification of healthcare. In the private healthcare setting this 
scenario is the opposite. A private patient can walk into the local pharmacy where her/his 
repeat script is and simply collect the ART drugs, without repetitive counselling every time; 
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indicating that those who utilize private healthcare can be trusted. This is where the economic 
inequalities come into play and the effect of commodification of healthcare becomes evident. 
Private healthcare patients have to pay for their own medication and are therefore seen to be 
responsible and in control of their own health (Farmer, 2003). However, the public healthcare 
patients receive treatment for free or for a nominal sum. In turn, the patients are made to feel 
eternally grateful for having access to lifesaving drugs, as one doctor told a patient: “You 
should be grateful that you have these tablets at all. Because there was a time when we didn’t 
have these tablets, and they are free.” That people should be grateful for something that is a 
basic human right, a right to health and healthcare, is an indication of the inequality present 
and the power imbalance between the healthcare workers and the patients.    
 
Fear also plays a big part in the invisibility of the violence created by the obstacles that the 
patients face. Patients often do not voice their concerns or criticisms because they are afraid 
of the health care workers who often shout at them, reprimanding them for not being ‘good 
behaving patients’. One male participant, Jack, said of the counselling, “you just have to keep 
quiet and do what they say. If you know how to behave in the clinic there are not problems. 
But when you begin complaining… that is when the difficulty start”. In addition to this 
Neville told me: “things are fine here in the clinic. I come early in the morning and as long 
as you do as they tell you and behave nicely then everything is just fine. They treat you nicely, 
there are no problems.” These statements might give the impression that there are no 
problems, that all is well. The fact that the patients have to ‘behave well’, ‘keep quiet and do 
what they say’ and follow instructions without question is, in reality, where the biggest 




Patients are expected to simply follow instructions without much discussion or negotiation. If 
they do not follow the rules of the healthcare system, and dare to speak out about sub-
standard services, they are treated harshly. In fact there is no room for any negotiation 
between the patients and the health care workers. This adds to the disempowerment of the 
patients which, in turn, further fuels discrimination and inequality in access to health care. 
One such example is that of Pamela.  
Pamela is a 28 year old female patient who is unemployed. She has numerous social 
difficulties at home and has experienced harsh discrimination from her mother about her HIV 
positive status. During the first month on ART Pamela lost her only child who was a month 
old. Her mother consequently evicted her from her house and forced Pamela to live out on the 
street. Eventually, through the help of a social worker, Pamela found a place to stay with a 
distant relative. Throughout this trying personal period Pamela remained adherent to her ART 
drugs even when it was physically difficult for her to reach the hospital. As time passed 
Pamela settled into the routine of attending the clinic every month but struggled to find 
employment, which created a major stress in her life. One day Pamela was sitting in the 
queue to be seen by the doctors when one of the counsellors came over to her. The counsellor 
began reprimanding her for not attending her adherence counselling session and demanded 
that she return to the counselling queue. A row ensued between the counsellor and Pamela 
that escalated to near physical violence. The reason behind Pamela’s refusal to attend the 
counselling is because she no longer felt that she needed it. When she refused she was 
reprimanded. Subsequently Pamela left the clinic and has not returned. Pamela’s lack of 
power reflects that the unequal power relations between the healthcare staff and the patients 




Fear is not the only motivating factor for the patients to comply with the healthcare system’s 
rule. Most of the patients tolerate the rules and regulations, for the simple reason that “This is 
our lives. We don’t have a choice. We must handle these things because this is our health and 
our lives.” The patients taking ART for life are prisoners of this system. They have no power 
to negotiate their treatment plans and even less power to demand better service. They have no 
choice but to comply with the system because their lives depend on the lifesaving drugs. The 
very strict obedience to the policies and protocols laid down by the Department of Health has 
a direct influence on the powerlessness of the patients. They simply have to follow the rules 
or face the consequences of having the access to their life-saving drugs threatened.  
In the literature (see for example Penchansky and Thomas 1981, Donabedian 1972, Aday and 
Andersen 1974) the difference in need assessment is identified as a factor that can influence 
access to healthcare. Patients perceive their needs for and within the healthcare system 
differently from how the healthcare system and healthcare workers do. This varying 
assessment of need is another structural driver of invisible violence within the healthcare 
setting.  
The ART program in particular has demonstrated how influential the healthcare system’s 
perceptions of patients’ needs are and that the healthcare system’s perception of needs 
override the very real needs of the patients. In the beginning of the ART era the healthcare 
system and government decided that those infected with HIV did not need ART drugs. Later, 
with mounting pressure from civil society and forced by law, the government and healthcare 
system conceded that those infected with HIV do need ART drugs. A confusing message was 
sent to the people living with HIV/AIDS who relied on the public healthcare sector to provide 
them with healthcare services. After seven years the damaging effects of those views held by 
government are still experienced by people in their everyday lives.  
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The concept of varying need is not recognised by the public healthcare system due to the fact 
that the ART program is situated in the biomedical system with a focus on adherence and not 
on continuous access to the service. For continuous access to occur all the dimensions of 
access to health care need to be considered, and not merely adherence as a catch all phrase.   
The monthly visits have a domino effect on the rest of the services provided within the clinic 
and result in less time being available for those patients who are new to the system or who 
require more intense medical attention.  As, Betty, a female patient said: “We would 
appreciate it if you could allow us to send our relatives to collect on our behalf. Also doctor 
to give us a three months script so that we can collect and then after three months we can see 
the doctor unless if one is not feeling too well then only they can come themselves and then 
request to see a doctor.” As indicated, the monthly visits were found to be a significant 
barrier. A reason behind this is because monthly visits directly influence some of the other 
organisational barriers mentioned, contributing to the biggest barrier identified in this clinic, 
namely waiting times. Time delays were identified by Penchansky and Thomas (1981) as a 
factor for user satisfaction. Users decide whether their time spent waiting for healthcare 
services is acceptable or not. If they find that the service offered are not worth the time spent 
waiting for the service, they may disengage with that service (Penchansky and Thomas, 
1981). Once the patients have entered into the healthcare system they no longer have control 
over their time, and therefore often have to choose between their health and income, for those 
who are employed. As Neville stated “Sometimes it takes me about 5 hours. When it is the 
clinic day I just dedicate the whole day to the clinic and tell myself that the day is reserved 
for the clinic.” His choice reflects the structural violence that the patients are subjected to and 




Only 10% of the participants attending this clinic said that time delays are not a problem for 
them while 60% reported that it does present a problem. Of those who reported waiting times 
to be a problem, 26% rated it as a catastrophic problem. The area where the patients felt that 
they wasted the most time was waiting for the adherence counselling; a service which many 
deemed to be irrelevant at every visit. Time delays are dependent on other areas in the 
hospital and clinic. A delay at the card office will impact on the time spent in the queue, so 
too will a delay at the counselling office cause a further delay. As was demonstrated in the 
observation of a day spent in the clinic, the time delay gets compounded and affects the total 
service of the clinic. This then  and ultimately contributes to the structural violence which 
patients face as they are forced to be absent from work in order to access health, yet, are 
frequently faced by constant threats of dismissal as a result.   
7.2) ‘The Bad Behaviour of the Patients’ 
 
The constrained agency of the patients and the lack of negotiation between the patients and 
the healthcare system have, at times, led to some instances of aggression and violence in the 
clinic. The patients who are taking ART and utilizing public healthcare services find 
themselves trapped within the system. They have to take their ART to stay alive and healthy, 
and are largely accepting of that fact, but although they feel powerless, they are also tired of 
having to face the constant barriers and perpetual inequality created by the system. They thus 
devise many interesting ways to manipulate and ‘cheat’ the system.   
These behaviours were noticed while I was conducting participant observation at the clinic. 
By engaging in what the clinic nurses refer to as ‘the bad behaviour’ of the patients, the 
disempowered patients exert a degree of agency to recapture some form of control over their 




At the clinic the patients are scolded, shouted at and threatened with the discontinuation of 
their treatment. They are blatantly treated like ‘naughty children’ for standing up against the 
autocratic biomedical system in which their role is limited to that of strict obedience. The first 
of the ‘bad behaviours’ of the patients is a recurring event. Some patients have taken to 
throwing their tablets, or excess tablets, away into the bins situated behind the clinic building. 
The tablets were discovered by the cleaners who separate out the waste.  
There are a number of reasons why they engaged in this sort of behaviour, depending on who 
you talk to. The healthcare workers in the clinic, and even some patients, say that those who 
throw their tablets away are ‘irresponsible’ and ‘ungrateful’ for the services that are available 
to them now. As is evident in the literature regarding the history of ART in South Africa (see 
for example Cullinan and Thom, 2009 and Fassin, 2007) it was a battle to get these drugs into 
the public healthcare system and make them available to those who need them. There are 
however other reasons why they would throw their tablets away and yet continue to endure 
the long queues in the clinic and the rude treatment from the healthcare staff. The first of 
these was mentioned earlier about the counsellors and their narrow focus on adherence. Some 
of the participants said that the counsellors are only interested in the number of tablets left in 
the pill containers; they are not interested in the explanations given by the patients, nor their 
concerns. If they have excess tablets they thus get labelled as being a ‘defaulter’ very 
quickly.  
The term ‘defaulter’, and to an extent ‘adherence’, has become a sore point for the patients 
and they are sensitive about being labelled as ‘defaulter’, or questioned about their 
adherence. There is a negative connotation attached to the term ‘defaulter’ and judgement is 
passed by the healthcare workers and by fellow patients. To avoid being labelled as a 
‘defaulter’ and thereby being ascribed additional stigma, some of the patients throw their 
tablets away in the bins. They also throw their drugs away at the clinic to uphold their social 
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image at home of being compliant. This is in keeping with what Ware et al., (2013) found in 
their study on disengagement from ART programs in the sub-Saharan region. Social support 
was identified in Ware et al., (2013) study to be important for accessing ART. Throwing 
tablets away in the bin could be explained as a way for the patients to regain some control 
over their live, while at the same time keeping a back-up plan by satisfying their social 
support in case they become ill again. By throwing the tablets away they are exerting some 
agency in the decision to take ART drugs. The patients are aware however that they are ill 
and will require assistance at some stage if they get ill. As a support plan they will pretend to 
take the tablets and attend the clinic to keep up the façade of being compliant. If they should 
fall ill, the blame would then not be theirs, but the ART drugs. In this way they manage to 
control some aspect of their health while simultaneously maintaining social support.    
As the ART program expanded at this clinic the number of patients within the system also 
rapidly expanded. At the beginning of the program patients were referred to their local clinics 
if they were happy to go. However, this was quickly stopped because, as one doctor put it: 
“apparently we did not follow the correct protocol, but no one even knew there was a 
protocol”. This measure, accompanied by the insistence by the clinic management that the 
patients should attend the clinic every month, resulted in the clinic becoming overpopulated. 
Soon overcrowding led to major problems. The delays that are caused by pre-existing barriers 
such as the poor administration at the card office, and the mandatory counselling at each visit 
has led to long delays at the clinic. These delays have resulted in frustrations growing, which 





One morning, while a nurse was giving health education to the patients in the clinic, conflict 
broke out. The patients became aggressive and shouted abusive words toward the staff. They 
demanded better quality service and insisted that the nursing staff provide the service 
immediately. Security was called to control the angry crowd but they were overpowered by 
the mass of angry patients shouting abuse at the clinic’s staff.  
Eventually after much talking and reprimanding by the clinic management who kept on 
reinforcing the hospital’s policies and procedures, the patients calmed down and the clinic 
continued. Later I asked Veronica, who was there that day, why the patients were so angry. 
She told me “some patients are unhappy about the order of flow in the clinic. They feel it is 
unfair that they have to wait so long just for their cards. Also they are complaining about 
other patients that take their hospital files home with them. When they return for their visits 
they get out of the same taxi. Those with their files then come straight up to the clinic while 
the others have to go and wait down there (at the card office).” 
Besides the violent outbursts other recurring behaviours have been noticed at the clinic. One 
of these behaviours involves the patients skipping the counselling queue and writing their 
own adherence results in their files. Another more serious activity involves patients signing 
their own medication scripts to avoid having to go to the doctor. Many of the stable
36
 patients 
have no medical complaints, and as Lauren told me earlier, also do not see the point of 
visiting with the doctor when they are well. So for most the visit to the doctor involves 
getting their scripts signed so that they can refill their medication for the next three months 
before they have to see the doctor again. 
                                                 
36
 Stable patients: these are patients who have been receiving ART for some time and are free of opportunistic 
infections or complications of ART side-effects. Their CD4 counts have increased and are stable, and their viral 
load counts are below detectable limits.  
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Engaging in behaviours such as these, are a direct result of the consistent barriers that the 
patients have to endure. The clinic has specific protocols and policies that dictate the running 
of the clinic service and the patients simply have to comply. By engaging in these 
behavioural strategies they are actually communicating with the healthcare staff and services, 
drawing attention to the invisible violence they are made to endure every month. 
The response from the clinic has simply been to label the patients as ‘rude’, ‘abusive’ and 
‘dangerous’. They were also blamed for ‘filling up the clinic’ and for the overcrowded 
situation. The clinic management, instead of addressing the issues of the patients, decided to 
punish them in the form of referring all the stable patients to their local clinics, whether they 
wanted to go or not. The clinic manager told me: “none of the patients ever said that they 
wanted to stay here and not go back to their local clinics.” This was just simply stated as 
being ‘policy’ and therefore devoid of considering the desperate plea of the patients for better 











7.3) Projected Violence as a result of the Structural Violence 
 
One the most interesting observations in the clinic, and a unique barrier, was the projected 
violence between the patients. The atmosphere in the clinic is almost always tense, and the 
slightest ‘misbehaviour’ can result in physical violence amongst the patients. 
 
On several occasions I observed fighting between groups of patients, and most of the time it 
involved someone skipping a queue for some reason. Often it was because the older patients, 
who had been in the system for some time, took advantage of the newer patient’s uncertainty 
and somehow pushed ahead of them in the line. The older patients blamed the newer patients 
regularly for holding up the queues because they needed more attention.  
 
Steven explained the situation between the new patients and the old patients: 
“Oh yes this [abuse and bullying] occurs regularly especially to new patients at the clinic. 
That is why I would prefer it if you staff can select new patients and put them separate from 
the older patients. In order to allow them enough time to get used to the processes such as 
meeting with counsellors and to follow other processes at the clinic that they are not familiar 
with. Patients must be treated fairly with respect. It doesn’t mean that because you have been 
collecting your treatment for two years or more you are now the boss at the clinic. Those old 
patients they need to be disciplined to respect others. Especially those patients who have 
recently started their treatment and experiencing side effects such as black sore marks on 
their legs all patients need to be constantly reminded that we are all different and treatment 
works in different ways to different patients. All depends on our strong immune system. 
Please emphasise to older patients at the clinic not to mock people who are affected by 
obvious skin side effects they did not ask for it. Side effects must never be discussed by 




This could frighten them to attend their clinic and also end up defaulting due to these bullies 
at the clinic. Sometimes they can say things they don’t mean joking around HIV issues.  Some 
people are very sensitive around the HIV issues”. 
 
While the newer patients are blamed for increasing the waiting times, others blamed sick 
patients for putting the stable patients at risk of infection. Chris, a male participant added to 
this: “I think you need to categorise patients based on how sick they are. Sick patients should 
be seen monthly and given extra care. Those who are not sick and who are also not at risk 
should be seen separately. I think the staff should prioritise time frame of seeing very sick 
patients especially TB patients who are more at risk infecting others while waiting and 
chatting on the queue.”  
 
Lauren added to this sentiment and highlighted the issue of threatened safety. “While you are 
standing on the queues people are coughing around you bacteria all over the place we are 
just not safe. People that are very ill and have Tuberculosis should be provided their own 
queues to be seen as soon as possible and sent away. Those who are normal and healthy just 
there at the hospital to collect treatment should be also allowed to have their own queues”. 
Many of the patients who are now stable had to endure a period of serious illness. While ART 
does improve the immune system, HIV positive patients are more susceptible to opportunistic 
infections and the poor organisational arrangements within the clinic places the stable 
patients at risk of re-infection and create a threat to their health. Furthermore, unnecessary 
structural violence is evident in the long waiting times and structural confines of the clinic 







Perhaps the most remarkable aspect of this blaming and fighting amongst the patients is the 
fact that they channel their aggression more often towards each other and not the healthcare 
system or other barriers that create the difficulties for them to continuously access their 
treatment. This demonstrates the invisibility of the barriers that they face and the ubiquitous 
nature of the structural violence that causes the inequality which they face on a continuous, 
repetitive basis. It is in the repetition that the violence is lost and over looked. The patients 
feel powerless to voice their anger against the system so most frequently they vent their anger 
against those who they feel structurally able to do, namely the new and sick patients.    
 
While there are a range of barriers that exist outside of the healthcare sector that impact upon 
access to life-supporting ART, the health care sector should not be one of these. Perhaps the 
greatest tragedy of the HIV pandemic is not that it could have been prevented all those 
decades ago, but that people are still dying of the disease today when effective treatment is 














CHAPTER EIGHT: Conclusion 
 
8.1) Summary of the Research 
 
The main objective of this ethnographic research within the healthcare setting was to identify 
the most significant barriers to accessing ART healthcare at a public healthcare clinic in 
Durban, as perceived by the patients who attend the clinic on a monthly basis. The project 
further aimed to gain a better understanding about the structural drivers behind the barriers 
and how these affect the lives of the patients. 
As the introduction discussed, the advent of ART drugs has provided an opportunity for those 
infected with HIV to regain their health. South Africa has the largest HIV epidemic in the 
world and as a result also has the biggest ART program. However initial access to ART was a 
struggle in South Africa largely as a result of poor policy. In recent years the situation has 
improved as a result of policy changes that have facilitated the procurement of ART drugs at 
a fair price and have expanded the eligibility criteria for receiving ART to the general 
population. However access to ART drugs requires more than the availability of the drugs 
and largely depends on the functioning of the public healthcare system. The success of the 
ART program depends on the continuous access to ART healthcare. This is crucial in the 
effort to reduce the devastating effect that the HIV epidemic has had on the country. However 
the literature, (see for example Brinkhof et al., 2008, Fox and Rosen, 2010, and Miller, 2010) 
reveals that nearly 30% of all those patients who initially entered the ART program have 





Healthcare facilities do not have the adequate resources to deal with this problem, and as a 
consequence this large group of virologically stable patients have been largely ignored by the 
healthcare system and literature. A reason for this can be related to the focus on adherence 
instead of access to ART services, in both the literature and the healthcare setting. According 
to the literature, sub-Saharan Africa has adherence levels to ART comparable to adherence in 
developed countries. However, as van Dyk (2010) points out these results are based on 
findings reported on research where the participants were already part of a larger trial and 
therefore presented artificial conditions in which adherence was augmented. Further to this, 
those participants who were lost to follow-up were not factored into the results, but excluded. 
This is a trend in quantitative research to not report the ‘outliers’. The lost to follow-up 
patients have largely been ignored as a result, and not much is known about the reasons for 
discontinuation of ART, or the mortality rate associated with discontinuation of ART. 
Adherence results should therefore be interpreted with caution, since the reported results are 
based exclusively on patients who are still in the ART program. Adherence as a concept is 
also limiting since the focus is placed on individual behaviour that is situated in a generalized 
program. This has resulted in the individual patient being blamed for any non-adherence to 
the ART program even if their inability to access and adhere to the ART regimen is beyond 
their control.  
This project thus focused on the concept of access to healthcare and explored its various 
dimensions. As was discussed, access to healthcare comprises of five interrelated dimensions, 
namely: availability, accessibility, affordability, acceptability and accommodation 
(Penchansky and Thomas, 1981). Contextualizing the patients’ ability to remain in the ART 
program within the concept of access elucidates the larger structural forces that create and 
perpetuate the barriers that cause discontinuation to the program. This focus facilitates the 
understanding that discontinuation from the ART program is often due to larger structural 
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forces instead of individual choice.  Using structural violence theory further highlights the 
powerlessness of the patients in their dealings with the healthcare system and the 
communities in which they live.   
To understand the broad concept of access to healthcare an ethnographic approach was taken 
to conduct this research project. Ethnography provides the appropriate lens with which to 
study a subject more holistically and gain a deeper insight into the everyday struggle of the 
patients. Various methods were used to collect the data, including participant observation, 
focus groups, semi-structured interviews and questionnaires. The mixing of data collection 
methods aided in providing a broader understanding of the problem and served as a validation 
technique for the data acquired.   
The data from the quantitative analysis revealed that organisational barriers pose greater 
obstacles to continuously accessing ART, with the overall waiting time being the greatest 
complaint. Second to this the adherence counselling services was identified as the biggest 
barrier to accessing ART within the clinic. The most problematic barrier outside the 
organisational barriers was stigma and the attitudes of community members to people living 
with HIV/AIDS, which was followed by economic barriers, in particular the cost of coming 
to the clinic that was divided between transport costs or a day off from work. 
Stigma remains a problem for PLWHA as its consequential discrimination is situated in both 
the community and healthcare sector. Stigma in the community revealed itself to be 
problematic in terms of the fear associated with disclosure of HIV status and having social 
support to continually access and take ART. Stigma within the healthcare sector was also an 
important barrier that is not often discussed. Stigma in the healthcare sector was experienced 
on two levels. Firstly the location and layout of the local clinics identify those who are HIV 
positive from people suffering with other diseases and this was a motivating factor for 
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PLWHA to seek ART services away from their local clinics. This contributed to their 
financial burdens by increasing the distance to their ART facility. Secondly stigma was 
experienced in the form of discrimination and harsh treatment by staff. The counsellors who 
are supposed to provide a supporting service in enhancing adherence to the ART regimen 
proved to be the source of most unhappiness related to staff.  
The in-depth emic perspective of the qualitative data revealed that, in line with structural 
violence theory, larger forces create situations which contribute to the vulnerability of the 
patients and further perpetuate their suffering. Their vulnerability and suffering is often 
overlooked as it is made invisible by the healthcare system and the policies that govern it. 
Most often poor policies, that were created by institutions removed from the local setting, had 
the most devastating effect. Most of the barriers related to the organisation can be related to 
policy that results in structural difficulties for the patients to access their ART drug.   
As the ART program expands more patients will enter into the healthcare system. 
Consequently the healthcare facilities providing the care are constrained by poor policies as 
well as limited resources which further exacerbate the problems that patients encounter. This 
can sometimes lead to violent outbursts from the patients, as was demonstrated in the clinic 
where this study was conducted, in an attempt to reclaim their agency and regain some form 
of power and control over their own health.  
The patients of the clinic also devised interesting methods to ‘cheat’ the system. While the 
healthcare system condemned these behaviours and even threatened criminal prosecution, 
little attempt was made to better understand the problems that the patients face within the 




As is evident from the data collected in this research project, the dimensions of accessing 
healthcare along with the associated barriers are interrelated and can impact on each other. 
This was seen in situations where patients who are employed are forced to decide between 
remaining employed or collecting ART drugs on a monthly basis. The structurally enforced 
organisational barrier of monthly visits and time spent in the clinic directly impacts upon the 
economic affordability aspect of accessing ART, without which the patients would not be 
able to continue to collect their ART drugs.  
It is the interrelatedness of the barriers that are best explained through the concept of access 
to healthcare rather than the narrow focus on adherence alone that formed the central finding 
of this research project.  
8.2) Recommendations 
 
This study has found that patients often experience difficulties when they collect their ART 
drugs and that the increased volume of patients into the ART program has negative 
consequences for the healthcare facilities and also for the quality of services delivered to the 
patients.  
Continued access to ART is vital in the combat against HIV and AIDS. In order to achieve 
this, better informed healthcare policies are needed that will improve the service delivery of 
ART drugs. Policy changes could include more rapid dispensing of the ART drugs, separate 
services for newly initiated patients and patients who have been in the ART program for 
some time, and perhaps even allowing the patients to choose the services that they feel they 
need per visit. Mandatory monthly visits just to collect ART drugs should also be revised as it 
has implication for both the patients and the healthcare system. Clinics should be given the 
autonomy to investigate the most relevant obstacles that their population groups experience 
and then create specific interventions to deal with the barriers.  
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Innovative programs that simplify the delivery of ART drugs are required. Lessons on 
simplified ART delivery can be gleaned from the private healthcare sector. Patients who 
attend the private healthcare sector are not constrained by structural policies. Instead, patients 
in the private sector are entrusted with the responsibility of their own health and therefore 
have easier access to ART drugs. This trust in patients must be enhanced within the public 
healthcare sector, where the healthcare system has far too often taken on the responsibility of 
patients’ health instead of entrusting it to them. 
Creative programs have been created elsewhere to facilitate long-term retention, such as the 
Adherence Clubs initiated by MSF in the Western Cape, (see Wilkinson, 2013). These 
strategies should be supported by policy so that collecting ART drugs is made easier for 
patients. These strategies also have beneficial consequences for the healthcare system, by 
decreasing the patient volumes and thereby reducing waiting times. This could potentially 
improve overall service delivery and be transferred to other primary healthcare programs 
where long term retention is an issue.  
8.3) Areas for Further Research 
 
More research is required into understanding the reasons why patients discontinue utilizing 
healthcare services, particularly within the ART setting.  A broader focus on the holistic 
concept of access to healthcare must be a focal point in order to contextualize the barriers that 
patients face when they want to access treatment and care.  
Another area that requires further research is to establish the timeframes of loss to follow-up. 
This might give more insight into the reasons why patients discontinue services and can 
provide an opportunity for the healthcare sector to intervene. If it is established at what points 




In conclusion to this research project, I found that patients who attend the public healthcare 
sector for ART services experience a range of obstacles that prevent them from continually 
accessing ART drugs, and in support of the findings in the literature, see for example 
Penchansky and Thomas (1981), and Donabedian (1964), patient satisfaction with the quality 
of service impacts on utilization. Barriers to accessing healthcare negatively impacts on 
patient satisfaction and consequently negatively effects continued utilization of services. Any 
one of the dimensions of access including, whether healthcare services are not available in 
terms of drugs being out of stock; or services are not accessible in terms of limited transport; 
or services are not affordable in terms of hidden expenses; or services are not acceptable for 
example the stigma that was reported in the local clinics; or services are not accommodating 
such as the forced monthly visits to collect treatment, present as barriers to accessing ART 
healthcare services and influences patient satisfaction with the service offered.   
It became evident throughout this project that understanding access to healthcare in a holistic 
frame is fundamental to improving the quality of healthcare services in the public health 
sector and in eliminating the barriers within the system itself. Much depends on the patients’ 
satisfaction with the service offered. This was made evident during the qualitative research 
where some participants alluded to the fact that the healthcare sector exists because of the 
patients. No patient should be made to feel grateful because she/he now has access to life 









Shortly after I began my adventure into the concept of access to healthcare I had a discussion 
one day with a Professor of Medicine while making a cup of coffee.  A very kind and 
inquisitive man, he asked me about my research project. I told him that I was interested in 
studying the barriers to accessing health care and ART drugs in our particular setting. “That 
is a difficult and humongous problem” he replied.  
He is right; the problem is far greater than what was captured in this small project. The 
subject is a big one that seems to be continually misinterpreted. This further added to the 
length of my inquiry and complicated a complex problem even further. The patients who rely 
on the public healthcare system face many obstacles when they want to get treatment. My 
argument however, is that the healthcare sector should not be the cause of any of the 
obstacles that they face. That is what we can strive for because we can eliminate these 
barriers if we care enough to listen to our patients when they complain about us. My initial 
enthusiasm for this topic remains and I feel it is our duty, as scholars and healthcare 
providers, to challenge these difficult and complex concepts and seek solutions that will 












Appendix 1: Revised WHO Clinical Staging of HIV/AIDS for Adults and 
Adolescents37  
 
PRIMARY HIV INFECTION 
 Asymptomatic  
 Acute retroviral syndrome  
CLINICAL STAGE 1 
 Asymptomatic  
 Persistent-generalized lymphadenopathy 
(PGL) 
CLINICAL STAGE 2 
 Moderate unexplained weight loss (<10% 
of presumed or measured body weight)  
 Recurrent respiratory tract infections 
(RTIs, sinusitis, bronchitis, otitis media, 
pharyngitis) 
 Herpes zoster  
 Angular cheilitis  
 Recurrent oral ulcerations  
CLINICAL STAGE 3 
 Conditions where a presumptive 
diagnosis can be made on the basis of 
clinical signs or simple investigations 
 Severe weight loss (>10% of presumed 
or measured body weight) 
 Unexplained chronic diarrhoea for longer 
than one month 
 Unexplained persistent fever (intermittent 
or constant for longer than one month)  
 Oral candidiasis  
 Oral hairy leukoplakia  
 Pulmonary tuberculosis (TB) diagnosed 
in last two years  
 Severe presumed bacterial infections 
(e.g. pneumonia, empyema, pyomyositis, 
bone or joint infection, meningitis, 
bacteraemia) 
 Acute necrotizing ulcerative stomatitis, 
gingivitis or periodontitis 
 Conditions where confirmatory 
diagnostic testing is necessary 
 Unexplained anaemia (<8 g/dl), and or 
neutropenia (<500/mm3) and or 
thrombocytopenia (<50 000/ mm3) for 
more than one month 
 
CLINICAL STAGE 4 
 Conditions where a presumptive 
diagnosis can be made on the basis of 
clinical signs or simple investigations  
 HIV wasting syndrome  
 Pneumocystis pneumonia  
 Recurrent severe or radiological bacterial 
pneumonia  
 Chronic herpes simplex infection 
(orolabial, genital or anorectal of more 
than one month’s duration) 
 Oesophageal candidiasis  
 Extrapulmonary TB 
 Kaposi’s sarcoma 
 Central nervous system (CNS) 
toxoplasmosis 
 HIV encephalopathy 
 Conditions where confirmatory 
diagnostic testing is necessary: 
 Extrapulmonary cryptococcosis including 
meningitis 
 Disseminated non-tuberculous 
mycobacteria infection  
 Progressive multifocal 
leukoencephalopathy (PML) 
 Candida of trachea, bronchi or lungs 
 Cryptosporidiosis  
 Isosporiasis  
 Visceral herpes simplex infection 
 Cytomegalovirus (CMV) infection 
(retinitis or of an organ other than liver, 
spleen or lymph nodes)  
 Any disseminated mycosis (e.g. 
histoplasmosis, coccidiomycosis, 
penicilliosis)  
 Recurrent non-typhoidal salmonella 
septicaemia  
 Lymphoma (cerebral or B cell non-
Hodgkin) 
 Invasive cervical carcinoma  
 Visceral leishmaniasis 
 
                                                 
37
 WHO Case Definitions of HIV Surveillance and Revised Clinical Staging and Immunological Classification 
of HIV-Related Disease In Adults and Children 
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Appendix 2: Chart Illustrating the Pathway through the Main Hospital to 








Appendix 4: Questionnaire 
 
This questionnaire is about access to HIV-health care services and treatment. Access to care 
refers to the affordability, physical accessibility, acceptability, availability and the 
accommodative ability of the health care system to meet the needs of their clients. Please 
answer all the questions as best as you can. Please remember that your answers are 
anonymous and that there are no right or wrong answers. 
Some questions will ask you to rate the answers according to how easy or difficult you find a 
certain factor. When you are asked to rate questions please select only one option that is most 
relevant for your response.  
The key for the values are as follows: 
Key 
1= this is not a problem for me (No problem) 
2= it can be a problem but I manage (Small problem) 
3= I am neutral about this/ don’t have an opinion (Neutral) 
4= this is a problem for me (Big problem) 
5= this is a big problem that can result in me not coming to the clinic. (Very big problem) 
 
Thank you for participating.    
 
     Questions 
     (Start here) 
1) 1) Male 
2) Female 
 
2) Age: 1) 18-24 
  2) 25-29 
  3) 30-34 
  4) 35-39 
  5) Other: _________________ 
 
3) Education level:  1) Uneducated 
2) Some primary education: ________ 
    3) Primary level (completed) 
    4) Some Secondary: __________ 
    5) Secondary/ High school (completed) 
    6) Current tertiary student: __________ 
    5) Tertiary (completed): _________________ 
    6) Other: __________________ 
 
4) Employment:  1) Unemployed 
    2) Casual (“Piece work”) 
    3) Part-time 
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    4) Full-time 
    5) Self-employed 
    6) Student 
5) Source of income:  1) Unemployed 
2) Social grant 
    3) Own/ employment 
    4) Other: ______________ 
    
6) Means of transport:  1) No transport/ walk 
    2) Public transport 
    3) Private transport –not own 
    4) Own transport 
    5) Other: _____________ 
 
7) Date of first HIV test: _____________  
8) Date first HIV-positive result: _________________ 
9) Date started on antiretroviral treatment: __________________ 
 
10) Regimen:1) TDF + 3TC + EFV TDF = Tenofovir     ABC = Abacavir 
  2) TDF + 3TC + NVP  3TC = Lamivudine   ddi = Didanosine 
  3) D4T + 3TC + EFV/NVP EFV = Efavirenz      Lodiz = 3TC+AZT  
  4) AZT + 3TC + EFV/NVP NVP = Nevirapine   d4t = Stavudine 
  5) TDF + 3TC/FTC + LPV/r AZT = Zidovudine   
  6) AZT + 3TC + LPV/r LPV/r =Lopinavir/Ritonavir   
  7) Other: ____________   
 
 
11) Type of visit today:  1) Just to collect treatment. 
2) To collect treatment and see the doctor. 
3) Other: ______________ 
 
12) Why do you collect treatment at this particular clinic? (you can select more than 
one answer)  
1) It is the closest clinic to my home. 
2) It is close to my work. 
3) It is on my way/route to work. 
4) There is better care and treatment here at this clinic 
5) My local clinic sometimes does not have treatment. 
6) My local clinic does not offer good service 
7) I prefer this clinic because nobody from my community knows me here 
 
13) How far is this clinic from your home? 
1) Very close to my house 
2) Near 
3) Not too far 
4) Far 






14) On average how much time do you spend per visit just to collect your treatment? 
1) 1-2 hrs. 
2) 3-5 hrs. 
3) 6-7 hrs.  
4) Other: ________ 
 
On a scale of 1-5, one, being no problem and five being a very big problem how would 
you rate the following factors’ effect on your ability to access your treatment? 
 
 
       
15) When you are physically ill? 
16) The side effects of the treatment? 
17) The distance between your house and the clinic?  
18) The mode of transport that you use?  
19) Monthly visits to the clinic to collect your 
treatment?  
20) The length of the waiting queue in the clinic?   
21) The operating times of the clinic?   
 
22) On average how much time do you spend per visit to collect treatment and to see 
the doctor? 
1) 1-2 hrs. 
2) 3-5 hrs. 
3) 6-7 hrs.  
4) Other: _________ 
 
23) In your opinion please indicate why it is important for you to take your ARV’s 
every day? 
(You can choose more than one answer) 
 
1) To improve my CD4 count 
2) To decrease my viral load 
3) To prevent me from getting sick 
4) The counsellor/ doctor/ nurse told me to take it 
5) My partner/ spouse want me to take it. 
6) Other: ___________________________ 
 




25) I sometimes cannot collect my treatment on my appointment date because? Please 
select the most appropriate answer to this question (you may choose more than 
one): 
1) I always collect on my date. 
2) I was physically too ill to get to the clinic. 
3) I had to attend another clinic appointment for a co-infection that I have, e.g. TB. 





Neutral Big Problem Very-big 
Problem 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
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5) I had to attend a social engagement. (e.g. a family function, wedding, funeral, 
etc…)  
6) I had no transport. 
7) I had no money to come to the clinic. 
8) I came earlier because my grant money would not last until my appointment date. 
9) I had to work and my employer does not want me to take time off to collect my 
treatment. 
10) I was out-of-town. 
11) I feel much better now and do not see why I should collect this treatment every 
month. 
12) I was scared a relative/ neighbour would see me come to the clinic. 
13) I used too much alcohol and was unable to make it to the clinic. 
14) The church/ traditional healer told me not to come for my visit to collect 
treatment. 
15) I was in prison for a short while. 
16) I did not want to sit in a long waiting queue. 
17) I did not want to come to the clinic because I did not feel like it. 
18) I forgot. 
19) Other: ____________ 
 
26) When you cannot make it for your appointment date to collect your treatment 
what do you do? 
1) I always come on my appointment date. 
2) Come on another day. 
3) Send a relative/ friend to collect treatment. 
4) Use my relative/ neighbour’s treatment until I can come. 
5) Go without treatment until I can come to the clinic. 
6) Other: ____________________________________ 
 
27) When you come on an un-booked day to collect your treatment and you are sent to 
the back of the queue, how do you feel? 
1) I always come on my date so this does not affect me.  
2) I understand why I get sent to the back of the line and I am fine with this. 
3) I do not really care about this. 
4) I feel it is unfair and the clinic should be able to accommodate this. 
5) It makes me very angry so that I feel like not returning to the clinic. 
 




4) Other: _____________ 
 
29) The adherence counselling at every visit is intended to help you remain adherent to 
your treatment. What is your experience with the adherence counselling (please 
select one)? 
1) I enjoy it and it helps with my adherence. 
2) I understand why I have to attend adherence counselling at every visit and do this 
without any complaints. 
3) It has no effect on me or my ability to access my treatment and remain adherent. 
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4) Makes me feel angry and irritable. 
5) It is a time consuming activity without much value and makes me so angry that I 
do not want to return to the clinic.  
 




31) How does it make you feel when you are told that your hospital card cannot be 
found? 
1) My card has never been lost. 
2) I am fine with it as long as they give me a duplicate card. 
3) I feel slightly upset. 
4) I get angry because all my information has been lost and I have to repeat tests.  
5) I get very angry and feel like not returning to the clinic to collect my treatment.  
 
32) How do you find the dispensing of your treatment in this clinic to be? 




5) Very slow and inefficient.  
 
On a scale of 1-5, one, being no problem and five being a very big problem how would 




33) Attitudes and service of the counsellors?  
34) Attitudes and service of the nurses?  
35) Attitudes and service of the pharmacists? 
36) Attitudes and service of the doctors?  
37) The length of the queue for the pharmacy?  
38) The length of the queue for counselling and 
counting your tablets?  
 
39) Why did you get an HIV test the first time?  
1) I was sick  
 2) My partner was sick 
 3) I was pregnant  
 4) My partner wanted me to test 
 5) I wanted to know my status 
 














1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
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41) Do you believe that there are other remedies such as traditional herbs or rituals 


















45) What effect does a treatment supporter have on your ability to access your 
treatment? 
1) My supporter is essential for me to collect my treatment. 
2) I appreciate my supporter but I do not rely on them to help me collect my 
treatment. 
3) I do not have a treatment buddy. 
4) My supporter does not help me. 
5) My supporter judges me and sometimes prevents me from collecting my 
treatment. 
46) How important is anonymity and confidentiality to you in terms of accessing your 
treatment? 
1) I do not mind being seen at the clinic collecting ARV’s. 
2) It does bother me a little to be known and seen at the clinic. 
3) I am neutral about this. 
4) Anonymity is very important to me. 
5) I will not collect my treatment if I know someone from my community there and 
know that my confidentiality will be compromised.  
 
On a scale of 1-5, one, being no problem and five being a very big problem how would 
you rate the following factors’ effect on your ability to access your treatment? 
 
47) How difficult was it for you to disclose your status at 
home  
48) Attitudes of family members towards HIV-positive 
people?  
49) Your own belief about the effectiveness of the 
ARV’s?   











1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
1 2 3 4 5 
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51) How does taking drugs and consuming alcohol affect your ability to access you 
treatment? 
1) It is not a problem for me because I do not take drugs or consume alcohol. 
2) I sometimes drink alcohol but it does not interfere with my treatment. 
3) I drink quite a bit of alcohol and it sometimes makes me forget to take my 
treatment or come for my appointment to collect.  
4) I spend all my money on drugs and alcohol and cannot afford to come to the clinic 
at those times.   
 
52) What is the most expensive thing for you to collect your treatment every month?  
1) Transport 
2) Hospital fees 
3) It costs a day off at work 
4) Other:______________ 
 
53) If you do not have enough money for transport to the clinic what do you do? 
1) I always have enough money. 
2) I walk, so transport money is not a problem for me. 
3) I borrow money from my relative/friends/neighbours. 
4) I do not come to the clinic that month for my appointment. 
Other: _________________________________ 
 
54) How does unemployment affect your ability to collect your treatment? 
1) I am employed/ earn some money. 
2) Not a problem, I have good social support. 
3) It is a small problem but I manage. 
4) This is a big problem because I cannot afford the transport to the clinic every 
month. 
5) It is a catastrophic problem that presents a big challenge for me, resulting in me 
not being able to come to the clinic some months.  
6) Other:________________________________________________ 
 
55) How does being employed create a barrier for you to access your treatment? 
1) It does not affect me, I am unemployed. 
2) It is not a problem being employed and having to collect my treatment. 
3) I have to take a day off work to collect my treatment.  
4) Coming every month to collect my treatment is threatening my job security but I 
can still collect my treatment even without employment so I am not very worried.   
5) Coming every month to collect my treatment is threatening my job security, and 
without my job I cannot afford to come to the clinic to collect my treatment.  
6) Other:____________________________________________________ 
 




57) If yes, in what way does the grant enable you to collect your treatment? 
1) I do not receive a grant. 
2) The money helps with the costs of collecting every month but it is only temporary 
until I am better and can return to work. 
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3) The grant is my main source of income and if it ends I will find it very difficult to 
come to the clinic.  
4) It is my only income. If it ends I will not be able to collect my treatment anymore.  
5) Other:__________________________________________________________ 
  
On a scale of 1-5, one, being no problem and five being a very big problem how would 




58) The costs involved too come to the clinic every 
month?   
59) The costs involved in obtaining hospital service? 
   
60) How do you feel about taking ARV’s for the rest of your life? 
 
1) I am happy and will take it for as long as I have too. 
2) I see the benefit because it has helped me to get better. 
3) My health has improved but the tablets have side-effects and that makes me feel 
sad. 
4) Taking tablets of the rest of my life is going to be difficult, I do not know if I can 
manage it for the rest of my life.  
5) Other: ______________________________________ 
 
61) Have you ever skipped a dose or defaulted on your treatment, even if it was just for 
a day?  
1) Yes 
2) No 
If yes, for how long did you not take your treatment? 
____________________________ 
If yes, please indicate your reason or reasons: 
 
1) I forgot 
2) I ran out of tablets before my next visit. 
3) I was at work and left my treatment at home. 
4) I was on a family/ social outing and left my treatment at home. 
5) I was in prison and did not have my treatment with me. 
6) I was afraid someone from my community will see me drink my tablets. 
7) I have another illness and all the tablets are just too many to take. 
8) I had bad side-effects and felt too ill to take the treatment. 
9) I do not have enough food at home to eat and take my treatment every day. 
10) I do not have clean water at home to take my treatment. 
11) Someone at my church/ traditional healer told me to stop taking my treatment.  














1 2 3 4 5 
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